תרופות הנמצאות בישראל עם שמות המסחריים שלהם ותופעות הלוואי

מספר_תכשיר | שם_באנגלית | שם_בעברית | התוויה | יצרן | כתובת_יצרן | בעל_רישום | כתובת_בעל_רישום | תאריך_תפוגה | תאריך_רישום | צורת_מינון | דרך_מתן | מרכיבים | אריזות | תכשיר_וטרינרי | נרקוטיקה | מרשם | סל_תרופות | קוד_ATC 116-24-23608-00 | KIT FOR TC-99m LABELED MDP | קיט לסימון מ.ד.פ. עם טכנציום 99 אמ. | Bone imaging. | ISOTOPIA MOLECULAR IMAGING LTD., ISRAEL | NAHAL SOREQ, YAVNE 81800, ISRAEL | ISOTOPIA MOLECULAR IMAGING, ISRAEL | 39 ALEXANDER YANEY ST., SGULA PETACH TIKVA 49277, ISRAEL | 31/01/2020 | 17/02/2015 | LYOPHILIZED POWDER FOR INJECTION | I.V | MEDRONIC ACID 7 MG | VIAL GLASS TYPE I 5 VIALS | HUMAN | כן | לא בסל תרופות | A01AA04 - Stannous fluoride 161-77-35102-00 | HEXIDYL MOUTHWASH | הקסידיל שטיפת פה | Antibacterial solution for the disinfection of the mouth:_x000D_ 1) As an aid to maintaining oral hygiene. _x000D_ 2) As an aid in the treatment and prevention of gingivitis. _x000D_ 3) Inhibition of formation of dental plaque. _x000D_ 4) For use in aphtous ulceration and oral candidal infections (e.g., denture stomatitis and thrush). _x000D_ 5) For use in a post- periodontal surgery or treatment regimen to promote gingival healing. | BEN SHIMON FLORIS LTD, ISRAEL | INDUSTRIAL PARK MISGAV , DN MISGAV, 2017400, ISRAEL | BEN SHIMON FLORIS LTD, ISRAEL | INDUSTRIAL PARK MISGAV (TARADION), 2017400, ISRAEL | 30/06/2020 | 11/02/2019 | SOLUTION | LOCAL ORAL | CHLORHEXIDINE DIGLUCONATE 0.2%W/V | BOTTLE PET 300 ML | HUMAN | לא | בסל עם הגבלה | A01AB03 - Chlorhexidine 161-78-35103-00 | HEXIDYL ALCOHOL FREE MOUTHWASH | הקסידיל ללא אלכוהול שטיפת פה | Antibacterial solution for the disinfection of the mouth:_x000D_ 1) As an aid to maintaining oral hygiene. _x000D_ 2) As an aid in the treatment and prevention of gingivitis. _x000D_ 3) Inhibition of formation of dental plaque. _x000D_ 4) For use in aphtous ulceration and oral candidal infections (e.g., denture stomatitis and thrush). _x000D_ 5) For use in a post- periodontal surgery or treatment regimen to promote gingival healing. | BEN SHIMON FLORIS LTD, ISRAEL | INDUSTRIAL PARK MISGAV , DN MISGAV, 2017400, ISRAEL | BEN SHIMON FLORIS LTD, ISRAEL | INDUSTRIAL PARK MISGAV (TARADION), 2017400, ISRAEL | 30/06/2020 | 11/02/2019 | SOLUTION | LOCAL ORAL | CHLORHEXIDINE DIGLUCONATE 0.2%W/V | BOTTLE PET 300 ML | HUMAN | לא | בסל עם הגבלה | A01AB03 - Chlorhexidine 163-01-36040-00 | SOLODENT MOUTHWASH | סולודנט שטיפת פה | Antibacterial solution for the disinfection of the mouth:_x000D_ 1) As an aid to maintaining oral hygiene._x000D_ 2) As an aid in the treatment and prevention of gingivitis. _x000D_ 3) Inhibition of formation of dental plaque. _x000D_ 4) For use in aphtous ulceration and oral candidal infections (e.g., denture stomatitis and thrush). _x000D_ 5) For use in a post- periodontal surgery or treatment regimen to promote gingival healing. | BEN SHIMON FLORIS LTD, ISRAEL | INDUSTRIAL PARK MISGAV , DN MISGAV, 2017400, ISRAEL | BEN SHIMON FLORIS LTD, ISRAEL | INDUSTRIAL PARK MISGAV (TARADION), 2017400, ISRAEL | 30/06/2020 | 03/12/2019 | SOLUTION (ORAL) | LOCAL ORAL | CHLORHEXIDINE DIGLUCONATE 0.2%W/V | BOTTLE HDPE 300 ML | HUMAN | לא | A01AB03 - Chlorhexidine 029-96-21599-00 | CORSODYL MOUTHWASH | קורסודיל שטיפת פה | Antibacterial solution for the disinfection of the mouth._x000D_ 1. As an aid to maintaining oral hygiene._x000D_ 2. As an aid in the treatment and prevention of gingivitis._x000D_ 3. Inhibition of formation of dental plaque._x000D_ 4. For use in aphtous ulceration and oral candidal infections (eg denture stomatitis and thrush)._x000D_ 5. For use in a post- periodontal surgery or treatment regimen to promote gingival healing._x000D_ | PURNA PHARMACEUTICALS, BELGIUM | RIJKSWEG 17, 2870 PUURS, BELGIUM | GSK CONSUMER HEALTHCARE, ISRAEL LTD | P.O.B 3256, PETACH TIKVA, 4951038, ISRAEL | 31/08/2029 | 31/08/2019 | SOLUTION | LOCAL ORAL | CHLORHEXIDINE DIGLUCONATE 0.2 %W/V | BOTTLE PET 300 ML; BOTTLE PET 600 ML | HUMAN | לא | בסל תרופות | A01AB03 - Chlorhexidine 062-94-27005-00 | PERIO-CHIP | פריו-צ'יפ | The Perio- chip is indicated for reduction and/or elimination of pathogenic periodontal pocket microbiota, delaying and/or arresting recolonization of the subgingival microflora, reduction and/or elimination of inflammatory lesions in the periodontal pockets, and as an adjunct to mechanical treatment in Periodontitis. | DEXCEL PHARMA TECHNOLOGIES LTD | 10 HAKIDMA ST., NORTHERN HI-TECH PARK, YOKNEAM, ISRAEL | DEXCEL PHARMA TECHNOLOGIES LTD | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | 29/02/2024 | 28/02/2014 | CHIP | INTRA-PERIODONTAL POCKET | CHLORHEXIDINE GLUCONATE 2.5 MG | BLISTER ALUMINIUM /ALUMINIUM 20 ; BLISTER ALUMINIUM /ALUMINIUM 10 | HUMAN | כן | לא בסל תרופות | A01AB03 - Chlorhexidine 060-32-27698-00 | TARODENT MOUTHWASH | תרודנט שטיפת פה | 1. As an aid to maintaining oral hygiene._x000D_ 2. As an aid in the treatment and prevention of gingivitis._x000D_ 3. Inhibition of formation of dental plaque._x000D_ 4. For use in aphtous ulceration and oral candidal infections (eg denture stomatitis and thrush)._x000D_ 5. For use in a post- periodontal surgery or treatment regimen to promote gingival healing._x000D_ | TARO PHARMACEUTICAL INDUSTRIES LTD | 14 HAKITOR ST., HAIFA BAY 2624761, ISRAEL | TARO PHARMACEUTICAL INDUSTRIES LTD | 14 HAKITOR ST., HAIFA BAY 2624761, ISRAEL | 31/05/2023 | 31/05/2013 | SOLUTION | LOCAL ORAL | CHLORHEXIDINE GLUCONATE 0.2%W/V | BOTTLE POLYETHYLENE 300 ML; BOTTLE POLYETHYLENE 50 ML | HUMAN | בסל תרופות | A01AB03 - Chlorhexidine 161-50-35132-00 | CHLORHEXIDINE LACER MOUTHWASH | כלורהקסידין לאסר שטיפת פה | 1. As an aid to maintaining oral hygiene. _x000D_ 2. As an aid in the treatment and prevention of gingivitis. _x000D_ 3. Inhibition of formation of dental plaque. _x000D_ 4. For use in aphtous ulceration and oral candidal infections (e.g. denture stomatitis and thrush). _x000D_ 5. For use in a post- periodontal surgery or treatment regimen to promote gingival healing. | LACER S.A., SPAIN | BOTERS 5 PARC TECNOLOGIC DEL VALLES, E-08290 CERDANYOLA DEL VALLES, BARCELONA, SPAIN | TARO INTERNATIONAL LTD, ISRAEL | 14 HAKITOR ST., HAIFA BAY 2624761, ISRAEL | 31/12/2023 | 01/01/2019 | SOLUTION (ORAL) | LOCAL ORAL | CHLORHEXIDINE DIGLUCONATE 0.12%W/V | BOTTLE PET 200 ML; BOTTLE PET 500 ML | HUMAN | לא | בסל עם הגבלה | A01AB03 - Chlorhexidine 161-51-35133-00 | CHLORHEXIDINE LACER GEL | כלורהקסידין לאסר ג'ל | 1. As an aid to maintaining oral hygiene._x000D_ 2. As an aid in the treatment and prevention of gingivitis._x000D_ 3. Inhibition of formation of dental plaque. _x000D_ 4. For use in aphtous ulceration and oral candidal infections (eg denture stomatitis and thrush). _x000D_ 5. For use in a post- periodontal surgery or treatment regimen to promote gingival healing. | LACER S.A., SPAIN | BOTERS 5 PARC TECNOLOGIC DEL VALLES, E-08290 CERDANYOLA DEL VALLES, BARCELONA, SPAIN | TARO INTERNATIONAL LTD, ISRAEL | 14 HAKITOR ST., HAIFA BAY 2624761, ISRAEL | 30/11/2023 | 25/12/2018 | OROMUCOSAL GEL | LOCAL ORAL | CHLORHEXIDINE DIGLUCONATE 0.2%W/W | TUBE ALUMINIUM 50 ML | HUMAN | לא | A01AB03 - Chlorhexidine 038-08-20857-00 | DAKTARIN ORAL GEL | דקטרין אורל ג'ל | Oral mycosis (thrush) and fungal infections of the upper gastrointestinal tract. Daktarin oral gel can be used for the prevention of oral thrush in patient receiving long-term treatment with antibiotics, steroids, cytotoxic and radiation therapy. | JANSSEN PHARMACEUTICA N.V.,BELGIUM | TURNHOUTSEWEG 30,B-2340,BEERSE,BELGIUM | J-C HEALTH CARE LTD | KIBBUTZ SHEFAYIM, SHEFAYIM MALL, 6099000 | 30/06/2027 | 30/06/2017 | GEL | LOCAL ORAL | MICONAZOLE 20MG/G | TUBE ALUMINIUM 15 G; TUBE ALUMINIUM 40 G; TUBE ALUMINIUM 80 G | HUMAN | לא | בסל תרופות | A01AB09 - Miconazole 159-13-34540-00 | AGISTEN LOZENGES | אגיסטן לכסניות | For local treatment of oropharyngeal candidiasis._x000D_ Prophylactic treatment to reduce incidence of oropharyngeal candidiasis in patients_x000D_ immunocompromised by:_x000D_ - chemotherapy,_x000D_ - radiotherapy,_x000D_ - steroid therapy in Leukemia,_x000D_ - solid tumors,_x000D_ - renal transplantation._x000D_ | PADDOCK LABORATORIES, LCC (PERRIGO MINNESOTA), USA | 3940 QUEBEC AVENUE NORTH MINNEAPOLIS, MN 55427 , USA | PERRIGO ISRAEL AGENCIES LTD, ISRAEL | 1 RAKEFET ST., SHOHAM, ISRAEL | 31/07/2022 | 09/08/2017 | LOZENGES | PER OS | CLOTRIMAZOLE 10 MG | BOTTLE HDPE 70 TABLETS | HUMAN | בסל עם הגבלה | A01AB18 - Clotrimazole 037-10-22812-00 | ORACORT E | אורוקורט E | Adjunctive treatment and temporary relief of pain and symptoms associated with oral inflammatory and ulcerative lesions._x000D_ | TARO PHARMACEUTICAL INDUSTRIES LTD | 14 HAKITOR ST., HAIFA BAY 2624761, ISRAEL | TARO PHARMACEUTICAL INDUSTRIES LTD | 14 HAKITOR ST., HAIFA BAY 2624761, ISRAEL | 31/05/2024 | 31/05/2014 | PASTE | LOCAL ORAL | LIDOCAINE HYDROCHLORIDE MONOHYDRATE 3G / 100 G ; TRIAMCINOLONE ACETONIDE 0.1G / 100 G | TUBE ALUMINIUM 5 G | HUMAN | לא | בסל תרופות | A01AC01 - Triamcinolone 016-08-24803-21 | ORACORT | אורקורט | Indicated for the adjunctive treatment and the temporary relief of symptoms associated with oral inflammatory and ulcerative lesions. | TARO PHARMACEUTICALS INC., CANADA | 130 EAST DRIVE, BRAMPTON, ONTARIO, CANADA | TARO INTERNATIONAL LTD, ISRAEL | 14 HAKITOR ST., HAIFA BAY 2624761, ISRAEL | 31/05/2020 | 31/05/2010 | PASTE | TOPICAL | TRIAMCINOLONE ACETONIDE 0.1% | TUBE ALUMINIUM 5 G | HUMAN | לא | בסל תרופות | A01AC01 - Triamcinolone 140-35-31801-00 | TANTUM VERDE | טנטום ורדה | Locally acting analgesic and anti-inflammatory treatment for the relief of painful inflammatory conditions of the mouth and throat influding: _x000D_ Traumatic conditions : Pharyngitis following tonsillectomy or the use of a naso-gastric tube ._x000D_ Inflammatory conditions : Pharyngitis, aphthous ulcers and oral ulceration due to radiation therapy. _x000D_ Dentistry : For use after dental operations. | AZIENDA CHIMICHE RIUNITE ANGELINI FRANSESCO A.C.R.A.F SPA, ITALY | VIA VECCHIA DEL PINOCCHINO 22, 60131, ANCONA, ITALY | RAZ PHARMACEUTICS LTD, ISRAEL | BUILDING HA'MATECHET ST. 6, NORTH INDUSTRIAL ZONE 60920 KADIMA, ISRAEL | 31/03/2024 | 31/03/2014 | MOUTHWASH | LOCAL ORAL | BENZYDAMINE HYDROCHLORIDE 0.15 %W/V | BOTTLE GLASS TYPE III 120 ML; BOTTLE GLASS TYPE III 240 ML | HUMAN | לא בסל תרופות | A01AD02 - Benzydamine 107-66-20355-01 | MAALOX PLUS CHEWABLE TABLETS | מאלוקס פלוס טבליות לעיסה | Antacid, antiflatulent, relief of sensation of heartburn. | SANOFI S.P.A., ITALY | STRADA STATALE 17 KM 22, I-67019 SCOPPITO (L'AQUILA), ITALY | SANOFI - AVENTIS ISRAEL LTD | 10 BENI GAON, POB 8090, NETANYA 4250499, ISRAEL | 31/10/2022 | 17/02/2015 | CHEWABLE TABLETS | PER OS | MAGNESIUM HYDROXIDE 200 MG ; DIMETHICONE 25 MG ; ALUMINIUM OXIDE HYDRATED 200 MG | BLISTER PVC/ALUMINIUM 40 TABLETS; BLISTER PVC/ALUMINIUM 50 TABLETS | HUMAN | A02AB10 - Combinations 107-03-22278-00 | TUMS REGULAR STRENGTH PEPPERMINT | טאמס חוזק רגיל בטעם מנטה | Antacid. | GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC, USA | 320 SOUTH BROADWAY, SAINT LOUIS MO 63102, USA | GSK CONSUMER HEALTHCARE, ISRAEL LTD | P.O.B 3256, PETACH TIKVA, 4951038, ISRAEL | 31/01/2022 | 31/01/2012 | CHEWABLE TABLETS | PER OS | CALCIUM CARBONATE 500 MG | BOTTLE POLYPROPYLENE 60 TABLETS; BOTTLE POLYPROPYLENE 75 TABLETS; ROLL PACK 3 x 12 TABLETS | HUMAN | בסל תרופות | A02AC - CALCIUM COMPOUNDS; A12AA04 - Calcium (as carbonate) 124-55-30280-00 | TUMS ULTRA ASSORTED BERRIES | טאמס אולטרה בטעם פירות יער | Antacid. | GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC, USA | 320 SOUTH BROADWAY, SAINT LOUIS MO 63102, USA | GSK CONSUMER HEALTHCARE, ISRAEL LTD | P.O.B 3256, PETACH TIKVA, 4951038, ISRAEL | 31/01/2022 | 31/01/2012 | CHEWABLE TABLETS | PER OS | CALCIUM CARBONATE 1000 MG | BOTTLE POLYPROPYLENE 265 TABLETS; BOTTLE POLYPROPYLENE 160 TABLETS; ROLL PACK 12 TABLETS | HUMAN | בסל תרופות | A02AC - CALCIUM COMPOUNDS; A12AA04 - Calcium (as carbonate) 131-14-30847-00 | TZAREVET X MINT FLAVOUR | צרבת X בטעם מנטה | Antacid, calcium supplement._x000D_ | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | 30/06/2024 | 30/06/2014 | CHEWABLE TABLETS | PER OS | CALCIUM AS CARBONATE 500 MG | BLISTER PVC/ALUMINIUM 2 ; BLISTER PVC/ALUMINIUM 3 ; BLISTER PVC/ALUMINIUM 6 ; BLISTER PVC/ALUMINIUM 12 ; BLISTER PVC/ALUMINIUM 18 ; BLISTER PVC/ALUMINIUM 24 ; BLISTER PVC/ALUMINIUM 36 ; BLISTER PVC/ALUMINIUM 1 | HUMAN | בסל תרופות | A02AC01 - Calcium (as carbonate) 131-17-30850-00 | TZAREVET X MELON FLAVOUR | צרבת X בטעם מלון | Antacid, calcium supplement._x000D_ | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | 30/06/2024 | 30/06/2014 | CHEWABLE TABLETS | PER OS | CALCIUM AS CARBONATE 500 MG | BLISTER PVC/ALUMINIUM 2 TABLETS; BLISTER PVC/ALUMINIUM 3 TABLETS; BLISTER PVC/ALUMINIUM 6 TABLETS; BLISTER PVC/ALUMINIUM 12 TABLETS; BLISTER PVC/ALUMINIUM 18 TABLETS; BLISTER PVC/ALUMINIUM 24 TABLETS; BLISTER PVC/ALUMINIUM 36 TABLETS; BLISTER PVC/ALUMINIUM 1 TABLETS | HUMAN | בסל תרופות | A02AC01 - Calcium (as carbonate) 028-58-21952-00 | FRESCO TABLETS | פרסקו טבליות | Antacid. | REKAH PHARMACEUTICAL PROD.LTD | 30,HAMELACHA ST. HOLON 58851 | REKAH PHARMACEUTICAL INDUSTRY | 30 HAMELACHA ST.HOLON 58859 | 31/12/2022 | 31/12/2012 | CHEWABLE TABLETS | PER OS | CALCIUM CARBONATE 500 MG ; MAGNESIUM CARBONATE 12 MG | BLISTER PVC/ALUMINIUM 40 TABLETS | HUMAN | בסל תרופות | A02AC01 - Calcium (as carbonate) 134-94-31175-00 | TUMS SMOOTHIES EX PEPPERMINT | טאמס EX סמוטיס בטעם מנטה | Antacid. | GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC, USA | 320 SOUTH BROADWAY, SAINT LOUIS MO 63102, USA | GSK CONSUMER HEALTHCARE, ISRAEL LTD | P.O.B 3256, PETACH TIKVA, 4951038, ISRAEL | 31/07/2021 | 31/07/2011 | CHEWABLE TABLETS | PER OS | CALCIUM CARBONATE 750 MG | BOTTLE POLYPROPYLENE 60 TABLETS; BOTTLE POLYPROPYLENE 72 TABLETS | HUMAN | בסל תרופות | A02AC01 - Calcium (as carbonate) 134-49-31378-00 | TUMS EX SUGAR FREE | טאמס EX ללא סוכר | Antacid. | GLAXO SMITH KLINE CONS.HEALTHCARE L.P. | ST.LOUIS, MO 63102, USA | GSK CONSUMER HEALTHCARE, ISRAEL LTD | P.O.B 3256, PETACH TIKVA, 4951038, ISRAEL | 31/05/2021 | 31/05/2011 | CHEWABLE TABLETS | PER OS | CALCIUM CARBONATE 750 MG | BOTTLE POLYPROPYLENE 80 TABLETS | HUMAN | בסל תרופות | A02AC01 - Calcium (as carbonate) 144-16-32043-00 | RENNIE ORANGE | רני בטעם תפוז | Relief of hyperacidity and heartburn. | DELPHARM GAILLARD, FRANCE | 33 RUE DE L'IDUSTRIE, 74240 GAILLARD, FRANCE | BAYER ISRAEL LTD | 36 HACHARASH ST., HOD HASHARON 45240 | 31/07/2025 | 31/07/2015 | CHEWABLE TABLETS | PER OS | CALCIUM CARBONATE 680 MG ; MAGNESIUM CARBONATE 80 MG HEAVY | BLISTER PVC/ALUMINIUM 36 TABLETS | HUMAN | לא | לא בסל תרופות | A02AC10 - Combinations 147-91-33516-00 | RENNIE ICE | רני אייס | Relief of hyperacidity and heartburn. | DELPHARM GAILLARD, FRANCE | 33 RUE DE L'IDUSTRIE, 74240 GAILLARD, FRANCE | BAYER ISRAEL LTD | 36 HACHARASH ST., HOD HASHARON 45240 | 31/03/2027 | 31/03/2017 | CHEWABLE TABLETS | PER OS | CALCIUM CARBONATE 680 MG ; MAGNESIUM CARBONATE 80 MG HEAVY | BLISTER PVC/ALUMINIUM 48 TABLETS | HUMAN | לא | A02AC10 - Combinations 131-13-30853-00 | GAZIM X | גזים X | Antiflatulence._x000D_ | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | 30/06/2024 | 30/06/2014 | TABLETS | PER OS | SIMETHICONE 125 MG | BOTTLE GLASS TYPE III 30 TABLETS | HUMAN | לא בסל תרופות | A02AD - COMBINATIONS OF COMPLEXES OF ALUMINIUM, CALCIUM AND MAGNESIUM COMPOUND; A03AX13 - Silicones 148-79-33834-00 | SIMICOL TABLETS | סימיקול טבליות | Antiflatulence._x000D_ | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | 30/06/2024 | 30/06/2014 | TABLETS | PER OS | SIMETHICONE 125 MG | BLISTER PVC/PE/PVDC/AL 30 TABLETS; BLISTER PVC/PE/PVDC/AL 20 TABLETS | HUMAN | לא בסל תרופות | A02AD - COMBINATIONS OF COMPLEXES OF ALUMINIUM, CALCIUM AND MAGNESIUM COMPOUND; A03AX13 - Silicones 048-59-24105-00 | MAALOX SUSPENSION | מאלוקס תרחיף | Antacid. | A.NATTERMANN & CIE GMBH, GERMANY | NATTERMANNALLEE 1, 50829 COLOGNE, GERMANY | SANOFI - AVENTIS ISRAEL LTD | 10 BENI GAON, POB 8090, NETANYA 4250499, ISRAEL | 31/05/2020 | 31/05/2010 | SUSPENSION | PER OS | ALUMINIUM HYDROXIDE 175 MG / 5 ML ; MAGNESIUM HYDROXIDE 200 MG / 5 ML | BOTTLE PET 250 ML; BOTTLE PET 355 ML | HUMAN | בסל תרופות | A02AD01 - Ordinary salt combinations 048-59-24105-01 | MAALOX SUSPENSION | מאלוקס תרחיף | Antacid. | SANOFI S.P.A., ITALY | VIALE EUROPA 11 I-21040 ORRIGIO, ITALY | SANOFI - AVENTIS ISRAEL LTD | 10 BENI GAON, POB 8090, NETANYA 4250499, ISRAEL | 31/05/2020 | 31/05/2010 | SUSPENSION | PER OS | ALUMINIUM HYDROXIDE 175 MG / 5 ML ; MAGNESIUM HYDROXIDE 200 MG / 5 ML | BOTTLE PET 250 ML; BOTTLE PET 355 ML | HUMAN | בסל תרופות | A02AD01 - Ordinary salt combinations 107-65-20354-00 | MAALOX PLUS SUSPENSION | מאלוקס פלוס תרחיף | Antacid, antiflatulent, relief of sensation of heatburn. | A.NATTERMANN & CIE GMBH, GERMANY | NATTERMANNALLEE 1, 50829 COLOGNE, GERMANY | SANOFI - AVENTIS ISRAEL LTD | 10 BENI GAON, POB 8090, NETANYA 4250499, ISRAEL | 31/10/2022 | 31/10/2012 | SUSPENSION | PER OS | ALUMINIUM HYDROXIDE 175 MG / 5 ML ; MAGNESIUM HYDROXIDE 200 MG / 5 ML; SIMETHICONE 25 MG / 5 ML | BOTTLE PET 355 ML | HUMAN | A02AF - ANTACIDS WITH ANTIFLATULENTS; A02AF02 - Ordinary salt combinations and antiflatulents 107-65-20354-01 | MAALOX PLUS SUSPENSION | מאלוקס פלוס תרחיף | Antacid, antiflatulent, relief of sensation of heatburn. | SANOFI S.P.A., ITALY | VIALE EUROPA 11 I-21040 ORRIGIO, ITALY | SANOFI - AVENTIS ISRAEL LTD | 10 BENI GAON, POB 8090, NETANYA 4250499, ISRAEL | 31/10/2022 | 31/10/2012 | SUSPENSION | PER OS | ALUMINIUM HYDROXIDE 175 MG / 5 ML ; MAGNESIUM HYDROXIDE 200 MG / 5 ML; SIMETHICONE 25 MG / 5 ML | BOTTLE PET 355 ML | HUMAN | A02AF - ANTACIDS WITH ANTIFLATULENTS; A02AF02 - Ordinary salt combinations and antiflatulents 109-28-29272-00 | ZARIDEX 150 | זרידקס 150 | Adults:_x000D_ ZARIDEX is indicated for the treatment of duodenal ulcer and benign gastric ulcer, including that associated with non-steroidal anti-inflammatory agents. Zaridex is also indicated for the treatment of post-operative ulcer, Zollinger-Ellison Syndrome and oesophageal reflux disease including long term management of healed oesophagitis. _x000D_ ZARIDEX is indicated for the following conditions where reduction of gastric secretion and acid output is desirable; the prophylaxis of gastro-intestinal haemorrhage from stress ulceration in seriously ill patients and before general anaesthesia in patients considered to be at risk of acid aspiration (Mendelson's Syndrome), particularly obstetric patients during labour. _x000D_ Children (6 to 18 years):_x000D_ Short term treatment of peptic ulcer. Treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptomatic relief of gastro-oesophageal reflux disease._x000D_ | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | 31/01/2023 | 31/01/2013 | TABLETS | PER OS | RANITIDINE AS HYDROCHLORIDE 150 MG | BLISTER ALUMINIUM /ALUMINIUM 10 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 20 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 100 TABLETS | HUMAN | כן | בסל תרופות | A02BA02 - Ranitidine 109-45-29273-00 | ZARIDEX 300 | זרידקס 300 | Adults:_x000D_ Zaridex is indicated for the treatment of duodenal ulcer and benign gastric ulcer, including that associated with non-steroidal anti-inflammatory agents. Zaridex is also indicated for the treatment of post-operative ulcer, Zollinger-Ellison Syndrome and oesophageal reflux disease including long term management of healed oesophagitis. _x000D_ Zaridex is indicated for the following conditions where reduction of gastric secretion and acid output is desirable; the prophylaxis of gastro-intestinal haemorrhage from stress ulceration in seriously ill patients and before general anaesthesia in patients considered to be at risk of acid aspiration (Mendelson's Syndrome), particularly obstetric patients during labour. _x000D_ Children (6 to 18 years):_x000D_ Short term treatment of peptic ulcer. Treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptomatic relief of gastro-oesophageal reflux disease._x000D_ | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | 31/01/2023 | 31/01/2013 | CAPLETS | PER OS | RANITIDINE AS HYDROCHLORIDE 300 MG | BLISTER ALUMINIUM /ALUMINIUM 10 CAPLETS; BLISTER ALUMINIUM /ALUMINIUM 20 CAPLETS; BLISTER ALUMINIUM /ALUMINIUM 30 CAPLETS; BLISTER ALUMINIUM /ALUMINIUM 100 CAPLETS | HUMAN | כן | בסל תרופות | A02BA02 - Ranitidine 022-96-24982-05 | ZANTAC INJECTION 25 MG/ML | זנטק זריקות 25 מ"ג/מ"ל | Adults:_x000D_ Zantac Injection is indicated for the treatment of duodenal ulcer, benign gastric ulcer, post - operative ulcer, reflux oesophagitis, Zollinger - Ellison Syndrome and the following conditions where reduction of gastric secretion and acid output is desirable._x000D_ _x000D_ The prophylaxis of gastrointestinal haemorrhage from stress ulceration in seriously ill patients and before general anaesthesia in patients considered to be at risk of acid aspiration (Mendelson’s Syndrome), particularly obstetric patients during labour. _x000D_ _x000D_ Children (6 months to 18 years):_x000D_ Zantac Injection is indicated for the short term treatment of peptic ulcer and the treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptomatic relief of gastro-oesophageal reflux disease. _x000D_ | GLAXO SMITHKLINE MANUFACTURING S.P.A., ITALY | SAN POLO DI TORRILE, 43056, PARMA, ITALY | GLAXO SMITH KLINE (ISRAEL) LTD | 25 BASEL ST., PETACH TIKVA 4900202, ISRAEL | 28/02/2023 | 28/02/2013 | SOLUTION FOR INJECTION | I.M; I.V | RANITIDINE AS HYDROCHLORIDE 25MG/ML | AMPOULES GLASS TYPE I 5 x 2 ML | HUMAN | כן | בסל עם הגבלה | A02BA02 - Ranitidine 061-99-27406-05 | ZANTAC SYRUP | זנטק סירופ | Adults:_x000D_ Zantac syrup is indicated for the treatment of duodenal ulcer and benign gastric ulcer, including that associated with non-steroidal anti-inflammatory agents. _x000D_ Zantac syrup is also indicated for the treatment of post-operative ulcer, Zollinger-Ellison Syndrome and oesophageal reflux disease including long term management of healed oesophagitis. _x000D_ Zantac syrup is indicated for the following conditions where reduction of gastric secretion and acid output is desirable; the prophylaxis of gastro-intestinal haemorrhage from stress ulceration in seriously ill patients and before general anaesthesia in patients considered to be at risk of acid aspiration (Mendelson's Syndrome), particularly obstetric patients during labour. _x000D_ Children (3 to 18 years):_x000D_ Short term treatment of peptic ulcer. _x000D_ Treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptomatic relief of gastro-oesophageal reflux disease._x000D_ | ASPEN BAD OLDESLOE GMBH, GERMANY | INDUSTRIESTRASSE 32 -36 , D - 23843 BAD OLDESLOE, GERMANY | GLAXO SMITH KLINE (ISRAEL) LTD | 25 BASEL ST., PETACH TIKVA 4900202, ISRAEL | 31/03/2023 | 31/03/2013 | SYRUP | PER OS | RANITIDINE AS HYDROCHLORIDE 150 MG / 10 ML | BOTTLE GLASS TYPE III 300 ML | HUMAN | כן | בסל עם הגבלה | A02BA02 - Ranitidine 043-39-25171-01 | GASTRO 40 | גאסטרו 40 | Treatment of gastric and duodenal ulcers, zollinger-ellison syndrome and oesophageal reflux disease. | TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL | KIBBUTZ MAABAROT 4023000, ISRAEL | UNIPHARM LTD, ISRAEL | POB 21429, TEL-AVIV 61213, ISRAEL | 31/01/2026 | 31/01/2016 | TABLETS | PER OS | FAMOTIDINE 40 MG | BLISTER PVC/ALUMINIUM 30 TABLETS; BLISTER PVC/ALUMINIUM 50 TABLETS; BLISTER PVC/ALUMINIUM 100 TABLETS; BLISTER PVC/ALUMINIUM 1000 TABLETS; BLISTER PVC/ALUMINIUM 20 TABLETS | HUMAN | כן | בסל תרופות | A02BA03 - Famotidine 043-39-25171-03 | GASTRO 40 | גאסטרו 40 | Treatment of gastric and duodenal ulcers, zollinger-ellison syndrome and oesophageal reflux disease. | UNIPHARM LTD, ISRAEL | "MAVO CARMEL" INDUSTRIAL PARK, ISRAEL | UNIPHARM LTD, ISRAEL | POB 21429, TEL-AVIV 61213, ISRAEL | 31/01/2026 | 26/05/2019 | TABLETS | PER OS | FAMOTIDINE 40 MG | BLISTER PVC/ALUMINIUM 30 TABLETS; BLISTER PVC/ALUMINIUM 50 TABLETS; BLISTER PVC/ALUMINIUM 100 TABLETS; BLISTER PVC/ALUMINIUM 1000 TABLETS; BLISTER PVC/ALUMINIUM 20 TABLETS | HUMAN | כן | בסל תרופות | A02BA03 - Famotidine 043-40-26198-01 | GASTRO 20 | גאסטרו 20 | For the treatment and prevention of heart burn and hyperacidity in the upper gastrointestinal tract. | TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL | KIBBUTZ MAABAROT 4023000, ISRAEL | UNIPHARM LTD, ISRAEL | POB 21429, TEL-AVIV 61213, ISRAEL | 31/01/2026 | 31/01/2016 | TABLETS | PER OS | FAMOTIDINE 20 MG | BLISTER PVC/ALUMINIUM 30 TABLETS; BLISTER PVC/ALUMINIUM 50 TABLETS; BLISTER PVC/ALUMINIUM 100 TABLETS; BLISTER PVC/ALUMINIUM 1000 TABLETS; BLISTER PVC/ALUMINIUM 20 TABLETS | HUMAN | לא | בסל תרופות | A02BA03 - Famotidine 043-40-26198-02 | GASTRO 20 | גאסטרו 20 | For the treatment and prevention of heart burn and hyperacidity in the upper gastrointestinal tract. | UNIPHARM LTD, ISRAEL | "MAVO CARMEL" INDUSTRIAL PARK, ISRAEL | UNIPHARM LTD, ISRAEL | POB 21429, TEL-AVIV 61213, ISRAEL | 31/01/2026 | 04/11/2019 | TABLETS | PER OS | FAMOTIDINE 20 MG | BLISTER PVC/ALUMINIUM 30 TABLETS; BLISTER PVC/ALUMINIUM 50 TABLETS; BLISTER PVC/ALUMINIUM 100 TABLETS; BLISTER PVC/ALUMINIUM 1000 TABLETS; BLISTER PVC/ALUMINIUM 20 TABLETS | HUMAN | לא | בסל תרופות | A02BA03 - Famotidine 107-36-28578-00 | GASTRO 10 | גאסטרו 10 | For the treatment and prevention of heartburn and hyperacidity in the upper gastrointestinal tract. | TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD, ISRAEL | KIBBUTZ MAABAROT 4023000, ISRAEL | UNIPHARM LTD, ISRAEL | POB 21429, TEL-AVIV 61213, ISRAEL | 31/10/2022 | 31/10/2012 | TABLETS | PER OS | FAMOTIDINE 10 MG | BLISTER PVC/ALUMINIUM 2 TABLETS; BLISTER PVC/ALUMINIUM 4 TABLETS; BLISTER PVC/ALUMINIUM 6 TABLETS; BLISTER PVC/ALUMINIUM 8 TABLETS; BLISTER PVC/ALUMINIUM 10 TABLETS; BLISTER PVC/ALUMINIUM 20 TABLETS; BLISTER PVC/ALUMINIUM 30 TABLETS | HUMAN | בסל תרופות | A02BA03 - Famotidine 106-78-28760-00 | FAMO 40 | פאמו 40 | Treatment of duodenal ulcer. _x000D_ Prevention of relapses of duodenal ulceration. _x000D_ Treatment of benign gastric ulcer. _x000D_ Pathological hypersecretory conditions such as zollinger-syndrome._x000D_ Gastroesophageal reflux disease. | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | 31/07/2022 | 31/07/2012 | TABLETS | PER OS | FAMOTIDINE 40 MG | BLISTER 10 ; BLISTER 30 | HUMAN | כן | בסל תרופות | A02BA03 - Famotidine 111-66-29371-11 | FAMOTIDINE TEVA ® 20 MG | פמוטידין טבע ® 20 מ"ג | Treatment and prevention of heartburn and hyperacidity in the upper gastrointestinal tract. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 30/06/2023 | 30/06/2013 | TABLETS | PER OS | FAMOTIDINE 20 MG | BLISTER PVC/ALUMINIUM 20 TABLETS; BLISTER PVC/ALUMINIUM 30 TABLETS | HUMAN | בסל תרופות | A02BA03 - Famotidine 111-66-29371-12 | FAMOTIDINE TEVA ® 20 MG | פמוטידין טבע ® 20 מ"ג | Treatment and prevention of heartburn and hyperacidity in the upper gastrointestinal tract. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 30/06/2023 | 05/01/2014 | TABLETS | PER OS | FAMOTIDINE 20 MG | BLISTER PVC/ALUMINIUM 20 TABLETS; BLISTER PVC/ALUMINIUM 30 TABLETS | HUMAN | בסל תרופות | A02BA03 - Famotidine 111-66-29371-13 | FAMOTIDINE TEVA ® 20 MG | פמוטידין טבע ® 20 מ"ג | Treatment and prevention of heartburn and hyperacidity in the upper gastrointestinal tract. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 30/06/2023 | 11/12/2014 | TABLETS | PER OS | FAMOTIDINE 20 MG | BLISTER PVC/ALUMINIUM 20 TABLETS; BLISTER PVC/ALUMINIUM 30 TABLETS | HUMAN | בסל תרופות | A02BA03 - Famotidine 111-67-29372-11 | FAMOTIDINE TEVA ® 40 MG | פמוטידין טבע ® 40 מ"ג | Treatment of Duodenal Ulcer, Benign Gastric Ulcer, Pathological hypersecretory conditions such as Zollinger-ellison syndrome, Gastroesophageal reflux disease. _x000D_ Prevention of relapses of duodenal ulceration. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 30/06/2023 | 30/06/2013 | TABLETS | PER OS | FAMOTIDINE 40 MG | BLISTER PVC/ALUMINIUM 20 TABLETS; BLISTER PVC/ALUMINIUM 30 TABLETS | HUMAN | כן | בסל תרופות | A02BA03 - Famotidine 111-67-29372-12 | FAMOTIDINE TEVA ® 40 MG | פמוטידין טבע ® 40 מ"ג | Treatment of Duodenal Ulcer, Benign Gastric Ulcer, Pathological hypersecretory conditions such as Zollinger-ellison syndrome, Gastroesophageal reflux disease. _x000D_ Prevention of relapses of duodenal ulceration. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 30/06/2023 | 05/01/2014 | TABLETS | PER OS | FAMOTIDINE 40 MG | BLISTER PVC/ALUMINIUM 20 TABLETS; BLISTER PVC/ALUMINIUM 30 TABLETS | HUMAN | כן | בסל תרופות | A02BA03 - Famotidine 111-67-29372-13 | FAMOTIDINE TEVA ® 40 MG | פמוטידין טבע ® 40 מ"ג | Treatment of Duodenal Ulcer, Benign Gastric Ulcer, Pathological hypersecretory conditions such as Zollinger-ellison syndrome, Gastroesophageal reflux disease. _x000D_ Prevention of relapses of duodenal ulceration. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 30/06/2023 | 11/12/2014 | TABLETS | PER OS | FAMOTIDINE 40 MG | BLISTER PVC/ALUMINIUM 20 TABLETS; BLISTER PVC/ALUMINIUM 30 TABLETS | HUMAN | כן | בסל תרופות | A02BA03 - Famotidine 106-77-28759-00 | FAMO 20 | פאמו 20 | Treatment of duodenal ulcer. Prevention of relapses of duodenal ulceration. Treatment of benign gastric ulcer. Pathological hypersecretory conditions such as zollinger-syndrome. Gastroesophageal reflux disease. | CTS CHEMICAL INDUSTRIES LTD | POB 385, KIRYAT-MALACHI | CTS CHEMICAL INDUSTRIES LTD | POB 385,KIRYAT-MALACHI,ISRAEL | 31/07/2022 | 31/07/2012 | TABLETS | PER OS | FAMOTIDINE 20 MG | BLISTER 10 ; BLISTER 30 | HUMAN | כן | בסל תרופות | A02BA03 - Famotidine 037-78-25161-00 | CYTOTEC 200 MCG TABLETS | צייטוטק 200 מק"ג טבליות | For the treatment of duodenal and gastric ulcer._x000D_ Treatment and prevention NSAID induced ulcers lesions, erosions, while NSAID therapy continues._x000D_ Use in conjunction with Mifepristone subject to the approval of a committee for the termination of pregnancy according to the Israeli penal law 1977._x000D_ First-trimester pregnancy failure: _x000D_ Use is intended for emptying the uterus in states of first trimester pregnancy failure, including: presentation of a pregnancy sac in the uterus with no fetal echo, missed abortion (until week 11+6 and a fetus 40 mm in length) or incomplete abortion. The preparation is to be used after location of the sac in the uterus has been proved and the diagnosis of pregnancy failure is certain. The preparation can be used for this purpose in an ambulatory setting. The dosage and route of administration will be similar to the use of Cytotec in pregnancy termination after using Mifegyne. Informed consent and medical surveillance are required._x000D_ Softening and dilation of the cervix for performing intrauterine procedures, such as: curettage, hysteroscopy, IUD insertion and others, according to clinical judgment. The preparation can be used for this purpose in an ambulatory setting. The route of administration (vaginal, sublingual, buccal, oral or rectal) and the dosage are according to the decision of the attending doctor._x000D_ _x000D_ | PIRAMAL HEALTHCARE UK LIMITED | WHALTON ROAD MORPETH,NORTHUMBERLAND NE61 3Y | PFIZER PFE PHARMACEUTICALS ISRAEL LTD | 9 SHENKAR STREET, 46725 HERZLIYA PITUACH, ISRAEL | 30/11/2023 | 30/11/2013 | TABLETS | PER OS; RECTAL; BUCCAL; SUBLINGUAL; VAGINAL | MISOPROSTOL 200 MCG | BLISTER ALUMINIUM LAMINATE 20 TABLETS; BLISTER ALUMINIUM LAMINATE 28 TABLETS | HUMAN | כן | A02BB01 - Misoprostol (טלפון נייד הושמט)-00 | LOSEC 20 MG RX | לוסק 20 מ"ג RX | Acute duodenal ulcer. _x000D_ Acute gastric ulcer. _x000D_ Helicobacter pylori-associated peptic ulcer disease in combination with antibiotics. _x000D_ Reflux esophagitis:_x000D_ - Treatment ; _x000D_ - Long-term management; _x000D_ - Maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. _x000D_ Treatment of severe reflux oesophagitis in children from one year of age and older. _x000D_ - Maintenance treatment for the prevention of relapse in patients with poorly responsive peptic ulcer. _x000D_ - Zollinger-ellison syndrome. _x000D_ - Treatment and prevention of NSAID - associated duodenal and gastric ulcers or erosions in high risk patients. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | ABIC LTD. | IND. ZONE, KIRYAT NORDAU,POB 8077,NATHANYA | 31/05/2020 | 31/05/2010 | CAPSULES | PER OS | OMEPRAZOLE 20 MG | BOTTLE HDPE 4 CAPSULES; BOTTLE HDPE 7 CAPSULES; BOTTLE HDPE 14 CAPSULES; BOTTLE HDPE 28 CAPSULES; BOTTLE HDPE 30 CAPSULES; BOTTLE HDPE 2 CAPSULES | HUMAN | כן | בסל עם הגבלה | A02BC01 - Omeprazole (טלפון נייד הושמט)-01 | LOSEC 20MG RX | לוסק RX 20MG | Acute duodenal ulcer. _x000D_ Acute gastric ulcer. _x000D_ Helicobacter pylori-associated peptic ulcer disease in combination with antibiotics. _x000D_ Reflux esophagitis:_x000D_ - Treatment ; _x000D_ - Long-term management; _x000D_ - Maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. _x000D_ Treatment of severe reflux oesophagitis in children from one year of age and older. _x000D_ - Maintenance treatment for the prevention of relapse in patients with poorly responsive peptic ulcer. _x000D_ - Zollinger-ellison syndrome. _x000D_ - Treatment and prevention of NSAID - associated duodenal and gastric ulcers or erosions in high risk patients. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | ABIC LTD. | IND. ZONE, KIRYAT NORDAU,POB 8077,NATHANYA | 31/05/2020 | 04/01/2015 | CAPSULES | PER OS | OMEPRAZOLE 20 MG | BOTTLE HDPE 4 CAPSULES; BOTTLE HDPE 7 CAPSULES; BOTTLE HDPE 14 CAPSULES; BOTTLE HDPE 28 CAPSULES; BOTTLE HDPE 30 CAPSULES; BOTTLE HDPE 2 CAPSULES | HUMAN | כן | בסל עם הגבלה | A02BC01 - Omeprazole 120-19-30048-00 | OMEPRADEX CAPLETS 20 MG | אומפרדקס קפליות 20 מ"ג | Acute duodenal ulcer. _x000D_ Acute gastric ulcer. _x000D_ Reflux esophagitis: treatment , long - term management. _x000D_ Maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. _x000D_ Maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. _x000D_ Zollinger-Ellison Syndrome. _x000D_ Treatment and prevention of NSAID-associated duodenal and gastric ulcers or erosions in high risk patients. _x000D_ Treatment of severe reflux oesophagitis in children overthe age of 6 year. Helicobacter pylori - associated peptic ulcer disease in combination with antibiotics. | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | 31/10/2020 | 31/10/2010 | CAPLETS | PER OS | OMEPRAZOLE 20 MG | BLISTER ALUMINIUM /ALUMINIUM 14 CAPLETS; BLISTER ALUMINIUM /ALUMINIUM 20 CAPLETS; BLISTER ALUMINIUM /ALUMINIUM 28 CAPLETS; BLISTER ALUMINIUM /ALUMINIUM 30 CAPLETS; BLISTER ALUMINIUM /ALUMINIUM 10 CAPLETS; BLISTER OPA/ALU/PE 10 CAPLETS; BLISTER OPA/ALU/PE 14 CAPLETS; BLISTER OPA/ALU/PE 20 CAPLETS; BLISTER OPA/ALU/PE 28 CAPLETS; BLISTER OPA/ALU/PE 30 CAPLETS | HUMAN | כן | בסל עם הגבלה | A02BC01 - Omeprazole 123-66-30228-00 | OMEPRADEX CAPLETS 10 MG | אומפרדקס קפליות 10 מ"ג | Acute duodenal ulcer. _x000D_ Acute gastric ulcer. _x000D_ Reflux esophagitis: treatment , long - term management. _x000D_ Maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. _x000D_ Maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. _x000D_ Zollinger-Ellison Syndrome. _x000D_ Treatment and prevention of NSAID-associated duodenal and gastric ulcers or erosions in high risk patients. _x000D_ Treatment of severe reflux oesophagitis in children overthe age of 6 year. _x000D_ Helicobacter pylori - associated peptic ulcer disease in combination with antibiotics. | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | 31/10/2020 | 31/10/2011 | CAPLETS | PER OS | OMEPRAZOLE 10 MG | BLISTER ALUMINIUM /ALUMINIUM 10 CAPLETS; BLISTER ALUMINIUM /ALUMINIUM 14 CAPLETS; BLISTER ALUMINIUM /ALUMINIUM 20 CAPLETS; BLISTER ALUMINIUM /ALUMINIUM 28 CAPLETS; BLISTER ALUMINIUM /ALUMINIUM 30 CAPLETS | HUMAN | כן | בסל עם הגבלה | A02BC01 - Omeprazole 123-65-30268-00 | OMEPRADEX CAPLETS 40 MG | אומפרדקס קפליות 40 מ"ג | Acute duodenal ulcer. _x000D_ Acute gastric ulcer. _x000D_ Reflux esophagitis: treatment , long - term management. _x000D_ Maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. _x000D_ Maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. _x000D_ Zollinger-Ellison Syndrome. _x000D_ Treatment and prevention of NSAID-associated duodenal and gastric ulcers or erosions in high risk patients. _x000D_ Treatment of severe reflux oesophagitis in children overthe age of 6 year._x000D_ Helicobacter pylori - associated peptic ulcer disease in combination with antibiotics. | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | 31/10/2020 | 31/10/2011 | CAPLETS | PER OS | OMEPRAZOLE 40 MG | BLISTER ALUMINIUM /ALUMINIUM 7 CAPLETS; BLISTER ALUMINIUM /ALUMINIUM 10 CAPLETS; BLISTER ALUMINIUM /ALUMINIUM 14 CAPLETS; BLISTER ALUMINIUM /ALUMINIUM 20 CAPLETS; BLISTER ALUMINIUM /ALUMINIUM 28 CAPLETS; BLISTER ALUMINIUM /ALUMINIUM 30 CAPLETS | HUMAN | כן | בסל עם הגבלה | A02BC01 - Omeprazole 131-25-30841-00 | OMEPRADEX - Z | אומפרדקס - Z | Relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over._x000D_ | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | 31/10/2020 | 31/05/2014 | CAPLETS | PER OS | OMEPRAZOLE 20 MG | BLISTER ALUMINIUM /ALUMINIUM 7 CAPLETS; BLISTER ALUMINIUM /ALUMINIUM 14 CAPLETS; BLISTER ALUMINIUM /ALUMINIUM 28 CAPLETS; BLISTER OPA/ALU/PE 7 CAPLETS; BLISTER OPA/ALU/PE 14 CAPLETS; BLISTER OPA/ALU/PE 28 CAPLETS | HUMAN | לא | בסל עם הגבלה | A02BC01 - Omeprazole 139-78-31879-00 | LOSEC 20MG | לוסק 20MG | Relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | ABIC LTD. | IND. ZONE, KIRYAT NORDAU,POB 8077,NATHANYA | 30/11/2023 | 30/11/2013 | CAPSULES | PER OS | OMEPRAZOLE 20 MG | BOTTLE HDPE 2 CAPSULES; BOTTLE HDPE 4 CAPSULES; BOTTLE HDPE 7 CAPSULES; BOTTLE HDPE 14 CAPSULES; BOTTLE HDPE 28 CAPSULES; BOTTLE HDPE 30 CAPSULES | HUMAN | לא בסל תרופות | A02BC01 - Omeprazole 139-78-31879-01 | LOSEC 20MG | לוסק 20MG | Relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 30/11/2023 | 03/12/2013 | CAPSULES | PER OS | OMEPRAZOLE 20 MG | BOTTLE HDPE 2 CAPSULES; BOTTLE HDPE 4 CAPSULES; BOTTLE HDPE 7 CAPSULES; BOTTLE HDPE 14 CAPSULES; BOTTLE HDPE 28 CAPSULES; BOTTLE HDPE 30 CAPSULES | HUMAN | לא בסל תרופות | A02BC01 - Omeprazole 136-80-31320-00 | OMEPRA 20 | אומפרה 20 | Acute duodenal ulcer, _x000D_ Acute gastric ulcer, _x000D_ Helicobacter pylori associated peptic ulcer disease in combination with antibiotics. _x000D_ Reflux esophagitis: Treatment long-term management, _x000D_ Maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. _x000D_ Treatment of severe reflux esophagitis in children from one year of age and older. _x000D_ Maintenance treatment for the prevention of relapse in patients with poorly responsive peptic ulcer. Zollinger-Ellison Syndrome. Treatment and prevention of NSAID-associated duodenal and gastric ulcer or erosions in high risk patients. | LABORATORIOS LICONSA S.A., SPAIN | AVDA MIRALCAMPO 7, POLIGONO INDUSTRIAL MIRALCAMPO, 19200 AZUQUECA DE HENARES ( GUADALAJARA), SPAIN | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/06/2022 | 30/06/2012 | CAPSULES | PER OS | OMEPRAZOLE 20 MG | BLISTER 28 CAPSULES; BLISTER 14 CAPSULES; BLISTER 14 CAPSULES | HUMAN | כן | בסל עם הגבלה | A02BC01 - Omeprazole 136-81-31380-00 | OMEPRA 40 | אומפרה 40 | Acute duodenal ulcer,_x000D_ Acute gastric ulcer, _x000D_ Helicobacter pylori associated peptic ulcer disease in combination with antibiotics._x000D_ Reflux esophagitis: Treatment long-term management, _x000D_ Maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. _x000D_ Treatment of severe reflux esophagitis in children from one year of age and older. _x000D_ Maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. _x000D_ Zollinger-Ellison Syndrome. Treatment and prevention of NSAID-associated duodenal and gastric ulcer or erosions in high risk patients. | LABORATORIOS LICONSA S.A., SPAIN | AVDA MIRALCAMPO 7, POLIGONO INDUSTRIAL MIRALCAMPO, 19200 AZUQUECA DE HENARES ( GUADALAJARA), SPAIN | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/06/2022 | 30/06/2012 | CAPSULES | PER OS | OMEPRAZOLE 40 MG | BLISTER 28 CAPSULES | HUMAN | כן | בסל עם הגבלה | A02BC01 - Omeprazole 144-43-33268-00 | OMEPRIX | אומפריקס | Relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over. | LABORATORIOS LICONSA S.A., SPAIN | AVDA MIRALCAMPO 7, POLIGONO INDUSTRIAL MIRALCAMPO, 19200 AZUQUECA DE HENARES ( GUADALAJARA), SPAIN | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/06/2022 | 30/06/2012 | CAPSULES | PER OS | OMEPRAZOLE 20 MG | BLISTER ALUMINIUM /ALUMINIUM 28 CAPSULES; BLISTER ALUMINIUM /ALUMINIUM 14 CAPSULES | HUMAN | בסל עם הגבלה | A02BC01 - Omeprazole 104-40-28684-00 | CONTROLOC 40 | קונטרולוק 40 | Short term treatment of acute duodenal ulcer. _x000D_ Acute gastric ulcer._x000D_ Moderate and severe reflux oesophagitis._x000D_ Eradication of the Helicobacter pylori in combination with clarithromycin and amoxycillin or clarithromycin and metronidazole/tinidazole or amoxycillin and metronidazole/tinidazole in cases of duodenal ulcer and gastric ulcer with the objective of reducing the recurrence of duodenal and gastric ulcers caused by this microorganism._x000D_ Zollinger-Ellison-Syndrome._x000D_ | TAKEDA GMBH, GERMANY | LEHNITZSTRASSE 70 - 98, D - 16515, ORANIENBURG, GERMANY | TAKEDA ISRAEL LTD | 25 EFAL ST., POB 4140, PETACH - TIKVA 4951125, ISRAEL | 31/01/2022 | 31/01/2012 | TABLETS | PER OS | PANTOPRAZOLE 40 MG | BLISTER ALUMINIUM /ALUMINIUM 5 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 14 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 28 TABLETS | HUMAN | כן | לא בסל תרופות | A02BC02 - Pantoprazole 116-36-29745-00 | CONTROLOC 20 MG | קונטרולוק 20 מ"ג | For the treatment of reflux oesophagitis and associated symptoms (e.g. heartburn, acid regurgitation, pain on swallowing)._x000D_ For long-term management and prevention of relapse in reflux oesophagitis._x000D_ Prevention of gastroduodenal ulcers induced by non-selective non-steroidal anti-inflammatory drugs (NSAIDs) in patients at risk with a need for continuous NSAIDs treatment._x000D_ | TAKEDA GMBH, GERMANY | LEHNITZSTRASSE 70 - 98, D - 16515, ORANIENBURG, GERMANY | TAKEDA ISRAEL LTD | 25 EFAL ST., POB 4140, PETACH - TIKVA 4951125, ISRAEL | 31/10/2024 | 31/10/2014 | TABLETS | PER OS | PANTOPRAZOLE 20 MG | BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS | HUMAN | כן | לא בסל תרופות | A02BC02 - Pantoprazole 129-41-30772-00 | CONTROLOC I.V. | קונטרולוק I.V | For the treatment of duodenal ulcer, gastric ulcer, moderate and severe forms of reflux oesophagitis. Zollinger Ellison Syndrome. | TAKEDA GMBH, GERMANY | BYR-GULDEN-STR. 2, D-78467 KONSTANZ, GERMANY | TAKEDA ISRAEL LTD | 25 EFAL ST., POB 4140, PETACH - TIKVA 4951125, ISRAEL | 31/10/2023 | 31/10/2013 | POWDER FOR SOLUTION FOR INJECTION | I.V | PANTOPRAZOLE AS SODIUM 40 MG/VIAL | VIAL GLASS TYPE I 1 VIAL | HUMAN | כן | לא בסל תרופות | A02BC02 - Pantoprazole 145-57-33064-00 | PANTOAVENIR IV | פנטואבניר IV | For the treatment of duodenal ulcer, gastric ulcer , moderate and severe forms of reflux oesophagitis. Zollinger Ellison Syndrome. | LABORATORY REIG JOFRE S.A., SPAIN | C/GRAN CAPITAN, 10 08970 SANT JOAN DESPI, SPAIN | BIOAVENIR LTD, ISRAEL | 1 DAVID HAMELECH ST., HERZELIA PITUACH 4666101, ISRAEL | 28/02/2026 | 29/02/2016 | POWDER FOR SOLUTION FOR INJECTION | I.V | PANTOPRAZOLE AS SODIUM 40MG/VIAL | VIAL 10 ML AMBER GLASS TYPE I 20 VIAL; VIAL 10 ML AMBER GLASS TYPE I 1 VIAL | HUMAN | כן | A02BC02 - Pantoprazole 150-02-33651-00 | ULCERON | אולסרון | For the treatment of duodenal ulcer, gastric ulcer, moderate and severe forms of reflux oesophagitis. _x000D_ Zollinger Ellison Syndrome. | ANFARM HELLAS S.A., GREECE | 53-57 PERIKLEOUS STR. 153 44 GERAKAS ATTIKIS, ATHENS, GREECE | K.S.KIM INTERNATIONAL LTD | 94 YIGAL ALON STR., TEL-AVIV-YAFO, 6789139 | 31/05/2028 | 31/05/2018 | POWDER FOR SOLUTION FOR INJECTION | I.V | PANTOPRAZOLE AS SODIUM 40MG/VIAL | VIAL GLASS TYPE I 1 VIAL; VIAL GLASS TYPE I 5 VIALS | HUMAN | כן | A02BC02 - Pantoprazole 133-19-30999-00 | LANSOPRAZOLE TEVA ® 30 MG | לנסופרזול טבע ® 30 מ"ג | For the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. _x000D_ Healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (GORD) or duodenal ulcer. _x000D_ Prevention of relapse in patients with GORD or duodenal ulcer. _x000D_ Eradication of H. Pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). _x000D_ Short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. _x000D_ Long-term management of pathological hypersecretory conditions including Zollinger Ellison syndrome. _x000D_ Treatment and prophylaxis of NSAID- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued NSAID treatment. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 31/07/2020 | 31/07/2010 | CAPSULES | PER OS | LANSOPRAZOLE 30 MG | BLISTER ALUMINIUM /ALUMINIUM 30 CAPSULES; BOTTLE HDPE 30 CAPSULES | HUMAN | כן | בסל עם הגבלה | A02BC03 - Lansoprazole 133-19-30999-02 | LANSOPRAZOLE TEVA ® 30 MG | לנסופרזול טבע ® 30 מ"ג | For the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. _x000D_ Healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (GORD) or duodenal ulcer. _x000D_ Prevention of relapse in patients with GORD or duodenal ulcer. _x000D_ Eradication of H. Pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). _x000D_ Short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. _x000D_ Long-term management of pathological hypersecretory conditions including Zollinger Ellison syndrome. _x000D_ Treatment and prophylaxis of NSAID- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued NSAID treatment. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 31/07/2020 | 31/07/2010 | CAPSULES | PER OS | LANSOPRAZOLE 30 MG | BLISTER ALUMINIUM /ALUMINIUM 30 CAPSULES; BOTTLE HDPE 30 CAPSULES | HUMAN | כן | בסל עם הגבלה | A02BC03 - Lansoprazole 133-19-30999-03 | LANSOPRAZOLE TEVA ® 30 MG | לנסופרזול טבע ® 30 מ"ג | For the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. _x000D_ Healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (GORD) or duodenal ulcer. _x000D_ Prevention of relapse in patients with GORD or duodenal ulcer. _x000D_ Eradication of H. Pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). _x000D_ Short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. _x000D_ Long-term management of pathological hypersecretory conditions including Zollinger Ellison syndrome. _x000D_ Treatment and prophylaxis of NSAID- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued NSAID treatment. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 31/07/2020 | 26/08/2013 | CAPSULES | PER OS | LANSOPRAZOLE 30 MG | BLISTER ALUMINIUM /ALUMINIUM 30 CAPSULES; BOTTLE HDPE 30 CAPSULES | HUMAN | כן | בסל עם הגבלה | A02BC03 - Lansoprazole 133-18-31051-00 | LANSOPRAZOLE TEVA ® 15 MG | לנסופרזול טבע ® 15 מ"ג | For the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. _x000D_ Healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (GORD) or duodenal ulcer. _x000D_ Prevention of relapse in patients with GORD or duodenal ulcer. _x000D_ Eradication of H. Pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). _x000D_ Short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. Long-term management of pathological hypersecretory conditions including Zollinger Ellison syndrome._x000D_ Treatment and prophylaxis of NSAID- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued NSAID treatment. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 31/07/2020 | 31/07/2010 | CAPSULES | PER OS | LANSOPRAZOLE 15 MG | BLISTER ALUMINIUM /ALUMINIUM 30 CAPSULES; BOTTLE HDPE 30 CAPSULES | HUMAN | כן | בסל עם הגבלה | A02BC03 - Lansoprazole 133-18-31051-02 | LANSOPRAZOLE TEVA ® 15 MG | לנסופרזול טבע ® 15 מ"ג | For the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. _x000D_ Healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (GORD) or duodenal ulcer. _x000D_ Prevention of relapse in patients with GORD or duodenal ulcer. _x000D_ Eradication of H. Pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). _x000D_ Short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. Long-term management of pathological hypersecretory conditions including Zollinger Ellison syndrome._x000D_ Treatment and prophylaxis of NSAID- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued NSAID treatment. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 31/07/2020 | 31/07/2010 | CAPSULES | PER OS | LANSOPRAZOLE 15 MG | BLISTER ALUMINIUM /ALUMINIUM 30 CAPSULES; BOTTLE HDPE 30 CAPSULES | HUMAN | כן | בסל עם הגבלה | A02BC03 - Lansoprazole 133-18-31051-03 | LANSOPRAZOLE TEVA ® 15 MG | לנסופרזול טבע ® 15 מ"ג | For the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. _x000D_ Healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (GORD) or duodenal ulcer. _x000D_ Prevention of relapse in patients with GORD or duodenal ulcer. _x000D_ Eradication of H. Pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). _x000D_ Short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. Long-term management of pathological hypersecretory conditions including Zollinger Ellison syndrome._x000D_ Treatment and prophylaxis of NSAID- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued NSAID treatment. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 31/07/2020 | 26/08/2013 | CAPSULES | PER OS | LANSOPRAZOLE 15 MG | BLISTER ALUMINIUM /ALUMINIUM 30 CAPSULES; BOTTLE HDPE 30 CAPSULES | HUMAN | כן | בסל עם הגבלה | A02BC03 - Lansoprazole 129-25-30761-00 | LANTON 30 | לנטון 30 | For the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. _x000D_ Healing, long- term treatment and maintenance therapy for patients with gastro-oesophageal reflux disease (GERD) or duodenal ulcer. Prevention of relapse in patients with GERD or duodenal ulcer. _x000D_ Eradication of H. Pylori from the upper gastrointestinal tract in patients ,with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). _x000D_ Short- term- treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. _x000D_ Long-term management of pathological hypersecretory conditions including Zollinger Ellison syndrome. _x000D_ Treatment and prophylaxis of NSAID- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued NSAID treatment. | LABORATORIOS LICONSA S.A., SPAIN | AVDA MIRALCAMPO 7, POLIGONO INDUSTRIAL MIRALCAMPO, 19200 AZUQUECA DE HENARES ( GUADALAJARA), SPAIN | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/10/2023 | 31/10/2013 | CAPSULES | PER OS | LANSOPRAZOLE 30 MG | BLISTER ALUMINIUM /ALUMINIUM 28 CAPSULES | HUMAN | כן | בסל עם הגבלה | A02BC03 - Lansoprazole 131-08-30988-00 | LANTON 15 | לנטון 15 | For the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. _x000D_ Healing, long- term treatment and maintenance therapy for patients with gastro-oesophageal reflux disease (GERD) or duodenal ulcer. Prevention of relapse in patients with GERD or duodenal ulcer. _x000D_ Eradication of H. Pylori from the upper gastrointestinal tract in patients ,with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). _x000D_ Short- term- treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. _x000D_ Long-term management of pathological hypersecretory conditions including Zollinger Ellison syndrome. _x000D_ Treatment and prophylaxis of NSAID- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued NSAID treatment. | LABORATORIOS LICONSA S.A., SPAIN | AVDA MIRALCAMPO 7, POLIGONO INDUSTRIAL MIRALCAMPO, 19200 AZUQUECA DE HENARES ( GUADALAJARA), SPAIN | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/10/2023 | 31/10/2013 | CAPSULES | PER OS | LANSOPRAZOLE 15 MG | BLISTER ALUMINIUM /ALUMINIUM 28 CAPSULES | HUMAN | כן | בסל עם הגבלה | A02BC03 - Lansoprazole 122-52-30237-00 | NEXIUM TABLETS 20 MG | נקסיום טבליות 20 מ"ג | Nexium tablets are indicated in adults for:_x000D_ Gastroesophageal Reflux Disease (GERD)_x000D_ - treatment of erosive reflux esophagitis_x000D_ - long-term management of patients with healed esophagitis to prevent relapse_x000D_ - symptomatic treatment of gastroesophageal reflux disease (GERD)_x000D_ In combination with an appropriate antibacterial therapeutic regimen for the eradication of Helicobacter pylori and:_x000D_ - healing of Helicobacter pylori associated duodenal ulcer and_x000D_ - prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers._x000D_ Patients requiring NSAID therapy_x000D_ - healing of gastric ulcers associated with NSAID therapy. _x000D_ - prevention of gastric and duodenal ulcers associated with NSAID therapy in _x000D_ patients at risk._x000D_ Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers._x000D_ Nexium 20 mg tablets are indicated in adolescents from the age of 12 years for_x000D_ Gastroesophageal Reflux Disease (GERD)_x000D_ - treatment of erosive reflux esophagitis_x000D_ - long-term management of patients with healed esophagitis to prevent relapse_x000D_ - symptomatic treatment of gastroesophgeal reflux disease (GERD)_x000D_ In combination with antibiotics in treatment of duodenal ulcer caused by Helicobactor pylori_x000D_ | ASTRA ZENECA AB., SWEDEN | S-151 85 SODERTALJE, SWEDEN | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 31/05/2021 | 31/05/2011 | TABLETS | PER OS | ESOMEPRAZOLE 20 MG | BLISTER ALUMINIUM/ALUMINIUM/PVC 3 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 7 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 14 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 15 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 28 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 30 TABLETS; BOTTLE HDPE 2 TABLETS; BOTTLE HDPE 5 TABLETS; BOTTLE HDPE 7 TABLETS; BOTTLE HDPE 14 TABLETS; BOTTLE HDPE 15 TABLETS; BOTTLE HDPE 28 TABLETS; BOTTLE HDPE 30 TABLETS | HUMAN | כן | A02BC05 - Esomeprazole 122-52-30237-11 | NEXIUM TABLETS 20 MG | נקסיום טבליות 20 מ"ג | Nexium tablets are indicated in adults for:_x000D_ Gastroesophageal Reflux Disease (GERD)_x000D_ - treatment of erosive reflux esophagitis_x000D_ - long-term management of patients with healed esophagitis to prevent relapse_x000D_ - symptomatic treatment of gastroesophageal reflux disease (GERD)_x000D_ In combination with an appropriate antibacterial therapeutic regimen for the eradication of Helicobacter pylori and:_x000D_ - healing of Helicobacter pylori associated duodenal ulcer and_x000D_ - prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers._x000D_ Patients requiring NSAID therapy_x000D_ - healing of gastric ulcers associated with NSAID therapy. _x000D_ - prevention of gastric and duodenal ulcers associated with NSAID therapy in _x000D_ patients at risk._x000D_ Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers._x000D_ Nexium 20 mg tablets are indicated in adolescents from the age of 12 years for_x000D_ Gastroesophageal Reflux Disease (GERD)_x000D_ - treatment of erosive reflux esophagitis_x000D_ - long-term management of patients with healed esophagitis to prevent relapse_x000D_ - symptomatic treatment of gastroesophgeal reflux disease (GERD)_x000D_ In combination with antibiotics in treatment of duodenal ulcer caused by Helicobactor pylori_x000D_ | ASTRA ZENECA AB., SWEDEN | S-151 85 SODERTALJE, SWEDEN | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 31/05/2021 | 31/05/2011 | TABLETS | PER OS | ESOMEPRAZOLE 20 MG | BLISTER ALUMINIUM/ALUMINIUM/PVC 30 TABLETS; BOTTLE HDPE 2 TABLETS; BOTTLE HDPE 5 TABLETS; BOTTLE HDPE 7 TABLETS; BOTTLE HDPE 14 TABLETS; BOTTLE HDPE 15 TABLETS; BOTTLE HDPE 28 TABLETS; BOTTLE HDPE 30 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 3 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 7 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 14 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 15 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 28 TABLETS | HUMAN | כן | A02BC05 - Esomeprazole 122-52-30237-12 | NEXIUM TABLETS 20 MG | נקסיום טבליות 20 מ"ג | Nexium tablets are indicated in adults for:_x000D_ Gastroesophageal Reflux Disease (GERD)_x000D_ - treatment of erosive reflux esophagitis_x000D_ - long-term management of patients with healed esophagitis to prevent relapse_x000D_ - symptomatic treatment of gastroesophageal reflux disease (GERD)_x000D_ In combination with an appropriate antibacterial therapeutic regimen for the eradication of Helicobacter pylori and:_x000D_ - healing of Helicobacter pylori associated duodenal ulcer and_x000D_ - prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers._x000D_ Patients requiring NSAID therapy_x000D_ - healing of gastric ulcers associated with NSAID therapy. _x000D_ - prevention of gastric and duodenal ulcers associated with NSAID therapy in _x000D_ patients at risk._x000D_ Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers._x000D_ Nexium 20 mg tablets are indicated in adolescents from the age of 12 years for_x000D_ Gastroesophageal Reflux Disease (GERD)_x000D_ - treatment of erosive reflux esophagitis_x000D_ - long-term management of patients with healed esophagitis to prevent relapse_x000D_ - symptomatic treatment of gastroesophgeal reflux disease (GERD)_x000D_ In combination with antibiotics in treatment of duodenal ulcer caused by Helicobactor pylori_x000D_ | ASTRA ZENECA AB., SWEDEN | S-151 85 SODERTALJE, SWEDEN | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 31/05/2021 | 11/06/2018 | TABLETS | PER OS | ESOMEPRAZOLE 20 MG | BLISTER ALUMINIUM/ALUMINIUM/PVC 30 TABLETS; BOTTLE HDPE 2 TABLETS; BOTTLE HDPE 5 TABLETS; BOTTLE HDPE 7 TABLETS; BOTTLE HDPE 14 TABLETS; BOTTLE HDPE 15 TABLETS; BOTTLE HDPE 28 TABLETS; BOTTLE HDPE 30 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 3 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 7 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 14 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 15 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 28 TABLETS | HUMAN | כן | A02BC05 - Esomeprazole 122-53-30238-00 | NEXIUM TABLETS 40 MG | נקסיום טבליות 40 מ"ג | Nexium tablets are indicated in adults for:_x000D_ Gastroesophageal Reflux Disease (GERD)_x000D_ - treatment of erosive reflux esophagitis_x000D_ - long-term management of patients with healed esophagitis to prevent relapse_x000D_ - symptomatic treatment of gastroesophageal reflux disease (GERD)_x000D_ In combination with an appropriate antibacterial therapeutic regimen for the eradication of Helicobacter pylori and:_x000D_ - healing of Helicobacter pylori associated duodenal ulcer and_x000D_ - prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers._x000D_ Patients requiring NSAID therapy_x000D_ - healing of gastric ulcers associated with NSAID therapy. _x000D_ - prevention of gastric and duodenal ulcers associated with NSAID therapy in _x000D_ patients at risk._x000D_ Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers._x000D_ Nexium 40 mg tablets are indicated in adolescents from the age of 12 years for;_x000D_ Gastroesophageal Reflux Disease (GERD)_x000D_ - treatment of erosive reflux esophagitis_x000D_ | ASTRA ZENECA AB., SWEDEN | S-151 85 SODERTALJE, SWEDEN | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 31/05/2021 | 31/05/2011 | TABLETS | PER OS | ESOMEPRAZOLE 40 MG | BLISTER ALUMINIUM/ALUMINIUM/PVC 3 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 7 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 14 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 15 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 28 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 30 TABLETS; BOTTLE HDPE 2 TABLETS; BOTTLE HDPE 5 TABLETS; BOTTLE HDPE 7 TABLETS; BOTTLE HDPE 14 TABLETS; BOTTLE HDPE 15 TABLETS; BOTTLE HDPE 28 TABLETS; BOTTLE HDPE 30 TABLETS | HUMAN | כן | A02BC05 - Esomeprazole 122-53-30238-11 | NEXIUM TABLETS 40 MG | נקסיום טבליות 40 מ"ג | Nexium tablets are indicated in adults for:_x000D_ Gastroesophageal Reflux Disease (GERD)_x000D_ - treatment of erosive reflux esophagitis_x000D_ - long-term management of patients with healed esophagitis to prevent relapse_x000D_ - symptomatic treatment of gastroesophageal reflux disease (GERD)_x000D_ In combination with an appropriate antibacterial therapeutic regimen for the eradication of Helicobacter pylori and:_x000D_ - healing of Helicobacter pylori associated duodenal ulcer and_x000D_ - prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers._x000D_ Patients requiring NSAID therapy_x000D_ - healing of gastric ulcers associated with NSAID therapy. _x000D_ - prevention of gastric and duodenal ulcers associated with NSAID therapy in _x000D_ patients at risk._x000D_ Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers._x000D_ Nexium 40 mg tablets are indicated in adolescents from the age of 12 years for;_x000D_ Gastroesophageal Reflux Disease (GERD)_x000D_ - treatment of erosive reflux esophagitis_x000D_ | ASTRA ZENECA AB., SWEDEN | S-151 85 SODERTALJE, SWEDEN | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 31/05/2021 | 31/05/2011 | TABLETS | PER OS | ESOMEPRAZOLE 40 MG | BLISTER ALUMINIUM/ALUMINIUM/PVC 3 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 7 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 14 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 15 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 28 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 30 TABLETS; BOTTLE HDPE 2 TABLETS; BOTTLE HDPE 5 TABLETS; BOTTLE HDPE 7 TABLETS; BOTTLE HDPE 14 TABLETS; BOTTLE HDPE 15 TABLETS; BOTTLE HDPE 28 TABLETS; BOTTLE HDPE 30 TABLETS | HUMAN | כן | A02BC05 - Esomeprazole 122-53-30238-12 | NEXIUM TABLETS 40 MG | נקסיום טבליות 40 מ"ג | Nexium tablets are indicated in adults for:_x000D_ Gastroesophageal Reflux Disease (GERD)_x000D_ - treatment of erosive reflux esophagitis_x000D_ - long-term management of patients with healed esophagitis to prevent relapse_x000D_ - symptomatic treatment of gastroesophageal reflux disease (GERD)_x000D_ In combination with an appropriate antibacterial therapeutic regimen for the eradication of Helicobacter pylori and:_x000D_ - healing of Helicobacter pylori associated duodenal ulcer and_x000D_ - prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers._x000D_ Patients requiring NSAID therapy_x000D_ - healing of gastric ulcers associated with NSAID therapy. _x000D_ - prevention of gastric and duodenal ulcers associated with NSAID therapy in _x000D_ patients at risk._x000D_ Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers._x000D_ Nexium 40 mg tablets are indicated in adolescents from the age of 12 years for;_x000D_ Gastroesophageal Reflux Disease (GERD)_x000D_ - treatment of erosive reflux esophagitis_x000D_ | ASTRA ZENECA AB., SWEDEN | S-151 85 SODERTALJE, SWEDEN | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 31/05/2021 | 11/06/2018 | TABLETS | PER OS | ESOMEPRAZOLE 40 MG | BLISTER ALUMINIUM/ALUMINIUM/PVC 3 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 7 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 14 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 15 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 28 TABLETS; BLISTER ALUMINIUM/ALUMINIUM/PVC 30 TABLETS; BOTTLE HDPE 2 TABLETS; BOTTLE HDPE 5 TABLETS; BOTTLE HDPE 7 TABLETS; BOTTLE HDPE 14 TABLETS; BOTTLE HDPE 15 TABLETS; BOTTLE HDPE 28 TABLETS; BOTTLE HDPE 30 TABLETS | HUMAN | כן | A02BC05 - Esomeprazole 135-56-31128-00 | NEXIUM POWDER FOR SOLUTION FOR INJ/INF ® 40 MG | נקסיום ® תמיסה להזרקה 40 מ"ג | Nexium for iniection and infusion is indicated in adult for:_x000D_ • Gastroesophageal reflux disease (GERD) in patients with esophagitis and/or severe symptoms of reflux as an alternative to oral therapy when oral intake is not appropriate. _x000D_ • Prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers._x000D_ Nexium for injection and infusion is indicated in children and adolescents aged 1-18 years for:_x000D_ • Gastric antisecretory treatment when the oral route is not possible, such as:_x000D_ gastroesophageal reflux disease (GERD) in patients with erosive reflux esophagitis and/or severe symptoms of reflux._x000D_ | ASTRA ZENECA AB., SWEDEN | S-151 85 SODERTALJE, SWEDEN | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 31/10/2021 | 31/10/2011 | POWDER FOR SOLUTION FOR INJ/INF | I.V | ESOMEPRAZOLE AS SODIUM 40 MG/DOSE | VIAL GLASS TYPE I 10 VIALS | HUMAN | כן | לא בסל תרופות | A02BC05 - Esomeprazole 159-99-34845-00 | SOLEZOL | סולזול | Solezol is indicated in adult for: :_x000D_ • Gastroesophageal reflux disease (GERD) in patients with esophagitis and/or severe symptoms of reflux as an alternative to oral therapy when oral intake is not appropriate. _x000D_ • Prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers. _x000D_ Solezol is indicated in children and adolescents aged 1-18 years for: _x000D_ • Gastric antisecretory treatment when the oral route is not possible, such as: _x000D_ gastroesophageal reflux disease (GERD) in patients with erosive reflux esophagitis and/or severe symptoms of reflux._x000D_ | ANFARM HELLAS S.A., GREECE | 53-57 PERIKLEOUS STR. 153 44 GERAKAS ATTIKIS, ATHENS, GREECE | K.S.KIM INTERNATIONAL LTD | 94 YIGAL ALON STR., TEL-AVIV-YAFO, 6789139 | 31/01/2023 | 04/02/2018 | POWDER FOR SOLUTION FOR INJ/INF | I.V | ESOMEPRAZOLE AS SODIUM 40MG/VIAL | VIAL 5 ML GLASS TYPE I 1 VIAL | HUMAN | כן | A02BC05 - Esomeprazole 161-48-35207-00 | ESOMEPRAZOLE INOVAMED 20 MG | אסומפראזול אינובמד 20 מ"ג | Esomeprazole Inovamed tablets are indicated in adults for:_x000D_ Gastroesophageal Reflux Disease (GERD)_x000D_ - treatment of erosive reflux esophagitis_x000D_ - long-term management of patients with healed esophagitis to prevent relapse_x000D_ - symptomatic treatment of gastroesophageal reflux disease (GERD)_x000D_ In combination with an appropriate antibacterial therapeutic regimen for the eradication of Helicobacter pylori and:_x000D_ - healing of Helicobacter pylori associated duodenal ulcer and_x000D_ - prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers._x000D_ Patients requiring NSAID therapy_x000D_ - healing of gastric ulcers associated with NSAID therapy. _x000D_ - prevention of gastric and duodenal ulcers associated with NSAID therapy in _x000D_ patients at risk._x000D_ Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers._x000D_ Esomeprazole Inovamed 20 mg tablets are indicated in adolescents from the age of 12 years for_x000D_ Gastroesophageal Reflux Disease (GERD)_x000D_ - treatment of erosive reflux esophagitis_x000D_ - long-term management of patients with healed esophagitis to prevent relapse_x000D_ - symptomatic treatment of gastroesophgeal reflux disease (GERD)_x000D_ In combination with antibiotics in treatment of duodenal ulcer caused by Helicobactor pylori_x000D_ _x000D_ _x000D_ | JUBILANT GENERICS LTD., INDIA | 1-A, SECTOR 16-A, NOIDA, UTTAR PRADESH 201 301, INDIA | INOVAMED LTD | 55 BEER GANIM STREET, P.O.B 62, EVEN YEHUDA 40500, ISRAEL | 31/12/2023 | 06/01/2019 | GASTRO RESISTANT TABLETS | PER OS | ESOMEPRAZOLE AS MAGNESIUM AMORPHOUS 20 MG | BLISTER ALUMINIUM /ALUMINIUM 7 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 14 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 28 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 50 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 56 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 60 TABLETS | HUMAN | כן | A02BC05 - Esomeprazole 161-49-35208-00 | ESOMEPRAZOLE INOVAMED 40 MG | אסומפראזול אינובמד 40 מ"ג | Esomeprazole Inovamed tablets are indicated in adults for:_x000D_ Gastroesophageal Reflux Disease (GERD)_x000D_ - treatment of erosive reflux esophagitis_x000D_ - long-term management of patients with healed esophagitis to prevent relapse_x000D_ - symptomatic treatment of gastroesophageal reflux disease (GERD)_x000D_ In combination with an appropriate antibacterial therapeutic regimen for the eradication of Helicobacter pylori and:_x000D_ - healing of Helicobacter pylori associated duodenal ulcer and_x000D_ - prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers._x000D_ Patients requiring NSAID therapy_x000D_ - healing of gastric ulcers associated with NSAID therapy. _x000D_ - prevention of gastric and duodenal ulcers associated with NSAID therapy in _x000D_ patients at risk._x000D_ Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers._x000D_ Esomeprazole Inovamed 40 mg tablets are indicated in adolescents from the age of 12 years for;_x000D_ Gastroesophageal Reflux Disease (GERD)_x000D_ - treatment of erosive reflux esophagitis_x000D_ _x000D_ _x000D_ | JUBILANT GENERICS LTD., INDIA | 1-A, SECTOR 16-A, NOIDA, UTTAR PRADESH 201 301, INDIA | INOVAMED LTD | 55 BEER GANIM STREET, P.O.B 62, EVEN YEHUDA 40500, ISRAEL | 31/12/2023 | 06/01/2019 | GASTRO RESISTANT TABLETS | PER OS | ESOMEPRAZOLE AS MAGNESIUM AMORPHOUS 40 MG | BLISTER ALUMINIUM /ALUMINIUM 7 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 14 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 28 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 50 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 56 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 60 TABLETS | HUMAN | כן | A02BC05 - Esomeprazole 162-75-35708-00 | ESOPRIM S.K 20 MG | אסופרים אס.קיי. 20 מ"ג | Esoprim S.K. 20 mg indicated in adults for:_x000D_ Gastroesophageal Reflux Disease (GERD)_x000D_ - treatment of erosive reflux esophagitis _x000D_ - long-term management of patients with healed esophagitis to prevent relapse _x000D_ - symptomatic treatment of gastroesophageal reflux disease. _x000D_ In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori and_x000D_ - healing of Helicobacter pylori associated duodenal ulcer and _x000D_ prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers -_x000D_ Patients requiring continued NSAID therapy _x000D_ Healing of gastric ulcers associated with NSAID therapy. _x000D_ - Prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk. _x000D_ - Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers. _x000D_ Esoprim S.K 20 mg is indicated in adolescents from the age of 12 years for: _x000D_ Gastro-esophageal Reflux Disease (GERD) _x000D_ - treatment of erosive reflux esophagitis _x000D_ -long-term management of patients with healed esophagitis to prevent relapse_x000D_ -symptomatic treatment of gastro-esophageal reflux disease_x000D_ In combination with antibiotics in treatment of duodenal ulcer caused by Helicobacter pylori._x000D_ | ESTEVE PHARMACEUTICALS, S.A, SPAIN | C/DE SANT MARTÍ 75-97, MARTORELLES, 08107 BARCELONA, SPAIN | K.S.KIM INTERNATIONAL LTD | 94 YIGAL ALON STR., TEL-AVIV-YAFO, 6789139 | 30/09/2024 | 07/10/2019 | HARD CAPSULE | PER OS | ESOMEPRAZOLE AS SODIUM 20 MG | BLISTER ALUMINIUM /ALUMINIUM 28 CAPSULES | HUMAN | כן | A02BC05 - Esomeprazole 162-76-35709-00 | ESOPRIM S.K 40 MG | אסופרים אס.קיי. 40 מ"ג | Esoprim S.K. 40 mg is indicated in adults for:_x000D_ Gastroesophageal Reflux Disease (GERD)_x000D_ - treatment of erosive reflux esophagitis _x000D_ - long-term management of patients with healed esophagitis to prevent relapse _x000D_ - symptomatic treatment of gastroesophageal reflux disease _x000D_ In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori and_x000D_ - healing of Helicobacter pylori associated duodenal ulcer and _x000D_ prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers -_x000D_ Patients requiring continued NSAID therapy _x000D_ Healing of gastric ulcers associated with NSAID therapy. _x000D_ - Prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk. _x000D_ - Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers. _x000D_ EsoprIM S.K 40 mg IS indicated in adolescents from the age of 12 years for: _x000D_ Gastro-esophageal Reflux Disease (GERD) _x000D_ - treatment of erosive reflux esophagitis _x000D_ | ESTEVE PHARMACEUTICALS, S.A, SPAIN | C/DE SANT MARTÍ 75-97, MARTORELLES, 08107 BARCELONA, SPAIN | K.S.KIM INTERNATIONAL LTD | 94 YIGAL ALON STR., TEL-AVIV-YAFO, 6789139 | 30/09/2024 | 07/10/2019 | HARD CAPSULE | PER OS | ESOMEPRAZOLE AS SODIUM 40 MG | BLISTER ALUMINIUM /ALUMINIUM 28 CAPSULES | HUMAN | כן | A02BC05 - Esomeprazole 155-45-34383-00 | DEXILANT 30 MG | דקסילנט 30 מ"ג | Dexilant 30 is indicated in adults and in adolescents aged 12 to 17 years for the following:_x000D_ • Maintenance of healed erosive reflux oesophagitis and maintenance of relief of heartburn_x000D_ • Short-term treatment of heartburn and acid regurgitation associated with symptomatic non-erosive gastro-oesophageal reflux disease (GORD)._x000D_ | TAKEDA PHARMA A/S, DENMARK | DYBENDAL ALLE 10, DK-2630 TAASTRUP, DENMARK | TAKEDA ISRAEL LTD | 25 EFAL ST., POB 4140, PETACH - TIKVA 4951125, ISRAEL | 31/01/2021 | 18/02/2016 | MODIFIED RELEASE CAPSULES | PER OS | DEXLANSOPRAZOLE 30 MG | BLISTER PVC/PE/PCTFE/AL 14 CAPSULES; BLISTER PVC/PE/PCTFE/AL 28 CAPSULES | HUMAN | כן | A02BC06 - Dexlansoprazole 155-45-34383-01 | DEXILANT 30 MG | דקסילנט 30 מ"ג | Dexilant 30 is indicated in adults and in adolescents aged 12 to 17 years for the following:_x000D_ • Maintenance of healed erosive reflux oesophagitis and maintenance of relief of heartburn_x000D_ • Short-term treatment of heartburn and acid regurgitation associated with symptomatic non-erosive gastro-oesophageal reflux disease (GORD)._x000D_ | TAKEDA PHARMA A/S, DENMARK | DYBENDAL ALLE 10, DK-2630 TAASTRUP, DENMARK | TAKEDA ISRAEL LTD | 25 EFAL ST., POB 4140, PETACH - TIKVA 4951125, ISRAEL | 31/01/2021 | 18/02/2016 | MODIFIED RELEASE CAPSULES | PER OS | DEXLANSOPRAZOLE 30 MG | BLISTER PVC/PE/PCTFE/AL 14 CAPSULES; BLISTER PVC/PE/PCTFE/AL 28 CAPSULES | HUMAN | כן | A02BC06 - Dexlansoprazole 155-46-34387-00 | DEXILANT 60 MG | דקסילנט 60 מ"ג | Dexilant 60 is indicated in adults and in adolescents aged 12 to 17 years for the following:_x000D_ • Treatment of erosive reflux oesophagitis_x000D_ | TAKEDA PHARMA A/S, DENMARK | DYBENDAL ALLE 10, DK-2630 TAASTRUP, DENMARK | TAKEDA ISRAEL LTD | 25 EFAL ST., POB 4140, PETACH - TIKVA 4951125, ISRAEL | 31/01/2021 | 18/02/2016 | MODIFIED RELEASE CAPSULES | PER OS | DEXLANSOPRAZOLE 60 MG | BLISTER PVC/PE/PCTFE/AL 14 CAPSULES; BLISTER PVC/PE/PCTFE/AL 28 CAPSULES | HUMAN | כן | A02BC06 - Dexlansoprazole 155-46-34387-01 | DEXILANT 60 MG | דקסילנט 60 מ"ג | Dexilant 60 is indicated in adults and in adolescents aged 12 to 17 years for the following:_x000D_ • Treatment of erosive reflux oesophagitis_x000D_ | TAKEDA PHARMA A/S, DENMARK | DYBENDAL ALLE 10, DK-2630 TAASTRUP, DENMARK | TAKEDA ISRAEL LTD | 25 EFAL ST., POB 4140, PETACH - TIKVA 4951125, ISRAEL | 31/01/2021 | 18/02/2016 | MODIFIED RELEASE CAPSULES | PER OS | DEXLANSOPRAZOLE 60 MG | BLISTER PVC/PE/PCTFE/AL 14 CAPSULES; BLISTER PVC/PE/PCTFE/AL 28 CAPSULES | HUMAN | כן | A02BC06 - Dexlansoprazole 140-65-31601-00 | BITNI X TABLETS | ביטני X טבליות | Relief of diarrhea, nausea, flatulence, convulsive stomach pains, uspet stomach. As a preventative treatment of traveler's diarrhea. | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | 30/04/2024 | 30/04/2014 | TABLETS | PER OS | BISMUTH SUB SALICYLATE 262 MG | BLISTER PVC/ALUMINIUM 2 TABLETS; BLISTER PVC/ALUMINIUM 7 TABLETS; BLISTER PVC/ALUMINIUM 10 TABLETS; BLISTER PVC/ALUMINIUM 15 TABLETS; BLISTER PVC/ALUMINIUM 20 TABLETS; BLISTER PVC/ALUMINIUM 30 TABLETS; BLISTER PVC/ALUMINIUM 50 TABLETS; BLISTER PVC/ALUMINIUM 60 TABLETS | HUMAN | בסל תרופות | A02BX - OTHER DRUGS FOR TREATMENT OF PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLU; A02BX05 - Bismuth subcitrate 068-93-28288-00 | KALBETEN SUSPENSION | קלבטן תרחיף | Relief of diarrhea, nausea, flatulence, convulsive stomach pains, uspet stomach. As a preventative treatment of traveler's diarrhea. | SAM-ON LTD.,ISRAEL | 25 HAAVODA ST., BAT-YAM, 59602 ISRAEL | SAM-ON LTD | 25 HAAVODA ST., BAT-YAM, 59602 ISRAEL | 30/09/2020 | 30/09/2010 | SUSPENSION | PER OS | BISMUTH SUB SALICYLATE 1.75%W/V | BOTTLE HDPE 100 ML; BOTTLE PET 200 ML | HUMAN | בסל תרופות | A02BX05 - Bismuth subcitrate 140-75-31557-00 | BITNI X SUSPENSION | ביטני X תרחיף | Relief of diarrhea, nausea, flatulence, convulsive stomach pains, uspet stomach. _x000D_ As a preventative treatment of traveler's diarrhea. | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | 30/04/2024 | 30/04/2014 | SUSPENSION | PER OS | BISMUTH SUB SALICYLATE 262 MG / 15 ML | BOTTLE PET 250 ML; BOTTLE GLASS TYPE III 100 ML | HUMAN | בסל תרופות | A02BX05 - Bismuth subcitrate 140-95-31841-00 | KALBETEN FORTE CAPLETS | קלבטן פורטה | Relief of diarrhea, nausea, flatulence, convulsive stomach pains, uspet stomach. _x000D_ As a preventative treatment of traveler's diarrhea. | SAM-ON LTD.,ISRAEL | 25 HAAVODA ST., BAT-YAM, 59602 ISRAEL | SAM-ON LTD | 25 HAAVODA ST., BAT-YAM, 59602 ISRAEL | 31/05/2024 | 31/05/2014 | CAPLETS | PER OS | BISMUTH SUB SALICYLATE 524 MG | BLISTER PVC/ALUMINIUM 10 CAPLETS; BLISTER PVC/ALUMINIUM 20 CAPLETS; BLISTER PVC/ALUMINIUM 5 CAPLETS | HUMAN | בסל תרופות | A02BX05 - Bismuth subcitrate 128-76-30717-00 | PINK BISMUTH CHEWABLE TABLETS | פינק ביסמוט טבליות לעיסה | For relief of diarrhea, nausea, flatulence, abdominal cramps, upset stomach and indigestion. | PERRIGO COMPANY, USA | 515 EASTERN AVE., ALLEGAN, MICHIGAN, USA | PERRIGO ISRAEL AGENCIES LTD, ISRAEL | 1 RAKEFET ST., SHOHAM, ISRAEL | 31/07/2023 | 31/07/2013 | CHEWABLE TABLETS | PER OS | BISMUTH SUB SALICYLATE 262 MG | STRIPS FILM POLYESTER/LLDPE 12 TABLETS; STRIPS FILM POLYESTER/LLDPE 24 TABLETS; STRIPS FILM POLYESTER/LLDPE 30 TABLETS | HUMAN | בסל תרופות | A02BX05 - Bismuth subcitrate 128-76-30717-02 | PINK BISMUTH CHEWABLE TABLETS | פינק ביסמוט טבליות לעיסה | For relief of diarrhea, nausea, flatulence, abdominal cramps, upset stomach and indigestion. | PERRIGO COMPANY, USA | 515 EASTERN AVE., ALLEGAN, MICHIGAN, USA | PERRIGO ISRAEL AGENCIES LTD, ISRAEL | 1 RAKEFET ST., SHOHAM, ISRAEL | 31/07/2023 | 31/07/2013 | CHEWABLE TABLETS | PER OS | BISMUTH SUB SALICYLATE 262 MG | STRIPS FILM POLYESTER/LLDPE 12 TABLETS; STRIPS FILM POLYESTER/LLDPE 24 TABLETS; STRIPS FILM POLYESTER/LLDPE 30 TABLETS | HUMAN | בסל תרופות | A02BX05 - Bismuth subcitrate 148-41-33716-00 | PEPTOLITE CHEWABLE TABLETS | פפטולייט טבליות לעיסה | For relief of diarrhea, nausea, flatulence, abdominal cramps, upset stomach and indigestion. | PERRIGO COMPANY, USA | 515 EASTERN AVE., ALLEGAN, MICHIGAN, USA | PERRIGO ISRAEL AGENCIES LTD, ISRAEL | 1 RAKEFET ST., SHOHAM, ISRAEL | 31/07/2023 | 31/07/2013 | CHEWABLE TABLETS | PER OS | BISMUTH SUB SALICYLATE 262 MG | BLISTER POLYESTER /LLDPE 12 TABLETS; BLISTER POLYESTER /LLDPE 24 TABLETS; BLISTER POLYESTER /LLDPE 30 TABLETS | HUMAN | לא | בסל תרופות | A02BX05 - Bismuth subcitrate 148-41-33716-02 | PEPTOLITE CHEWABLE TABLETS | פפטולייט טבליות לעיסה | For relief of diarrhea, nausea, flatulence, abdominal cramps, upset stomach and indigestion. | PERRIGO COMPANY, USA | 515 EASTERN AVE., ALLEGAN, MICHIGAN, USA | PERRIGO ISRAEL AGENCIES LTD, ISRAEL | 1 RAKEFET ST., SHOHAM, ISRAEL | 31/07/2023 | 31/07/2013 | CHEWABLE TABLETS | PER OS | BISMUTH SUB SALICYLATE 262 MG | BLISTER POLYESTER /LLDPE 12 TABLETS; BLISTER POLYESTER /LLDPE 24 TABLETS; BLISTER POLYESTER /LLDPE 30 TABLETS | HUMAN | לא | בסל תרופות | A02BX05 - Bismuth subcitrate 156-99-34986-00 | BETEN CARE | בטן קאר | For relief of diarrhea, nausea, flatulence, abdominal cramps, upset stomach and indigestion. | PERRIGO COMPANY, USA | 515 EASTERN AVE., ALLEGAN, MICHIGAN, USA | PERRIGO ISRAEL AGENCIES LTD, ISRAEL | 1 RAKEFET ST., SHOHAM, ISRAEL | 31/08/2021 | 21/09/2016 | CHEWABLE TABLETS | PER OS | BISMUTH SUB SALICYLATE 262 MG | STRIPS FILM POLYESTER/LLDPE 12 TABLETS; STRIPS FILM POLYESTER/LLDPE 24 TABLETS; STRIPS FILM POLYESTER/LLDPE 30 TABLETS | HUMAN | לא | בסל תרופות | A02BX05 - Bismuth subcitrate 156-99-34986-01 | BETEN CARE | בטן קאר | For relief of diarrhea, nausea, flatulence, abdominal cramps, upset stomach and indigestion. | PERRIGO COMPANY, USA | 515 EASTERN AVE., ALLEGAN, MICHIGAN, USA | PERRIGO ISRAEL AGENCIES LTD, ISRAEL | 1 RAKEFET ST., SHOHAM, ISRAEL | 31/08/2021 | 21/09/2016 | CHEWABLE TABLETS | PER OS | BISMUTH SUB SALICYLATE 262 MG | STRIPS FILM POLYESTER/LLDPE 12 TABLETS; STRIPS FILM POLYESTER/LLDPE 24 TABLETS; STRIPS FILM POLYESTER/LLDPE 30 TABLETS | HUMAN | לא | A02BX05 - Bismuth subcitrate 141-57-31835-00 | GAVISCON FORTE PEPPERMINT | גביסקון פורטה מנטה | Treatment of symptoms of gastro-oesophageal reflux such as acid regurgitation, heartburn, indigestion occurring due to the reflux of stomach contents for instance, after gastric surgery, as a result of hiatus hernia, during pregnancy or accompanying reflux oesophagitis. | RECKITT BENCKISER HEALTHCARE (UK) LIMITED | DANSON LANE , HULL, HU8 7DS, ENGLAND | RECKITT BENCKISER (NEAR EAST) LTD | HANAGAR 6, HOD HASHARON 4527704, ISRAEL | 31/08/2024 | 31/08/2014 | SUSPENSION | PER OS | ALGINIC ACID AS SODIUM 100 MG/ML ; POTASSIUM HYDROGENCARBONATE 20 MG/ML | BOTTLE AMBER GLASS TYPE III 150 ML; BOTTLE AMBER GLASS TYPE III 250 ML; BOTTLE AMBER GLASS TYPE III 300 ML; BOTTLE AMBER GLASS TYPE III 500 ML | HUMAN | לא | לא בסל תרופות | A02BX13 - Alginic acid; A12BA04 - Potassium hydrogencarbonate 035-72-25831-00 | COLOTAL TABLETS 135 MG | קולוטאל טבליות 135 מ"ג | Irritable bowel syndrome and conditions included in this group such as: Chronic irritable colon, Gastro- intestinal spasm secondary to organic diseases_x000D_ _x000D_ _x000D_ _x000D_ | PERRIGO ISRAEL PHARMACEUTICALS LTD | P.O.B 16, YERUHAM | PERRIGO ISRAEL PHARMACEUTICALS LTD | POB 16, YERUHAM | 31/08/2023 | 31/08/2013 | TABLETS | PER OS | MEBEVERINE HYDROCHLORIDE 135 MG | BLISTER PVC/PVDC/ALUMINIUM 20 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 50 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 100 TABLETS | HUMAN | לא | בסל תרופות | A03AA04 - Mebeverine 117-85-23254-00 | NOTENSYL TABLETS | נוטנסיל טבליות | Adjunctive therapy in irritable bowel syndrome, neurogenic bowel disturbance. | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | 28/02/2025 | 28/02/2015 | TABLETS | PER OS | DICYCLOMINE HYDROCHLORIDE 10 MG | BLISTER PVC/ALUMINIUM 20 TABLETS | HUMAN | כן | בסל תרופות | A03AA07 - Dicycloverine 117-84-23253-00 | NOTENSYL SYRUP | נוטנסיל סירופ | Adjunctive therapy in irritable bowel syndrome, neurogenic bowel disturbance. | CTS CHEMICAL INDUSTRIES LTD | POB 385, KIRYAT-MALACHI | CTS CHEMICAL INDUSTRIES LTD | POB 385,KIRYAT-MALACHI,ISRAEL | 29/02/2020 | 28/02/2010 | SYRUP | PER OS | DICYCLOMINE HYDROCHLORIDE 10 MG / 5 ML | BOTTLE GLASS 110 ML | HUMAN | כן | בסל תרופות | A03AA07 - Dicycloverine 149-18-33751-01 | SEEBRI BREEZHALER 50 MCG | סיברי בריזהלר 50 מק"ג | Maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). | NOVARTIS PHARMA STEIN AG, SWITZERLAND | SCHAFFHAUSERSTRASSE,CH-4332 STEIN,SWITZERLAND | NOVARTIS ISRAEL LTD | P.O.B 7126, TEL AVIV, ISRAEL | 31/12/2027 | 31/12/2017 | INHALATION POWDER HARD CAPSULES | INHALATION | GLYCOPYRRONIUM AS BROMIDE 50 MCG | BLISTER PVC/OPA/AL 30 CAPSULES | HUMAN | כן | בסל עם הגבלה | A03AB02 - Glycopyrronium 151-39-33990-00 | ULTIBRO BREEZHALER 110/50 MCG | אולטיברו בריזהלר 110/50 מק"ג | Ultibro Breezhaler is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). | NOVARTIS PHARMA STEIN AG, SWITZERLAND | SCHAFFHAUSERSTRASSE,CH-4332 STEIN,SWITZERLAND | NOVARTIS ISRAEL LTD | P.O.B 7126, TEL AVIV, ISRAEL | 31/01/2029 | 31/01/2019 | INHALATION POWDER HARD CAPSULES | INHALATION | INDACATEROL AS MALEATE 110 MCG ; GLYCOPYRRONIUM AS BROMIDE 50 MCG | BLISTER PVC/OPA/AL 6 CAPSULES; BLISTER PVC/OPA/AL 30 CAPSULES | HUMAN | כן | בסל עם הגבלה | A03AB02 - Glycopyrronium; R03AC18 - Indacaterol 125-63-30456-00 | SPASMOMEN TABLETS | ספזמומן טבליות | Treatment of irritable bowel, pain and spasm of the distal enteric tract. | A. MENARINI MANUF. LOGIST. & SERVICES S.R.L | VIA SETTE SANTI 3 - 50131 FLORENCE, ITALY | GENMEDIX , ISRAEL | 12 BEIT HARISHONIM STREET, EMEK-HEFER INDUSTRIAL PARK, 3877701 ISRAEL | 30/06/2024 | 07/07/2019 | TABLETS | PER OS | OTILONIUM BROMIDE 40 MG | BLISTER PVC/PVDC/ALUMINIUM 10 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 30 TABLETS | HUMAN | כן | לא בסל תרופות | A03AB06 - Otilonium bromide; A03AB06 - Otilonium bromide 027-68-22028-21 | PAPAVERINE TEVA INJECTION | פאפאוורין טבע להזרקה | Antispasmodic in visceral spasm, e.g. gastrointestinal colic, biliary and urinary tract spasms. _x000D_ Peripheral vascular disease with vasospastic element. _x000D_ Vascular spasm associated with acute myocardial infarcion, angina pectoris, peripheral and pulmonary embolism. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 31/12/2022 | 31/12/2012 | SOLUTION FOR INJECTION | I.M; I.V | PAPAVERINE HYDROCHLORIDE 40 MG / 2 ML | AMPOULES GLASS TYPE I 10 x 2 ML | HUMAN | כן | A03AD01 - Papaverine 114-88-22094-00 | PAPAVERINE HCL 40 MG | פפברין הידרוכלוריד 40 מ"ג | Treatment of arterial spasm._x000D_ | REKAH PHARMACEUTICAL PROD.LTD | 30,HAMELACHA ST. HOLON 58851 | REKAH PHARMACEUTICAL INDUSTRY | 30 HAMELACHA ST.HOLON 58859 | 30/06/2024 | 30/06/2014 | TABLETS | PER OS | PAPAVERINE HYDROCHLORIDE 40 MG | BLISTER PVC/ALUMINIUM 250 TABLETS; BLISTER PVC/ALUMINIUM 30 TABLETS | HUMAN | כן | בסל תרופות | A03AD01 - Papaverine 118-18-23297-00 | PAPAVERINE HYDROCHLORIDE 80 MG | פאפאברין הידרוכלוריד 80 מ"ג | Antispasmodic. Vasodilator. | REKAH PHARMACEUTICAL PROD.LTD | 30,HAMELACHA ST. HOLON 58851 | REKAH PHARMACEUTICAL INDUSTRY | 30 HAMELACHA ST.HOLON 58859 | 28/02/2025 | 28/02/2015 | TABLETS | PER OS | PAPAVERINE HYDROCHLORIDE 80 MG | BLISTER PVC/ALUMINIUM 25 x 10 TABLETS; BLISTER PVC/ALUMINIUM 3 x 10 TABLETS; BLISTER PVC/ALUMINIUM 10 x 10 TABLETS | HUMAN | כן | בסל תרופות | A03AD01 - Papaverine 161-86-35093-00 | PAPAVERINE HCL STEROP 40 MG/2 ML | פפברין הידרוכלוריד סטרופ 40 מ"ג/ 2 מ"ל | Antispasmodic in visceral spasm, e.g. gastrointestinal colic, biliary and urinary tract spasms. _x000D_ Peripheral vascular disease with vasospastic element. _x000D_ Vascular spasm associated with acute myocardial infarction, angina pectoris, peripheral and pulmonary embolism. | LABORATOIRES STEROP, BELGIUM | AVENUE DE SCHEUT 46-50- 1070 BRUSSELS, BELGIUM | RAZ PHARMACEUTICS LTD, ISRAEL | BUILDING HA'MATECHET ST. 6, NORTH INDUSTRIAL ZONE 60920 KADIMA, ISRAEL | 31/01/2024 | 14/02/2019 | SOLUTION FOR INJECTION | I.M; I.V | PAPAVERINE HYDROCHLORIDE 40 MG / 2 ML | AMPOULES GLASS TYPE I 10 x 2 ML; AMPOULES GLASS TYPE I 100 x 2 ML | HUMAN | כן | בסל עם הגבלה | A03AD01 - Papaverine 149-82-33682-00 | RESOLOR 1 MG | רזולור 1 מ"ג | Resolor is indicated for symptomatic treatment of chronic constipation in adults in whom laxatives fail to provide adequate relief | JANSSEN CILAG S.P.A., ITALY | VIA C. JANSSEN 04100, BORGO S.MICHELE, LATINA | J-C HEALTH CARE LTD | KIBBUTZ SHEFAYIM, SHEFAYIM MALL, 6099000 | 30/04/2028 | 30/04/2018 | FILM COATED TABLETS | PER OS | PRUCALOPRIDE AS SUCCINATE 1 MG | BLISTER ALUMINIUM /ALUMINIUM 28 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 14 TABLETS | HUMAN | A03AE04 - prucalopride 149-83-33683-00 | RESOLOR 2 MG | רזולור 2 מ"ג | Resolor is indicated for symptomatic treatment of chronic constipation in adults in whom laxatives fail to provide adequate relief | JANSSEN CILAG S.P.A., ITALY | VIA C. JANSSEN 04100, BORGO S.MICHELE, LATINA | J-C HEALTH CARE LTD | KIBBUTZ SHEFAYIM, SHEFAYIM MALL, 6099000 | 30/04/2028 | 30/04/2018 | FILM COATED TABLETS | PER OS | PRUCALOPRIDE AS SUCCINATE 2 MG | BLISTER ALUMINIUM /ALUMINIUM 28 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 14 TABLETS | HUMAN | כן | A03AE04 - prucalopride 109-07-26971-00 | COLPERMIN | קולפרמין | For the treatment of symptoms of discomfort abdominal colic and distension following irritable bowel syndrome | TILLOTTS PHARMA AG, SWITZERLAND | BASLERSTRASSE 15, 4310 RHEINFELDEN, SWITZERLAND | TRADIS GAT LTD | 32 HASHACHAM ST., PETAH TIQVA | 28/02/2023 | 28/02/2013 | CAPSULES | PER OS | PEPPERMINT OIL 187 MG | BLISTER PVC/ALUMINIUM 20 CAPSULES; BLISTER PVC/ALUMINIUM 30 CAPSULES; BLISTER PVC/ALUMINIUM 50 CAPSULES; BLISTER PVC/ALUMINIUM 100 CAPSULES | HUMAN | A03AX - OTHER DRUGS FOR FUNCTIONAL BOWEL DISORDERS; A16AX99 - Peppermint oil (טלפון נייד הושמט)-21 | ATROPINE TEVA 1 MG/ML | אטרופין טבע 1 מ"ג/מ"ל | Preanesthetic medication to decrease excessive salivation and secretions of the respiratory tract. Treatment of sinus bradycardia, particularly if complicated by hypotension. Antidote in poisoning by organophosphorus. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 31/01/2023 | 31/01/2013 | SOLUTION FOR INJECTION | I.M; I.V | ATROPINE SULFATE 1 MG/ML | AMPOULES GLASS TYPE I 10 x 1 ML | HUMAN | כן | לא בסל תרופות | A03BA01 - Atropine 021-02-27809-21 | ATROPINE TEVA 20 MG/10 ML | אטרופין טבע 20 מ"ג/10 מ"ל | Preanesthetic medication to decrease excessive salivation and secretions of the respiratory tract. Treatment of sinus bradycardia, particularly if complicated by hypotension. Antidote in poisoning by organophosphorus. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 31/08/2021 | 31/08/2011 | SOLUTION FOR INJECTION | I.V; I.M | ATROPINE SULFATE 20 MG / 10 ML | AMPOULES GLASS TYPE I 5 x 10 ML | HUMAN | כן | בסל תרופות | A03BA01 - Atropine 096-08-28438-00 | ATROPINE CARTRIDGE FOR AUTOMATIC INJECTION 0.5 MG | אטרופין קרפולה למזרק אוטומטי 0.5 מ"ג | For the treatment of organophosphate cholinesterase inhibitors, chemical warfare and nerve gas. | RAFA LABORATORIES LTD, JERUSALEM | POB 405, JERUSALEM 9100301, ISRAEL | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/11/2020 | 30/11/2010 | SOLUTION FOR INJECTION | I.M | ATROPINE AS SULFATE 0.5 MG | CARTRIDGE STAINLESS STEEL 1 x 0.7 ML | HUMAN | כן | A03BA01 - Atropine 096-09-28439-00 | ATROPINE CARTRIDGE FOR AUTOMATIC INJECTION 1 MG | אטרופין קרפולה למזרק אוטומטי 1 מ"ג | For the treatment of organophosphate cholinesterase inhibitors, chemical warfare and nerve gas. | RAFA LABORATORIES LTD, JERUSALEM | POB 405, JERUSALEM 9100301, ISRAEL | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/11/2020 | 30/11/2010 | SOLUTION FOR INJECTION | I.M | ATROPINE AS SULFATE 1 MG | CARTRIDGE STAINLESS STEEL 1 x 0.7 ML | HUMAN | כן | A03BA01 - Atropine 096-10-28440-00 | ATROPINE CARTRIDGE FOR AUTOMATIC INJECTION 2 MG | אטרופין קרפולה למזרק אוטומי 2 מ"ג | For the treatment of organophosphate cholinesterase inhibitors, chemical warfare and nerve gas. | RAFA LABORATORIES LTD, JERUSALEM | POB 405, JERUSALEM 9100301, ISRAEL | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/11/2020 | 30/11/2010 | SOLUTION FOR INJECTION | I.M | ATROPINE AS SULFATE 2 MG | CARTRIDGE STAINLESS STEEL 1 x 0.7 ML | HUMAN | כן | A03BA01 - Atropine 096-27-28668-00 | T.A. 0.5 MG | ת.א. 0.5 מ"ג | For the treatment of organophosphate cholinesterase inhibitors, chemical warfare and nerve gas. | RAFA LABORATORIES LTD, JERUSALEM | POB 405, JERUSALEM 9100301, ISRAEL | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/06/2021 | 30/06/2011 | SOLUTION FOR INJECTION | I.M | TRIMEDOXIME BROMIDE (TMB-4) 20 MG ; ATROPINE SULFATE 0.5 MG | CARTRIDGE STAINLESS STEEL 1 x 0.7 ML | HUMAN | כן | A03BA01 - Atropine 096-28-28669-00 | T.A. 1.0 MG | ת.א. 1 מ"ג | For the treatment of organophosphate cholinesterase inhibitors, chemical warfare and nerve gas. | RAFA LABORATORIES LTD, JERUSALEM | POB 405, JERUSALEM 9100301, ISRAEL | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/06/2021 | 30/06/2011 | SOLUTION FOR INJECTION | I.M | ATROPINE AS SULFATE 1.0 MG ; TRIMEDOXIME BROMIDE (TMB-4) 40 MG | CARTRIDGE STAINLESS STEEL 1 x 0.7 ML | HUMAN | כן | לא בסל תרופות | A03BA01 - Atropine 096-29-28670-00 | T.A. 2.0 MG | ת.א. 2 מ"ג | For the treatment of organophosphate cholinesterase inhibitors, chemical warfare and nerve gas. | RAFA LABORATORIES LTD, JERUSALEM | POB 405, JERUSALEM 9100301, ISRAEL | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/06/2021 | 30/06/2011 | SOLUTION FOR INJECTION | I.M | TRIMEDOXIME BROMIDE (TMB-4) 80 MG ; ATROPINE SULFATE 2 MG | CARTRIDGE STAINLESS STEEL 1 x 0.7 ML | HUMAN | כן | לא בסל תרופות | A03BA01 - Atropine 159-21-34594-00 | ATROPINE SULPHATE S.A.L.F. 1 MG/ML | אטרופין סולפאט ס.א.ל.פ 1 מ"ג/1 מ"ל | Preanesthetic medication to decrease excessive salivation and secretions of the respiratory tract. Treatment of sinus bradycardia, particularly if complicated by hypotension._x000D_ Antidote in poisoning by organophosphorus._x000D_ | S.A.L.F. S.P.A. LABORATORIO FARMACOLOGICO, ITALY | VIA G. MAZZINI 9, 24069 CENATE SOTTO (BERGAMO), ITALY | RAZ PHARMACEUTICS LTD, ISRAEL | BUILDING HA'MATECHET ST. 6, NORTH INDUSTRIAL ZONE 60920 KADIMA, ISRAEL | 31/08/2022 | 04/09/2017 | SOLUTION FOR INJECTION | I.M; I.V | ATROPINE SULFATE 1 MG / 1 ML | AMPOULES GLASS TYPE I 5 x 1 ML | HUMAN | כן | בסל עם הגבלה | A03BA01 - Atropine 142-14-31805-00 | SPASMEX 30 | ספזמקס 30 | For the treatment of vegetative bladder dysfunction accompanied by urgency and/or frequency and/or urinary incontinence. | DR. R. PFLEGER CHEMISCHE FABRIK GMBH, GERMANY | EMIL - KREMMER - STR., 33 D - 96103 HALLSTADT, GERMANY | TEC-O-PHARM-LIBRA LTD | POB 45054, JERUSALEM 91450 | 30/11/2024 | 30/11/2014 | FILM COATED TABLETS | PER OS | TROSPIUM CHLORIDE 30 MG | BLISTER PVC/ALUMINIUM 30 TABLETS; BLISTER PVC/ALUMINIUM 100 TABLETS; BLISTER PVC/ALUMINIUM 10 TABLETS | HUMAN | כן | בסל עם הגבלה | A03DA06 - Trospium and analgesics; G04BD09 - Trospium chloride (טלפון נייד הושמט)-00 | PRAMIN TABLETS | פראמין טבליות | Metoclopramide is an antiemetic and stimulates GI motility. _x000D_ Adult population :_x000D_ Pramin is indicated in adults for: _x000D_ - Prevention of postoperative nausea and vomiting (PONV)_x000D_ - Prevention of delayed nausea and vomiting caused by chemotherapy (delayed CINV)_x000D_ - Prevention of nausea and vomiting caused by radiation therapy_x000D_ - Symptomatic treatment of nausea and vomiting, including nausea and vomiting caused by migraine attack. In migraine attacks, metoclopramide can be used concomitantly with oral analgesics to improve their absorption._x000D_ - Diabetic gastroparesis _x000D_ Pediatric population:_x000D_ Pramin is indicated in children aged 1 to 18 years for: _x000D_ - Second line-therapy: Treatment of established postoperative nausea and vomiting (PONV)_x000D_ - Second-line therapy: Prevention of delayed nausea and vomiting caused by chemotherapy (delayed CINV)_x000D_ | RAFA LABORATORIES LTD, JERUSALEM | POB 405, JERUSALEM 9100301, ISRAEL | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/10/2020 | 31/10/2010 | TABLETS | PER OS | METOCLOPRAMIDE HYDROCHLORIDE 10.52 MG | BLISTER PVC/ALUMINIUM 30 TABLETS | HUMAN | כן | בסל תרופות | A03FA01 - Metoclopramide (טלפון נייד הושמט)-00 | PRAMIN INJECTION | פראמין זריקות | Metoclopramide is an antiemetic and stimulates GI motility. _x000D_ Adult population:_x000D_ Pramin is indicated in adults for: _x000D_ - Prevention of postoperative nausea and vomiting (PONV)_x000D_ - Prevention of delayed nausea and vomiting caused by chemotherapy (delayed CINV)_x000D_ - Prevention of nausea and vomiting caused by radiation therapy_x000D_ - Symptomatic treatment of nausea and vomiting, including nausea and vomiting caused by migraine attack. In migraine attacks, metoclopramide can be used concomitantly with oral analgesics to improve their absorption._x000D_ - Diabetic gastroparesis _x000D_ - To faciliate diagnostic procedures (ie, to faciliate small bowel intubation and as an aid in radiological examinations) (injection only) _x000D_ Pediatric population._x000D_ Pramin is indicated in children aged 1 to 18 years for: _x000D_ - Second line-therapy: Treatment of established postoperative nausea and vomiting (PONV)_x000D_ - Second-line therapy: Prevention of delayed nausea and vomiting caused by chemotherapy (delayed CINV)_x000D_ - To facilitate diagnostic procedures (ie, to faciliate small bowel intubation and as an aid in radiological examinations) (injection only)_x000D_ | RAFA LABORATORIES LTD, JERUSALEM | POB 405, JERUSALEM 9100301, ISRAEL | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/10/2020 | 31/10/2010 | SOLUTION FOR INJECTION | I.M; I.V | METOCLOPRAMIDE HYDROCHLORIDE 10 MG / 2 ML | AMPOULES GLASS TYPE I 5 x 2 ML; AMPOULES GLASS TYPE I 50 x 2 ML; AMPOULES GLASS TYPE I 100 x 2 ML; AMPOULES GLASS TYPE I 25 x 2 ML | HUMAN | כן | בסל תרופות | A03FA01 - Metoclopramide 158-39-34558-00 | METOCLOPRAMIDE S.A.L.F 10 MG/2 ML | מתוקלופראמיד ס.א.ל.פ 10 מ"ג/2 מ"ל | METOCLOPRAMIDE S.A.L.F 10 MG/2 ML is indicated in adults for: _x000D_ - Prevention of postoperative nausea and vomiting (PONV) _x000D_ - Prevention of delayed nausea and vomiting caused by chemotherapy (delayed CINV) _x000D_ - Prevention of nausea and vomiting caused by radiation therapy _x000D_ - Symptomatic treatment of nausea and vomiting, including nausea and vomiting caused by migraine attack. In migraine attacks, metoclopramide can be used concomitantly with oral analgesics to improve their absorption. _x000D_ - Diabetic gastroparesis _x000D_ - To faciliate diagnostic procedures (ie, to faciliate small bowel intubation and as an aid in radiological examinations) Pediatric population. _x000D_ METOCLOPRAMIDE S.A.L.F 10 MG/2 ML is indicated in children aged 1 to 18 years for: _x000D_ - Second line-therapy: _x000D_ Treatment of established postoperative nausea and vomiting (PONV) _x000D_ - Second-line therapy: _x000D_ Prevention of delayed nausea and vomiting caused by chemotherapy (delayed CINV) _x000D_ - To facilitate diagnostic procedures (ie, to faciliate small bowel intubation and as an aid in radiological examinations). | S.A.L.F. S.P.A. LABORATORIO FARMACOLOGICO, ITALY | VIA G. MAZZINI 9, 24069 CENATE SOTTO (BERGAMO), ITALY | RAZ PHARMACEUTICS LTD, ISRAEL | BUILDING HA'MATECHET ST. 6, NORTH INDUSTRIAL ZONE 60920 KADIMA, ISRAEL | 30/04/2022 | 08/05/2017 | SOLUTION FOR INJECTION | I.M; I.V | METOCLOPRAMIDE AS HYDROCHLORIDE MONOHYDRATE 10 MG / 2 ML | AMPOULES GLASS TYPE I 5 x 2 ML | HUMAN | כן | בסל עם הגבלה | A03FA01 - Metoclopramide 013-03-24314-00 | MOTILIUM | מוטיליום | Motilium is indicated for the relief of the symptoms of nausea and vomiting. | JANSSEN CILAG S.A., FRANCE | DOMAINE DE MAIGREMONT 27100, VAL DE REUIL | J-C HEALTH CARE LTD | KIBBUTZ SHEFAYIM, SHEFAYIM MALL, 6099000 | 30/11/2020 | 30/11/2010 | TABLETS | PER OS | DOMPERIDONE 10 MG | BLISTER PVC/ALUMINIUM 20 TABLETS; BLISTER PVC/ALUMINIUM 24 TABLETS; BLISTER PVC/ALUMINIUM 30 TABLETS | HUMAN | כן | בסל תרופות | A03FA03 - Domperidone 049-94-26548-05 | ZOFRAN INJECTION 2MG/ML | זופרן זריקות 2 מ"ג/מ"ל | Adults:_x000D_ Zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. Zofran is indicated for the prevention and treatment of post-operative nausea and vomiting (PONV). _x000D_ Paediatric Population:_x000D_ Zofran is indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in children aged ≥6 months, and for the prevention and treatment of PONV in children aged ≥ 1 month._x000D_ | GLAXO SMITHKLINE MANUFACTURING S.P.A., ITALY | STRADA PROVINCIALE ASOLANA N.90 , 43056 SAN POLO DI TORILLE, PARMA, ITALY | NOVARTIS ISRAEL LTD | P.O.B 7126, TEL AVIV, ISRAEL | 30/06/2023 | 30/06/2013 | SOLUTION FOR INJECTION | I.M; I.V | ONDANSETRON AS HYDROCHLORIDE DIHYDRATE 2MG/ML | AMPOULES GLASS TYPE I 5 x 2 ML; AMPOULES GLASS TYPE I 5 x 4 ML | HUMAN | כן | בסל עם הגבלה | A04AA01 - Ondansetron 049-96-26549-22 | ZOFRAN TABLETS 4 MG | זופרן טבליות 4 מ"ג | Adults:_x000D_ Zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. _x000D_ Zofran is indicated for the prevention and treatment of post-operative nausea and vomiting (PONV). _x000D_ Paediatric Population:_x000D_ Zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy. _x000D_ | ASPEN BAD OLDESLOE GMBH, GERMANY | INDUSTRIESTRASSE 32 -36 , D - 23843 BAD OLDESLOE, GERMANY | NOVARTIS ISRAEL LTD | P.O.B 7126, TEL AVIV, ISRAEL | 31/07/2020 | 31/07/2010 | TABLETS | PER OS | ONDANSETRON AS HYDROCHLORIDE DIHYDRATE 4 MG | BLISTER PVC/ALUMINIUM 10 TABLETS | HUMAN | כן | בסל עם הגבלה | A04AA01 - Ondansetron 049-95-26560-22 | ZOFRAN TABLETS 8 MG | זופרן טבליות 8 מ"ג | Adults:_x000D_ Zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. _x000D_ Zofran is indicated for the prevention and treatment of post-operative nausea and vomiting (PONV). _x000D_ Paediatric Population:_x000D_ Zofran is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy. _x000D_ | ASPEN BAD OLDESLOE GMBH, GERMANY | INDUSTRIESTRASSE 32 -36 , D - 23843 BAD OLDESLOE, GERMANY | NOVARTIS ISRAEL LTD | P.O.B 7126, TEL AVIV, ISRAEL | 31/07/2020 | 31/07/2010 | TABLETS | PER OS | ONDANSETRON AS HYDROCHLORIDE DIHYDRATE 8 MG | BLISTER PVC/ALUMINIUM 10 TABLETS | HUMAN | כן | בסל עם הגבלה | A04AA01 - Ondansetron 148-94-33550-00 | ONDANSETRON - FRESENIUS | אונדאנסטרון - פרזניוס | Adults:_x000D_ For the mangement of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy._x000D_ For the prevention and treatment of post-operative nausea and vomiting (PONV)._x000D_ Paediatric Population:_x000D_ For the mangement of chemotherapy-induced nausea and vomiting (CINV) in children aged ≥ 6 months, and for the prevention and treatment of PONV in children aged ≥ 1 month. | LABESFAL - LABORATORIOS ALMIRO S.A, FRESENIUS KABI GROUP, PORTUGAL | LAGEDO, SANTIAGO DE BESTEIROS, 3465 - 157, PORTUGAL | NEOPHARM (ISRAEL) 1996 LTD | HASHILOACH 6, POB 7063 PETACH TIQVA 4917001 | 30/11/2027 | 30/11/2017 | SOLUTION FOR INJECTION | I.V | ONDANSETRON AS HYDROCHLORIDE DIHYDRATE 2MG/ML | AMPOULES GLASS 50 x 2 ML; AMPOULES GLASS 1 x 4 ML; AMPOULES GLASS 5 x 4 ML; AMPOULES GLASS 10 x 4 ML; AMPOULES GLASS 50 x 4 ML; AMPOULES GLASS 1 x 2 ML; AMPOULES GLASS 5 x 2 ML; AMPOULES GLASS 10 x 2 ML | HUMAN | כן | בסל עם הגבלה | A04AA01 - Ondansetron 150-38-33805-00 | ODNATRON | אודנטרון | Adults:_x000D_ Odnatron is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. Odnatron is indicated for the prevention and treatment of post-operative nausea and vomiting (PONV). _x000D_ Paediatric Population:_x000D_ Odnatron is indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in children aged ≥6 months, and for the prevention and treatment of PONV in children aged ≥ 1 month. | KLEVA S.A., GREECE | 189 PARNITHOS AVENUE, ACHARNAI, ATHENS, GR 13675, GREECE | K.S.KIM INTERNATIONAL LTD | 94 YIGAL ALON STR., TEL-AVIV-YAFO, 6789139 | 31/07/2028 | 31/07/2018 | SOLUTION FOR INJECTION | I.V; I.M | ONDANSETRON AS HYDROCHLORIDE DIHYDRATE 2MG/ML | AMPOULES GLASS TYPE I 5 x 4 ML; AMPOULES GLASS TYPE I 5 x 2 ML | HUMAN | כן | בסל עם הגבלה | A04AA01 - Ondansetron 152-96-34210-00 | ONDANSETRON INOVAMED 8 MG | אונדנסטרון אינובמד 8 מ"ג | Adults : Ondansetron Inovamed is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. _x000D_ For prevention and treatment of post operative nausea and vomiting (PONV)._x000D_ Pediatric population : Ondansetron Inovamed is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy. | AUROBINDO PHARMA LTD., INDIA | PLOT # 2, MAITRIVIHAR, AMEERPET, HYDERABAD, TELANGANA 500 038, INDIA | INOVAMED LTD | 55 BEER GANIM STREET, P.O.B 62, EVEN YEHUDA 40500, ISRAEL | 31/10/2029 | 31/10/2019 | FILM COATED TABLETS | PER OS | ONDANSETRON AS HYDROCHLORIDE DIHYDRATE 8 MG | BLISTER PVC/ALUMINIUM 3 TABLETS; BLISTER PVC/ALUMINIUM 4 TABLETS; BLISTER PVC/ALUMINIUM 6 TABLETS; BLISTER PVC/ALUMINIUM 7 TABLETS; BLISTER PVC/ALUMINIUM 10 TABLETS; BLISTER PVC/ALUMINIUM 14 TABLETS; BLISTER PVC/ALUMINIUM 15 TABLETS; BLISTER PVC/ALUMINIUM 20 TABLETS; BLISTER PVC/ALUMINIUM 28 TABLETS; BLISTER PVC/ALUMINIUM 30 TABLETS; BLISTER PVC/ALUMINIUM 40 TABLETS; BLISTER PVC/ALUMINIUM 49 TABLETS; BLISTER PVC/ALUMINIUM 50 TABLETS; BLISTER PVC/ALUMINIUM 60 TABLETS; BLISTER PVC/ALUMINIUM 90 TABLETS; BLISTER PVC/ALUMINIUM 100 TABLETS; BLISTER PVC/ALUMINIUM 200 TABLETS; BLISTER PVC/ALUMINIUM 300 TABLETS; BLISTER PVC/ALUMINIUM 500 TABLETS | HUMAN | כן | A04AA01 - Ondansetron 152-95-34231-00 | ONDANSETRON INOVAMED 4 MG | אונדנסטרון אינובמד 4 מ"ג | Adults : Ondansetron Inovamed is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. _x000D_ For prevention and treatment of post operative nausea and vomiting (PONV)._x000D_ Pediatric population : Ondansetron Inovamed is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy. | AUROBINDO PHARMA LTD., INDIA | PLOT # 2, MAITRIVIHAR, AMEERPET, HYDERABAD, TELANGANA 500 038, INDIA | INOVAMED LTD | 55 BEER GANIM STREET, P.O.B 62, EVEN YEHUDA 40500, ISRAEL | 31/10/2029 | 31/10/2019 | FILM COATED TABLETS | PER OS | ONDANSETRON AS HYDROCHLORIDE DIHYDRATE 4 MG | BLISTER PVC/ALUMINIUM 3 TABLETS; BLISTER PVC/ALUMINIUM 4 TABLETS; BLISTER PVC/ALUMINIUM 6 TABLETS; BLISTER PVC/ALUMINIUM 7 TABLETS; BLISTER PVC/ALUMINIUM 10 TABLETS; BLISTER PVC/ALUMINIUM 14 TABLETS; BLISTER PVC/ALUMINIUM 15 TABLETS; BLISTER PVC/ALUMINIUM 20 TABLETS; BLISTER PVC/ALUMINIUM 28 TABLETS; BLISTER PVC/ALUMINIUM 30 TABLETS; BLISTER PVC/ALUMINIUM 40 TABLETS; BLISTER PVC/ALUMINIUM 49 TABLETS; BLISTER PVC/ALUMINIUM 50 TABLETS; BLISTER PVC/ALUMINIUM 60 TABLETS; BLISTER PVC/ALUMINIUM 90 TABLETS; BLISTER PVC/ALUMINIUM 100 TABLETS; BLISTER PVC/ALUMINIUM 200 TABLETS; BLISTER PVC/ALUMINIUM 300 TABLETS; BLISTER PVC/ALUMINIUM 500 TABLETS | HUMAN | כן | A04AA01 - Ondansetron 159-95-34421-00 | ONDANSETRON BAXTER 2 MG/ML | אונדנסטרון בקסטר 2 מ"ג/מ"ל | Adults: Odnasetron Baxter is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. Odnasetron Baxter is indicated for the prevention and treatment of post-operative nausea and vomiting (PONV). Paediatric Population: Odnasetron Baxter is indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in children aged 6 months, and for the prevention and treatment of PONV in children aged 2 years. | BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, INDIA | RAMDAS ROAD, OFF. SINDHU BHAVAN ROAD, BODAKDEV, AHMEDABAD - 380054, GUJARAT, INDIA | DAVID MARGALIT & CO.LTD | POB 16666 , TEL AVIV 61166 | 31/12/2022 | 24/01/2018 | SOLUTION FOR INJECTION | I.M; I.V | ONDANSETRON AS HYDROCHLORIDE DIHYDRATE 2MG/ML | AMPOULES GLASS TYPE I 5 x 4 ML; AMPOULES GLASS TYPE I 10 x 4 ML; AMPOULES GLASS TYPE I 25 x 4 ML | HUMAN | כן | בסל עם הגבלה | A04AA01 - Ondansetron 108-57-29244-00 | SETRON 1 MG | סטרון 1 מ"ג | Prevention of nausea and vomiting induced by cytostatic therapy. | PERRIGO ISRAEL PHARMACEUTICALS LTD | P.O.B 16, YERUHAM | PERRIGO ISRAEL PHARMACEUTICALS LTD | POB 16, YERUHAM | 31/12/2022 | 31/12/2012 | TABLETS | PER OS | GRANISETRON AS HYDROCHLORIDE 1 MG | BLISTER PVC/PVDC 10 TABLETS | HUMAN | כן | בסל עם הגבלה | A04AA02 - Granisetron 134-84-31150-00 | PALOXI INJECTION | פאלוקסי זריקות | Paloxi is indicated in adults and in paediatric patients 1 month of age and older for the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy, and prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. | HELSINN HEALTHCARE SA, SWITZERLAND | CH-6915 PAMBIO-NORANCO (LUGANO),SWITZERLAND | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/06/2021 | 30/06/2011 | SOLUTION FOR INJECTION | I.V | PALONOSETRON AS HYDROCHLORIDE 0.25 MG/VIAL | VIAL GLASS TYPE I 1 x 5 ML | HUMAN | כן | בסל עם הגבלה | A04AA05 - Palonosetron 134-84-31150-11 | PALOXI INJECTION | פאלוקסי זריקות | Paloxi is indicated in adults and in paediatric patients 1 month of age and older for the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy, and prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. | HELSINN HEALTHCARE SA, SWITZERLAND | CH-6915 PAMBIO-NORANCO (LUGANO),SWITZERLAND | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/06/2021 | 30/06/2011 | SOLUTION FOR INJECTION | I.V | PALONOSETRON AS HYDROCHLORIDE 0.25MG/VIAL | VIAL GLASS TYPE I 1 x 5 ML | HUMAN | כן | בסל עם הגבלה | A04AA05 - Palonosetron 162-08-35271-00 | PALONOSETRON S.K. | פלונוסטרון אס.קיי. | Palonosetron S.K. is indicated in adults and in paediatric patients 1 month of age and older for the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy, and prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. | RAFARM S.A., GREECE | 12 KORINTHOU ST.,154 51 N PSIHIKO ATHENS, GREECE | K.S.KIM INTERNATIONAL LTD | 94 YIGAL ALON STR., TEL-AVIV-YAFO, 6789139 | 31/03/2024 | 11/04/2019 | SOLUTION FOR INJECTION | I.V | PALONOSETRON AS HYDROCHLORIDE 250 MCG / 5 ML | VIAL GLASS TYPE I 5 ML | HUMAN | כן | בסל עם הגבלה | A04AA05 - Palonosetron 162-48-35784-00 | PALOXI CAPSULES | פאלוקסי כמוסות | Paloxi is indicated in adult for the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. | HELSINN BIREX PHARMACEUTICALS, LTD., IRELAND | DAMASTOWN, MULHUDDART, DUBLIN 15, IRELAND | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/06/2024 | 14/07/2019 | CAPSULES | PER OS | PALONOSETRON AS HYDROCHLORIDE 0.5 MG | BLISTER ALUMINIUM /ALUMINIUM 1 CAPSULES; BLISTER ALUMINIUM /ALUMINIUM 5 CAPSULES | HUMAN | כן | בסל עם הגבלה | A04AA05 - Palonosetron 155-79-34343-00 | AKYNZEO | אקינזאו | Prevention of Acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy. | HELSINN BIREX PHARMACEUTICALS, LTD., IRELAND | DAMASTOWN, MULHUDDART, DUBLIN 15, IRELAND | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/03/2021 | 04/04/2016 | CAPSULES | PER OS | NETUPITANT 300 MG ; PALONOSETRON AS HYDROCHLORIDE 0.50 MG | BLISTER ALUMINIUM /ALUMINIUM 4 CAPSULES; BLISTER ALUMINIUM /ALUMINIUM 1 CAPSULES | HUMAN | כן | בסל עם הגבלה | A04AA55 - Palonosetron, combinations 020-17-20777-00 | TRAVAMIN TABLETS | טרבמין טבליות | For prevention and treatment of motion sickness (air, sea, car sickness) and radiation sickness. | REKAH PHARMACEUTICAL PROD.LTD | 30,HAMELACHA ST. HOLON 58851 | REKAH PHARMACEUTICAL INDUSTRY | 30 HAMELACHA ST.HOLON 58859 | 31/05/2023 | 31/05/2013 | TABLETS | PER OS | DIMENHYDRINATE 100 MG | BLISTER PVC/ALUMINIUM 10 TABLETS | HUMAN | לא | בסל תרופות | A04AD - OTHER ANTIEMETICS; R06AA52 - Diphenhydramine, combinations 135-08-31206-00 | EMEND 80 MG CAPSULES | אימנד 80 מ"ג קפסולות | Emend in combination with other antiemetic agents is indicated for the: _x000D_ - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. _x000D_ - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. | MERCK SHARP & DOHME CORP., USA | ONE MERCK DRIVE, POB 100, WHITEHOUSE STATION, NJ 08889-0100, USA | MERCK SHARP & DOHME ISRAEL LTD | POB 7121,PETAH-TIQVA 49170 | 31/08/2021 | 31/08/2011 | CAPSULES | PER OS | APREPITANT 80 MG | BLISTER PVC/ALUMINIUM 2 CAPSULES; BLISTER PVC/ALUMINIUM 1 + 2 CAPSULES | HUMAN | כן | בסל עם הגבלה | A04AD12 - Aprepitant 135-08-31206-12 | EMEND 80 MG CAPSULES | אימנד 80 מ"ג קפסולות | Emend in combination with other antiemetic agents is indicated for the: _x000D_ - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. _x000D_ - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. | MERCK SHARP & DOHME CORP., USA | ONE MERCK DRIVE, POB 100, WHITEHOUSE STATION, NJ 08889-0100, USA | MERCK SHARP & DOHME ISRAEL LTD | POB 7121,PETAH-TIQVA 49170 | 31/08/2021 | 31/08/2011 | CAPSULES | PER OS | APREPITANT 80 MG | BLISTER PVC/ALUMINIUM 2 CAPSULES; BLISTER PVC/ALUMINIUM 1 + 2 CAPSULES | HUMAN | כן | בסל עם הגבלה | A04AD12 - Aprepitant 135-08-31206-13 | EMEND 80 MG CAPSULES | אימנד 80 מ"ג קפסולות | Emend in combination with other antiemetic agents is indicated for the: _x000D_ - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. _x000D_ - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. | MERCK SHARP & DOHME CORP., USA | ONE MERCK DRIVE, POB 100, WHITEHOUSE STATION, NJ 08889-0100, USA | MERCK SHARP & DOHME ISRAEL LTD | POB 7121,PETAH-TIQVA 49170 | 31/08/2021 | 30/04/2013 | CAPSULES | PER OS | APREPITANT 80 MG | BLISTER PVC/ALUMINIUM 2 CAPSULES; BLISTER PVC/ALUMINIUM 1 + 2 CAPSULES | HUMAN | כן | בסל עם הגבלה | A04AD12 - Aprepitant 135-09-31207-00 | EMEND 125 MG CAPSULES | אימנד 125 מ"ג קפסולות | Emend in combination with other antiemetic agents is indicated for the: _x000D_ - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. _x000D_ - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. | MERCK SHARP & DOHME CORP., USA | ONE MERCK DRIVE, POB 100, WHITEHOUSE STATION, NJ 08889-0100, USA | MERCK SHARP & DOHME ISRAEL LTD | POB 7121,PETAH-TIQVA 49170 | 31/08/2021 | 31/08/2011 | CAPSULES | PER OS | APREPITANT 125 MG | BLISTER PVC/ALUMINIUM 5 CAPSULES; BLISTER PVC/ALUMINIUM 1 + 2 CAPSULES; BLISTER PVC/ALUMINIUM 1 CAPSULES; BLISTER PVC/ALUMINIUM 2 CAPSULES | HUMAN | כן | בסל עם הגבלה | A04AD12 - Aprepitant 135-09-31207-12 | EMEND 125 MG CAPSULES | אימנד 125 מ"ג קפסולות | Emend in combination with other antiemetic agents is indicated for the: _x000D_ - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. _x000D_ - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. | MERCK SHARP & DOHME CORP., USA | ONE MERCK DRIVE, POB 100, WHITEHOUSE STATION, NJ 08889-0100, USA | MERCK SHARP & DOHME ISRAEL LTD | POB 7121,PETAH-TIQVA 49170 | 31/08/2021 | 31/08/2011 | CAPSULES | PER OS | APREPITANT 125 MG | BLISTER PVC/ALUMINIUM 2 CAPSULES; BLISTER PVC/ALUMINIUM 5 CAPSULES; BLISTER PVC/ALUMINIUM 1 + 2 CAPSULES; BLISTER PVC/ALUMINIUM 1 CAPSULES | HUMAN | כן | בסל עם הגבלה | A04AD12 - Aprepitant 135-09-31207-13 | EMEND 125 MG CAPSULES | אימנד 125 מ"ג קפסולות | Emend in combination with other antiemetic agents is indicated for the: _x000D_ - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. _x000D_ - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. | MERCK SHARP & DOHME CORP., USA | ONE MERCK DRIVE, POB 100, WHITEHOUSE STATION, NJ 08889-0100, USA | MERCK SHARP & DOHME ISRAEL LTD | POB 7121,PETAH-TIQVA 49170 | 31/08/2021 | 30/04/2013 | CAPSULES | PER OS | APREPITANT 125 MG | BLISTER PVC/ALUMINIUM 5 CAPSULES; BLISTER PVC/ALUMINIUM 1 + 2 CAPSULES; BLISTER PVC/ALUMINIUM 1 CAPSULES; BLISTER PVC/ALUMINIUM 2 CAPSULES | HUMAN | כן | בסל עם הגבלה | A04AD12 - Aprepitant 159-45-35040-00 | CHENODEOXYCHOLIC ACID LEADIANT | חומצה כנודאוקסיכולית לדיאנט | The treatment of inborn errors of primary bile acid synthesis due to sterol 27 hydroxylase deficiency (presenting as cerebrotendinous xanthomatosis (CTX)) in infants, children and adolescents aged 1 month to 18 years and adults. | PHARMALOOP S.L, SPAIN | C/BOLIVIA, NO15, POLIGONO INDUSTRIAL AZQUE, ALCALA DE HENARES, MADRID 28806, SPAIN | MBI PHARMA LTD., ISRAEL | P.O.B 5061, KADIMA | 30/09/2022 | 30/10/2017 | HARD CAPSULE | PER OS | CHENODEOXYCHOLIC ACID 250 MG | BLISTER PVC/ALUMINIUM 100 CAPSULES | HUMAN | כן | בסל עם הגבלה | A05AA01 - Chenodeoxycholic acid 019-25-20542-00 | URSOLIT 100 | אורסוליט 100 | Dissolution or reductin in size of radiolucent cholesterol in patient with a functioning gallbladder. _x000D_ Treatment of chronic liver diseases including primary billiary cirrhosis, primary sclerosing cholangitis, cystic fibrosis associated liver disease, biliary atresia, chronic hepatitis, and alcohol cirrhosis. | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | 31/12/2021 | 31/12/2011 | TABLETS | PER OS | URSODEOXYCHOLIC ACID 100 MG | BLISTER PVC/ALUMINIUM 100 TABLETS; BLISTER PVC/ALUMINIUM 500 TABLETS; BLISTER PVC/ALUMINIUM 1000 TABLETS; BLISTER PVC/ALUMINIUM 60 TABLETS | HUMAN | כן | בסל תרופות | A05AA02 - Ursodeoxycholic acid (טלפון נייד הושמט)-00 | URSOLIT 300 | אורסוליט 300 | Dissolution or reduction in size of radiolucent cholesterol gallstones in patients with a functioning gallbladder. _x000D_ Treatment of chronic liver diseases including primary biliary cirrhosis, primary sclerosing cholangitis, cystic fibrosis associated liver disease, biliary atresia chronic hepatitis and alcoholic cirrhosis. | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | 30/09/2022 | 30/09/2012 | TABLETS | PER OS | URSODEOXYCHOLIC ACID 300 MG | BLISTER PVC/ALUMINIUM 30 TABLETS | HUMAN | כן | בסל תרופות | A05AA02 - Ursodeoxycholic acid 130-82-30680-00 | URSOFALK CAPSULES 250 | אורסופאלק כמוסות 250 | Treatment of chronic liver diseases Primary Biliary Cirrhosis & Primary Sclerosing Cholangitis. | DR. FALK PHARMA, GERMANY | LEINENWEBERSTR.5, FREIBURG, GERMANY | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/04/2024 | 30/04/2014 | CAPSULES | PER OS | URSODEOXYCHOLIC ACID 250 MG | BLISTER PVC/ALUMINIUM 100 CAPSULES | HUMAN | כן | בסל תרופות | A05AA02 - Ursodeoxycholic acid 130-82-30680-01 | URSOFALK CAPSULES 250 | אורסופאלק כמוסות 250 | Treatment of chronic liver diseases Primary Biliary Cirrhosis & Primary Sclerosing Cholangitis. | DR. FALK PHARMA, GERMANY | LEINENWEBERSTR.5, FREIBURG, GERMANY | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/04/2024 | 24/06/2014 | CAPSULES | PER OS | URSODEOXYCHOLIC ACID 250 MG | BLISTER PVC/ALUMINIUM 100 CAPSULES | HUMAN | כן | בסל תרופות | A05AA02 - Ursodeoxycholic acid 130-82-30680-02 | URSOFALK CAPSULES 250 | אורסופאלק כמוסות 250 | Treatment of chronic liver diseases Primary Biliary Cirrhosis & Primary Sclerosing Cholangitis. | DR. FALK PHARMA, GERMANY | LEINENWEBERSTR.5, FREIBURG, GERMANY | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/04/2024 | 13/12/2018 | CAPSULES | PER OS | URSODEOXYCHOLIC ACID 250 MG | BLISTER PVC/ALUMINIUM 100 CAPSULES | HUMAN | כן | בסל תרופות | A05AA02 - Ursodeoxycholic acid 150-68-33832-00 | URSOFALK 500 | אורסופאלק 500 | For the symptomatic treatment of primary biliary cirrhosis (PBC), in patients without decompensated hepatic cirrhosis. | DR. FALK PHARMA, GERMANY | LEINENWEBERSTR.5, FREIBURG, GERMANY | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/08/2028 | 31/08/2018 | FILM COATED TABLETS | PER OS | URSODEOXYCHOLIC ACID 500 MG | BLISTER PVC/PVDC/ALUMINIUM 50 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 100 TABLETS | HUMAN | כן | בסל תרופות | A05AA02 - Ursodeoxycholic acid 150-68-33832-01 | URSOFALK 500 | אורסופאלק 500 | For the symptomatic treatment of primary biliary cirrhosis (PBC), in patients without decompensated hepatic cirrhosis. | DR. FALK PHARMA, GERMANY | LEINENWEBERSTR.5, FREIBURG, GERMANY | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/08/2028 | 13/12/2018 | FILM COATED TABLETS | PER OS | URSODEOXYCHOLIC ACID 500 MG | BLISTER PVC/PVDC/ALUMINIUM 50 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 100 TABLETS | HUMAN | כן | בסל תרופות | A05AA02 - Ursodeoxycholic acid 155-88-34268-00 | CHOLBAM 50 MG | כולבם 50 מ"ג | •Cholbam is indicated for the treatment of inborn errors in primary bile acid synthesis due to Sterol 27-hydroxylase (presenting as cerebrotendinous xanthomatosis, CTX) deficiency, _x000D_ • 2- (or alfa - ) methylacyl-CoA racemase (AMACR) deficiency in infants, children and adolescents aged 1 month to 18 years and adults_x000D_ • Cholesterol 7 alfa - hydroxylase (CYP7A1) deficiency in infants, children and adolescents aged 1 month to 18 years and adults_x000D_ • 3β-hydroxy-5-C27-steroid oxidoreductase deficiency (also known as 3β-hydroxy-5-C27-steroid dehydrogenase/isomerase or 3β-HSD or HSD3β7. | PATHEON PHARMACEUTICALS INC. | 2110 EAST GALBRAITH RD, CINCINNATI, OH 45237, USA | MEGAPHARM LTD | POB 519, HOD HASHARON 4510501 | 30/04/2021 | 05/05/2016 | HARD CAPSULE | PER OS | CHOLIC ACID 50 MG | BOTTLE HDPE 90 CAPSULES | HUMAN | כן | בסל עם הגבלה | A05AA03 - Cholic acid 155-89-34270-00 | CHOLBAM 250 MG | כולבם 250 מ"ג | • Cholbam is indicated for the treatment of inborn errors in primary bile acid synthesis due to Sterol 27-hydroxylase (presenting as cerebrotendinous xanthomatosis, CTX) deficiency, _x000D_ • 2- (or alfa - ) methylacyl-CoA racemase (AMACR) deficiency in infants, children and adolescents aged 1 month to 18 years and adults_x000D_ • Cholesterol 7 alfa - hydroxylase (CYP7A1) deficiency in infants, children and adolescents aged 1 month to 18 years and adults_x000D_ • 3β-hydroxy-5-C27-steroid oxidoreductase deficiency (also known as 3β-hydroxy-5-C27-steroid dehydrogenase/isomerase or 3β-HSD or HSD3β7. | PATHEON PHARMACEUTICALS INC. | 2110 EAST GALBRAITH RD, CINCINNATI, OH 45237, USA | MEGAPHARM LTD | POB 519, HOD HASHARON 4510501 | 30/04/2021 | 05/05/2016 | HARD CAPSULE | PER OS | CHOLIC ACID 250 MG | BOTTLE HDPE 90 CAPSULES | HUMAN | כן | בסל עם הגבלה | A05AA03 - Cholic acid 160-32-35217-00 | OCALIVA™ 5 MG | אוקליבה 5 מ"ג | OCALIVA is indicated for the treatment of primary biliary cholangitis (also known as primary biliary cirrhosis) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA. | INTERCEPT PHARMA LTD, UK | TWO PANCRAS SQUARE, KINGS CROSS N1C 4AG, LONDON, UK | NEOPHARM LTD, ISRAEL | HASHILOACH 6, POB 7063, PETACH TIKVA 4917001, ISRAEL | 28/02/2023 | 29/03/2018 | FILM COATED TABLETS | PER OS | OBETICHOLIC ACID 5 MG | BOTTLE POLYETHYLENE 30 TABLETS | HUMAN | כן | A05AA04 - Obeticholic acid 160-33-35218-00 | OCALIVA™ 10 MG | אוקליבה 10 מ"ג | OCALIVA is indicated for the treatment of primary biliary cholangitis (also known as primary biliary cirrhosis) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA. | INTERCEPT PHARMA LTD, UK | TWO PANCRAS SQUARE, KINGS CROSS N1C 4AG, LONDON, UK | NEOPHARM LTD, ISRAEL | HASHILOACH 6, POB 7063, PETACH TIKVA 4917001, ISRAEL | 28/02/2023 | 29/03/2018 | FILM COATED TABLETS | PER OS | OBETICHOLIC ACID 10 MG | BOTTLE POLYETHYLENE 30 TABLETS | HUMAN | כן | A05AA04 - Obeticholic acid 140-20-22366-00 | AGIOLAX | אגיולקס | For short - term treatment of constipation. | MADAUS GmbH, GERMANY | 51101 KOELN, GERMANY | MEGAPHARM LTD | POB 519, HOD HASHARON 4510501 | 29/02/2024 | 28/02/2014 | GRANULES | PER OS | ISPAGHULA HUSKS 2.2 G / 100 G ; SENNA 6.74G / 100 G ; ISPAGHULA SEED 52G / 100 G | CONTAINER PVC/PVDC 100 G; CONTAINER PVC/PVDC 200 G | HUMAN | כן | בסל תרופות | A06AB - CONTACT LAXATIVES 118-13-23519-01 | CONTALAX | קונטלקס | Laxative for the relief of constipation. | BEN SHIMON FLORIS LTD, ISRAEL | INDUSTRIAL PARK MISGAV , DN MISGAV, 2017400, ISRAEL | FISCHER PHARMACEUTICALS LTD | POB 39071, TEL-AVIV | 28/02/2025 | 28/02/2015 | SUPPOSITORIES | RECTAL | BISACODYL 0.566% | BLISTER PVC/PE 25 SUPPOSITORIES | HUMAN | כן | בסל תרופות | A06AB02 - Bisacodyl 018-16-24419-12 | LAXADIN | לקסעדין | All types of constipation in ambulatory and bedridden in patients over the age of 6 years . _x000D_ Preparation of patients for abdominal radiography and proctoscopy. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 28/02/2021 | 09/10/2013 | TABLETS | PER OS | BISACODYL 5 MG | BLISTER PVC/ALUMINIUM 10 TABLETS; BLISTER PVC/ALUMINIUM 20 TABLETS; BLISTER PVC/ALUMINIUM 30 TABLETS; BLISTER PVC/ALUMINIUM 50 TABLETS; BLISTER PVC/ALUMINIUM 1000 TABLETS | HUMAN | כן | בסל תרופות | A06AB02 - Bisacodyl 018-16-24419-14 | LAXADIN | לקסעדין | All types of constipation in ambulatory and bedridden in patients over the age of 6 years . _x000D_ Preparation of patients for abdominal radiography and proctoscopy. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 28/02/2021 | 21/12/2014 | TABLETS | PER OS | BISACODYL 5 MG | BLISTER PVC/ALUMINIUM 10 TABLETS; BLISTER PVC/ALUMINIUM 20 TABLETS; BLISTER PVC/ALUMINIUM 30 TABLETS; BLISTER PVC/ALUMINIUM 50 TABLETS; BLISTER PVC/ALUMINIUM 1000 TABLETS | HUMAN | כן | בסל תרופות | A06AB02 - Bisacodyl 130-99-30854-00 | ATZIRUT X | עצירות X | All types of constipation in ambulatory and bedridden patients over the age of 6 years. _x000D_ Preparation of patients for abdominal radiography and proctoscopy._x000D_ | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | 30/06/2024 | 30/06/2014 | TABLETS ENTERIC COATED | PER OS | BISACODYL 5 MG | BLISTER PVC/ALUMINIUM 10 TABLETS; BLISTER PVC/ALUMINIUM 30 TABLETS; BLISTER PVC/ALUMINIUM 50 TABLETS | HUMAN | כן | בסל תרופות | A06AB02 - Bisacodyl 035-84-22447-00 | EASYLAX TABLETS | איזילקס טבליות | Laxative. | SAM-ON LTD.,ISRAEL | 25 HAAVODA ST., BAT-YAM, 59602 ISRAEL | SAM-ON LTD | 25 HAAVODA ST., BAT-YAM, 59602 ISRAEL | 30/09/2023 | 30/09/2013 | TABLETS | PER OS | PHENOLPHTALEIN YELLOW 120 MG | BOTTLE HDPE 20 TABLETS | HUMAN | כן | לא בסל תרופות | A06AB04 - Phenolphthalein 130-27-20919-00 | MIDRO TEA | מידרו תה | Laxative._x000D_ _x000D_ | MIDRO AG, SWITZERLAND | LORRACHER STRASSE 50, 4125 RICHEN, SWITZERLAND | NEOPHARM (ISRAEL) 1996 LTD | HASHILOACH 8, POB 7063 PETACH TIQVA 49170 | 31/03/2020 | 02/03/2015 | TEA | PER OS | SENNAE FOLIUM 75% | BOX PVDC 80 G | HUMAN | כן | בסל תרופות | A06AB06 - Senna glycosides 036-62-25740-00 | BEKUNIS | בקוניס | Laxative. | ROHA ARZNEIMITTEL GmbH, GERMANY | ROCKWINKELER HEERSTR.100 28355 BREMEN GERMANY | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | 31/10/2023 | 31/10/2013 | DRAGEE | PER OS | SENNA 150-220 MG | BOTTLE PLASTIC 45 DRAGEES; BOTTLE PLASTIC 4 DRAGEES | HUMAN | כן | לא בסל תרופות | A06AB06 - Senna glycosides (טלפון נייד הושמט)-00 | LAXATIVE COMPOUND | לקסטיב מורכב | Constipation. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 30/09/2021 | 30/09/2011 | TABLETS | PER OS | IPECACUANHA 4 MG ; BELLADONNA DRY EXTRACT 2.7 MG ; ALOIN 4.5 MG ; ALOE 6 MG ; PHENOLPHTHALEIN 32 MG | BLISTER PVC/ALUMINIUM 10 TABLETS; BLISTER PVC/ALUMINIUM 50 TABLETS | HUMAN | כן | בסל תרופות | A06AB20 - Contact laxatives in combination 151-44-33901-00 | CITRAFLEET | ציטראפליט | For bowel cleansing prior to any diagnostic procedures requiring a clean bowel e.g. colonoscopy or x-ray examination. | CASEN RECORDATI S.L., SPAIN | AUTOVIA DE LOGRONO, KM 13,300, 50 180 UTEBO, ZARAGOZA, SPAIN | DOR PHARMACEUTICAL SERVICES, ISRAEL | 6 HASHFELA ST., KOCHAVE YAIR 44864, ISRAEL | 28/02/2029 | 28/02/2019 | POWDER FOR SOLUTION | PER OS | CITRIC ACID ANHYDROUS 10.97G ; LIGHT MAGNESIUM OXIDE 3.5G ; SODIUM PICOSULFATE 10 MG | SACHET ALUMINIUM 2 x 15.08 G | HUMAN | כן | בסל תרופות | A06AB58 - Sodium picosulfate, combinations 157-91-35155-00 | PICO SALAX CRANBERRY | פיקו סלקס קרנברי | To clean the bowel Prior to X-ray examination, endoscopy or surgery._x000D_ _x000D_ | FERRING GmbH ,GERMANY | WITTLAND 11 d-24109 KIEL, GERMANY | FERRING PHARMACEUTICALS LTD | 8 HASHITA ST, IND. PARK CAESAREA 3088900 | 31/07/2025 | 12/02/2017 | POWDER FOR SOLUTION | PER OS | CITRIC ACID ANHYDROUS 12G ; MAGNESIUM OXIDE 3.5G ; SODIUM PICOSULFATE 10 MG | SACHET PAPER/POLYETHYLENE /ALUMINIUM 2 x 16.1 G | HUMAN | כן | בסל תרופות | A06AB58 - Sodium picosulfate, combinations 062-97-25777-00 | AGIOCUR | אגיוקור | Managemant of bowel function. | MADAUS GmbH, GERMANY | 51101 KOELN, GERMANY | MEGAPHARM LTD | POB 519, HOD HASHARON 4510501 | 29/02/2024 | 28/02/2014 | GRANULES | PER OS | ISPAGHULA HUSKS 2.2G / 100 G; ISPAGHULA SEED 65G / 100 G | CONTAINER PVC/PVDC 200 G; CONTAINER PVC/PVDC 250 G; CONTAINER PVC/PVDC 100 G | HUMAN | לא בסל תרופות | A06AC - BULK PRODUCERS 120-22-30064-00 | KONSYL EASY MIX | קונסיל איזי מיקס | For the treatment of constipation. | KONSYL PHARMACEUTICALS, INC.,USA | 8050 IND.PARK RD., EASTON, MARYLAND 21601 USA | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/11/2020 | 30/11/2010 | POWDER | PER OS | PSYLLIUM 95 % 4.3G | BOTTLE HDPE 300 G | HUMAN | A06AC06 - Methylcellulose 120-21-30065-00 | KONSYL ORANGE SUGAR FREE | קונסיל תפוז ללא סוכר | For the treatment of constipation. | KONSYL PHARMACEUTICALS, INC.,USA | 8050 IND.PARK RD., EASTON, MARYLAND 21601 USA | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/11/2020 | 30/11/2010 | POWDER | PER OS | PSYLLIUM 95 % 3.5G | BOTTLE HDPE 450 G; BOTTLE HDPE 300 G | HUMAN | A06AC06 - Methylcellulose 142-15-32012-00 | NORMALAX | נורמלקס | For the treatment of constipation. | TARO PHARMACEUTICAL INDUSTRIES LTD | 14 HAKITOR ST., HAIFA BAY 2624761, ISRAEL | TARO PHARMACEUTICAL INDUSTRIES LTD | 14 HAKITOR ST., HAIFA BAY 2624761, ISRAEL | 30/11/2024 | 30/11/2014 | POWDER FOR SOLUTION | PER OS | POLYETHYLENE GLYCOL 3350 100 %W/W | BOTTLE HDPE 70 G; BOTTLE HDPE 240 G; SACHET PET/PE/AL 17 G | HUMAN | לא | לא בסל תרופות | A06AD - OSMOTICALLY ACTING LAXATIVES; A06AD15 - Macrogol 062-36-27922-00 | MEROKEN | מרוקן | Bowel cleansing prior to colonoscopy and barium enema x-ray examinations. | TARO PHARMACEUTICAL INDUSTRIES LTD | 14 HAKITOR ST., HAIFA BAY 2624761, ISRAEL | TARO PHARMACEUTICAL INDUSTRIES LTD | 14 HAKITOR ST., HAIFA BAY 2624761, ISRAEL | 31/12/2023 | 31/12/2013 | POWDER FOR SOLUTION | PER OS | MACROGOLS 315.0 G ; POTASSIUM CHLORIDE 1.1175 G ; SODIUM BICARBONATE 4.2840 G ; SODIUM CHLORIDE 8.4240 G | BOTTLE HDPE 3 L | HUMAN | כן | בסל תרופות | A06AD10 - Mineral salts in combination 031-75-25187-00 | AVILAC SYRUP | אבילק סירופ | Constipation. Acute and chronic hepatic encephalopathy. | PERRIGO ISRAEL PHARMACEUTICALS LTD | P.O.B 16, YERUHAM | PERRIGO ISRAEL PHARMACEUTICALS LTD | POB 16, YERUHAM | 31/03/2023 | 31/03/2013 | SYRUP | PER OS | LACTULOSE 66.7G / 100 ML | BOTTLE PET 300 ML; BOTTLE HDPE 300 ML | HUMAN | בסל תרופות | A06AD11 - Lactulose 115-98-29714-00 | LAEVOLAC | לבולק | Constipation. _x000D_ Acute and chronic hepatic encephalopathy. | FRESENIUS KABI AUSTRIA GmbH | HAFNERSTRASSE 36,A-8055 GRAZ, AUSTRIA | MEGAPHARM LTD | POB 519, HOD HASHARON 4510501 | 30/09/2024 | 30/09/2014 | SOLUTION (ORAL) | PER OS | LACTULOSE 670MG/ML | BOTTLE PET 500 ML; BOTTLE PET 300 ML | HUMAN | לא | בסל עם הגבלה | A06AD11 - Lactulose 144-49-33236-00 | PEGLAX NEUTRAL | פגלקס נוטראל | Treatment of constipation. | BEN SHIMON FLORIS LTD, ISRAEL | INDUSTRIAL PARK MISGAV (TARADION), 20179 ISRAEL | NEOPHARM CONSUMER PRODUCTS LTD, ISRAEL | 6 HASHILOACH ST., P.O.B. 7641 PETACH - TIKVA 49170, ISRAEL | 31/10/2025 | 31/10/2015 | POWDER FOR SUSPENSION | PER OS | POLYETHYLENE GLYCOL 3350 99.973%W/W | BOTTLE POLYPROPYLENE 250 G | HUMAN | לא | A06AD15 - Macrogol 144-50-33237-00 | PEGLAX ORANGE | פגלקס תפוז | Treatment of constipation. | BEN SHIMON FLORIS LTD, ISRAEL | INDUSTRIAL PARK MISGAV (TARADION), 20179 ISRAEL | NEOPHARM CONSUMER PRODUCTS LTD, ISRAEL | 6 HASHILOACH ST., P.O.B. 7641 PETACH - TIKVA 49170, ISRAEL | 31/10/2025 | 31/10/2015 | POWDER FOR SUSPENSION | PER OS | POLYETHYLENE GLYCOL 3350 99.365%W/W | BOTTLE POLYPROPYLENE 250 G | HUMAN | לא | A06AD15 - Macrogol 150-25-33953-00 | REGULAX | רגולקס | Treatment of constipation. | BEN SHIMON FLORIS LTD, ISRAEL | INDUSTRIAL PARK MISGAV (TARADION), 20179 ISRAEL | NEOPHARM CONSUMER PRODUCTS LTD, ISRAEL | 6 HASHILOACH ST., P.O.B. 7641 PETACH - TIKVA 49170, ISRAEL | 31/10/2025 | 30/04/2017 | POWDER FOR SUSPENSION | PER OS | POLYETHYLENE GLYCOL 3350 99.973%W/W | BOTTLE POLYPROPYLENE 250 G | HUMAN | לא | A06AD15 - Macrogol 144-87-33306-00 | NORMALAX KIDS | נורמלקס קידס | For the treatment of constipation. | TARO PHARMACEUTICAL INDUSTRIES LTD | 14 HAKITOR ST., HAIFA BAY 2624761, ISRAEL | TARO PHARMACEUTICAL INDUSTRIES LTD | 14 HAKITOR ST., HAIFA BAY 2624761, ISRAEL | 30/11/2025 | 30/11/2015 | POWDER FOR SOLUTION | PER OS | POLYETHYLENE GLYCOL 3350 4G | SACHET ALUMINIUM 100 x 4 G; SACHET ALUMINIUM 20 x 4 G; SACHET ALUMINIUM 30 x 4 G; SACHET ALUMINIUM 50 x 4 G | HUMAN | לא | A06AD15 - Macrogol 158-37-34394-00 | RAZALAX ADULT | רזלקס מבוגרים | Constipation. | ACRAF SPA, ITALY | VIA VECCHIA DEL PINOCCHIO 22, 60131 ANCONA, ITALY | RAZ PHARMACEUTICS LTD, ISRAEL | BUILDING HA'MATECHET ST. 6, NORTH INDUSTRIAL ZONE 60920 KADIMA, ISRAEL | 30/04/2022 | 04/05/2017 | ENEMA | RECTAL | GLYCEROL 6.75G | BOTTLE POLYETHYLENE 6 x 9 G | HUMAN | לא | בסל תרופות | A06AG04 - Glycerol 158-38-34408-00 | RAZALAX CHILDREN | רזלקס ילדים | Constipation. | ACRAF SPA, ITALY | VIA VECCHIA DEL PINOCCHIO 22, 60131 ANCONA, ITALY | RAZ PHARMACEUTICS LTD, ISRAEL | BUILDING HA'MATECHET ST. 6, NORTH INDUSTRIAL ZONE 60920 KADIMA, ISRAEL | 30/04/2022 | 04/05/2017 | ENEMA | RECTAL | GLYCEROL 2.25G | BOTTLE POLYETHYLENE 6 x 3 G | HUMAN | לא | בסל תרופות | A06AG04 - Glycerol 122-09-30186-21 | CLINOLEIC 20 % | קלינולאיק 20% | Source of lipids during parenteral nutrition in situations where oral or enteral feeding is impossible, insufficient or contra-indicated. | BAXTER S.A., BELGIUM | BOULEVARD RENE BRANQUART 80, B-7860 LESSINES,BELGIUM | TEVA MEDICAL MARKETING LTD. | HAORGIM ST. 8, ASHDOD 77100 | 31/03/2023 | 31/03/2013 | EMULSION FOR INFUSION | I.V | OLIVE OIL 80% ; SOYA OIL 20% | BAG PLASTIC 100 ML; BAG PLASTIC 250 ML; BAG PLASTIC 500 ML; BAG PLASTIC 1000 ML; BAG PLASTIC 350 ML | HUMAN | כן | A06AG06 - Oil 034-95-22406-11 | FLEET ENEMA 133 | פליט אנמה 133 | Cleaning the colon before surgery, child birth or medical examinations. | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | 31/08/2023 | 31/08/2013 | ENEMA | RECTAL | SODIUM PHOSPHATE 60MG/ML DIBASIC HEPTAHYDRATE; SODIUM PHOSPHATE 160MG/ML MONOBASIC MONOHYDRATE | BOTTLE POLYETHYLENE 133 ML | HUMAN | בסל תרופות | A06AG20 - Combinations 047-20-23432-03 | MICROLET | מיקרולט | Constipation. | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | 30/09/2029 | 30/09/2019 | ENEMA | RECTAL | GLYCEROL 12.5%W/V ; SODIUM CITRATE 9%W/V ; LAURYLSULPHOACETATE SODIUM 0.9%W/V | TUBE PLASTIC 12 x 5 ML; TUBE PLASTIC 100 x 5 ML; TUBE PLASTIC 500 x 5 ML | HUMAN | בסל תרופות | A06AG20 - Combinations 149-41-33912-00 | FLEET ENEMA 250 | פליט אנמה 250 | Cleaning the colon before surgery, child birth or medical examinations. | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | 31/08/2023 | 31/08/2013 | ENEMA | RECTAL | SODIUM PHOSPHATE 60MG/ML DIBASIC HEPTAHYDRATE; SODIUM PHOSPHATE 160MG/ML MONOBASIC MONOHYDRATE | BOTTLE POLYETHYLENE 250 ML | HUMAN | כן | בסל תרופות | A06AG20 - Combinations 158-90-34907-00 | MOVENTIG 12.5 MG | מובנטיג 12.5 מ"ג | Moventig is indicated for the treatment of opioid-induced constipation (OIC) in adult patients who have had an inadequate response to laxative(s)._x000D_ | ASTRA ZENECA AB, SWEDEN | GÄRTUNAVÄGEN SE-151 85 SÖDERTÄLJE, SWEDEN | ABIR THERAPEUTICS LTD, ISRAEL | WEIZMAN ST. 2, P.O.B. 33123, TEL AVIV 6133101, ISRAEL | 30/06/2022 | 10/07/2017 | FILM COATED TABLETS | PER OS | NALOXEGOL AS OXALATE 12.5 MG | BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 90 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 90 x 1 TABLETS | HUMAN | כן | A06AH03 - Naloxegol 158-90-34907-01 | MOVENTIG 12.5 MG | מובנטיג 12.5 מ"ג | Moventig is indicated for the treatment of opioid-induced constipation (OIC) in adult patients who have had an inadequate response to laxative(s)._x000D_ | ASTRA ZENECA AB, SWEDEN | GÄRTUNAVÄGEN SE-151 85 SÖDERTÄLJE, SWEDEN | ABIR THERAPEUTICS LTD, ISRAEL | WEIZMAN ST. 2, P.O.B. 33123, TEL AVIV 6133101, ISRAEL | 30/06/2022 | 10/07/2017 | FILM COATED TABLETS | PER OS | NALOXEGOL AS OXALATE 12.5 MG | BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 90 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 90 x 1 TABLETS | HUMAN | כן | A06AH03 - Naloxegol 158-91-34908-00 | MOVENTIG 25 MG | מובנטיג 25 מ"ג | Moventig is indicated for the treatment of opioid-induced constipation (OIC) in adult patients who have had an inadequate response to laxative(s)._x000D_ | ASTRA ZENECA AB, SWEDEN | GÄRTUNAVÄGEN SE-151 85 SÖDERTÄLJE, SWEDEN | ABIR THERAPEUTICS LTD, ISRAEL | WEIZMAN ST. 2, P.O.B. 33123, TEL AVIV 6133101, ISRAEL | 30/06/2022 | 10/07/2017 | FILM COATED TABLETS | PER OS | NALOXEGOL AS OXALATE 25 MG | BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 90 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 90 x 1 TABLETS | HUMAN | כן | A06AH03 - Naloxegol 158-91-34908-01 | MOVENTIG 25 MG | מובנטיג 25 מ"ג | Moventig is indicated for the treatment of opioid-induced constipation (OIC) in adult patients who have had an inadequate response to laxative(s)._x000D_ | ASTRA ZENECA AB, SWEDEN | GÄRTUNAVÄGEN SE-151 85 SÖDERTÄLJE, SWEDEN | ABIR THERAPEUTICS LTD, ISRAEL | WEIZMAN ST. 2, P.O.B. 33123, TEL AVIV 6133101, ISRAEL | 30/06/2022 | 10/07/2017 | FILM COATED TABLETS | PER OS | NALOXEGOL AS OXALATE 25 MG | BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 90 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 90 x 1 TABLETS | HUMAN | כן | A06AH03 - Naloxegol 137-97-21926-00 | GLYCERIN SUPPOSITORIES FOR ADULTS | גליצרין פתילות למבוגרים | For relief of constipation. | REKAH PHARMACEUTICAL PROD.LTD | 30,HAMELACHA ST. HOLON 58851 | REKAH PHARMACEUTICAL INDUSTRY | 30 HAMELACHA ST.HOLON 58859 | 31/01/2023 | 31/01/2013 | SUPPOSITORIES | RECTAL | GLYCEROL 2160 MG | FOIL PE/ALUMINIUM 20 SUPPOSITORIES; FOIL PE/ALUMINIUM 1000 SUPPOSITORIES | HUMAN | בסל תרופות | A06AX - OTHER LAXATIVES; A06AX01 - Glycerol 031-38-25506-00 | GLYCERIN SUPPOSITORIES | גליצרין פתילות | For relief of constipation. | SAM-ON LTD.,ISRAEL | 25 HAAVODA ST., BAT-YAM, 59602 ISRAEL | SAM-ON LTD | 25 HAAVODA ST., BAT-YAM, 59602 ISRAEL | 28/02/2023 | 28/02/2013 | SUPPOSITORIES | RECTAL | GLYCEROL 2.35G | FOIL ALUMINIUM 20 SUPPOSITORIES; FOIL ALUMINIUM 40 SUPPOSITORIES; FOIL ALUMINIUM 100 SUPPOSITORIES; FOIL ALUMINIUM 500 SUPPOSITORIES | HUMAN | בסל תרופות | A06AX01 - Glycerol 033-81-25843-00 | GLYCERIN PEDIATRIC SUPPOSITORIES | גליצרין פתילות לילדים | For relief of constipation. | SAM-ON LTD.,ISRAEL | 25 HAAVODA ST., BAT-YAM, 59602 ISRAEL | SAM-ON LTD | 25 HAAVODA ST., BAT-YAM, 59602 ISRAEL | 31/05/2023 | 31/05/2013 | SUPPOSITORIES | RECTAL | GLYCEROL 1337 MG | STRIPS ALUMINIUM 5 SUPPOSITORIES; STRIPS ALUMINIUM 500 SUPPOSITORIES | HUMAN | בסל תרופות | A06AX01 - Glycerol 142-84-32039-00 | GLYCERIN FORTE SUPPOSITORIES | גליצרין פורטה פתילות | For relief of constipation. | SAM-ON LTD.,ISRAEL | 25 HAAVODA ST., BAT-YAM, 59602 ISRAEL | SAM-ON LTD | 25 HAAVODA ST., BAT-YAM, 59602 ISRAEL | 31/01/2025 | 31/01/2015 | SUPPOSITORIES | RECTAL | GLYCERIN 3.2G | STRIPS ALUMINIUM FOIL 10 SUPPOSITORIES; STRIPS ALUMINIUM FOIL 20 SUPPOSITORIES; STRIPS ALUMINIUM FOIL 100 SUPPOSITORIES; STRIPS ALUMINIUM FOIL 500 SUPPOSITORIES | HUMAN | לא | בסל תרופות | A06AX01 - Glycerol 146-41-33387-00 | GLYCERIN SUPPOSITORIES FOR CHILDREN | גליצרין פתילות לילדים | For relief of constipation. | REKAH PHARMACEUTICAL PROD.LTD | 30,HAMELACHA ST. HOLON 58851 | REKAH PHARMACEUTICAL INDUSTRY | 30 HAMELACHA ST.HOLON 58859 | 31/07/2022 | 02/08/2017 | SUPPOSITORIES | RECTAL | GLYCERIN 1.104G | FOIL ALUMINIUM 5 SUPPOSITORIES | HUMAN | לא | A06AX01 - Glycerol 130-97-21681-00 | NEOMYCIN TABLETS | נאומיצין טבליות | Diarrhea due to enteropathogenic escherichia coli. _x000D_ Supression of intestinal bacteria prior to intestinal surgery or as an adjunct in hepatic coma._x000D_ | REKAH PHARMACEUTICAL PROD.LTD | 30,HAMELACHA ST. HOLON 58851 | REKAH PHARMACEUTICAL INDUSTRY | 30 HAMELACHA ST.HOLON 58859 | 31/05/2024 | 31/05/2014 | TABLETS | PER OS | NEOMYCIN AS SULFATE 500 MG | JAR HDPE 20 TABLETS | HUMAN | כן | בסל תרופות | A07AA01 - Neomycin 123-50-25007-00 | NYSTATIN READY MIX | ניסטטין רדי מיקס | For the treatment of oral fungal infections. | TARO PHARMACEUTICAL INDUSTRIES LTD | 14 HAKITOR ST., HAIFA BAY 2624761, ISRAEL | TARO PHARMACEUTICAL INDUSTRIES LTD | 14 HAKITOR ST., HAIFA BAY 2624761, ISRAEL | 31/10/2021 | 31/10/2011 | SUSPENSION | PER OS | NYSTATIN 100000IU/ML | BOTTLE GLASS 30 ML | HUMAN | כן | בסל תרופות | A07AA02 - Nystatin 161-56-35146-00 | NYSTATIN TARO | ניסטטין תרו | For the treatment of oral fungal infections. | TARO PHARMACEUTICAL INDUSTRIES LTD | 14 HAKITOR ST., HAIFA BAY 2624761, ISRAEL | TARO PHARMACEUTICAL INDUSTRIES LTD | 14 HAKITOR ST., HAIFA BAY 2624761, ISRAEL | 31/12/2023 | 09/01/2019 | SUSPENSION | PER OS | NYSTATIN 100000 IU / 1 ML | BOTTLE PET 60 ML | HUMAN | כן | בסל עם הגבלה | A07AA02 - Nystatin 133-63-27437-00 | VANCO-TEVA 500 MG | ונקו-טבע 500 מ"ג | Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci. _x000D_ It is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. _x000D_ Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. _x000D_ Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. For endocarditis due to Streptococcus viridans or Streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside. _x000D_ Vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg Enterococcus fecalis). _x000D_ Vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. In early-onset prosthetic valve endocarditis caused by Staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. Bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. _x000D_ Oral Therapy: _x000D_ Vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated Pseudomembrannous colitis due to Staphylococcus enterocolitis and Clostridium difficile. _x000D_ Vancomycin hydrochloride is not effective orally when administered for other types of infection. | TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY | PALLAGI UT 13, DEBRECEN, HUNGARY 4042 | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 30/11/2020 | 30/11/2010 | LYOPHILIZED POWDER FOR INJECTION | I.V | VANCOMYCIN AS HYDROCHLORIDE 500 MG/VIAL | VIAL GLASS TYPE I 1 VIAL; VIAL GLASS TYPE I 50 VIALS | HUMAN | כן | בסל עם הגבלה | A07AA09 - Vancomycin 133-62-29157-00 | VANCO-TEVA 1 GR | ונקו-טבע 1 גר' | Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci. _x000D_ It is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. _x000D_ Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. _x000D_ Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. For endocarditis due to Streptococcus viridans or Streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside. _x000D_ Vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg Enterococcus fecalis). _x000D_ Vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. In early-onset prosthetic valve endocarditis caused by Staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. _x000D_ Bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. _x000D_ Oral Therapy : _x000D_ Vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated Pseudomembrannous colitis due to Staphylococcus enterocolitis and Clostridium difficile. _x000D_ Vancomycin hydrochloride is not effective orally when administered for other types of infection. | TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY | PALLAGI UT 13, DEBRECEN, HUNGARY 4042 | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 30/11/2020 | 30/11/2010 | LYOPHILIZED POWDER FOR INJECTION | I.V | VANCOMYCIN AS HYDROCHLORIDE 1G/VIAL | VIAL GLASS TYPE I 1 VIAL; VIAL GLASS TYPE I 50 VIALS | HUMAN | כן | בסל עם הגבלה | A07AA09 - Vancomycin 123-63-30297-00 | VANCOMYCIN MYLAN 500 MG | ונקומיצין מיילן 500 מ"ג | Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci. _x000D_ It is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs._x000D_ Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. _x000D_ Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. _x000D_ Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. _x000D_ For endocarditis due to Streptococcus viridans or Streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside. _x000D_ Vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg Enterococcus fecalis). _x000D_ Vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. In early-onset prosthetic valve endocarditis caused by Staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. _x000D_ Bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. _x000D_ Oral Therapy Vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated Pseudomembrannous colitis due to Staphylococcus enterocolitis and Clostridium difficile. _x000D_ Vancomycin hydrochloride is not effective orally when administered for other types of infection. | MYLAN S.A.S., FRANCE | 117 ALLEE DES PARCS, 69800 SAINT PRIEST | GENMEDIX , ISRAEL | 12 BEIT HARISHONIM STREET, EMEK-HEFER INDUSTRIAL PARK, 3877701 ISRAEL | 31/10/2021 | 31/10/2011 | LYOPHILIZED POWDER FOR CONCENTRATED SOLUTION | I.V; ORAL | VANCOMYCIN AS HYDROCHLORIDE 500 MG/VIAL | VIAL GLASS TYPE II 1 VIAL | HUMAN | כן | בסל עם הגבלה | A07AA09 - Vancomycin 123-63-30297-11 | VANCOMYCIN MYLAN 500 MG | ונקומיצין מיילן 500 מ"ג | Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci. _x000D_ It is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. _x000D_ Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. _x000D_ Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. _x000D_ For endocarditis due to Streptococcus viridans or Streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside. Vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg Enterococcus fecalis). _x000D_ Vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. In early-onset prosthetic valve endocarditis caused by Staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. _x000D_ Bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. _x000D_ Oral Therapy Vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated Pseudomembrannous colitis due to Staphylococcus enterocolitis and Clostridium difficile. _x000D_ Vancomycin hydrochloride is not effective orally when administered for other types of infection. | MYLAN S.A.S., FRANCE | 117 ALLEE DES PARCS, 69800 SAINT PRIEST | GENMEDIX , ISRAEL | 12 BEIT HARISHONIM STREET, EMEK-HEFER INDUSTRIAL PARK, 3877701 ISRAEL | 31/10/2021 | 31/10/2011 | LYOPHILIZED POWDER FOR CONCENTRATED SOLUTION | I.V; ORAL | VANCOMYCIN AS HYDROCHLORIDE 500 MG/VIAL | VIAL GLASS TYPE II 1 VIAL | HUMAN | כן | בסל עם הגבלה | A07AA09 - Vancomycin 123-64-30298-00 | VANCOMYCIN MYLAN 1 G. | ונקומיצין מיילן 1 גרם | Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci. _x000D_ It is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs._x000D_ Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. _x000D_ Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. _x000D_ Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. _x000D_ For endocarditis due to Streptococcus viridans or Streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside. _x000D_ Vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg Enterococcus fecalis). _x000D_ Vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. In early-onset prosthetic valve endocarditis caused by Staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. _x000D_ Bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. _x000D_ Oral Therapy Vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated Pseudomembrannous colitis due to Staphylococcus enterocolitis and Clostridium difficile. _x000D_ Vancomycin hydrochloride is not effective orally when administered for other types of infection. | MYLAN S.A.S., FRANCE | 117 ALLEE DES PARCS, 69800 SAINT PRIEST | GENMEDIX , ISRAEL | 12 BEIT HARISHONIM STREET, EMEK-HEFER INDUSTRIAL PARK, 3877701 ISRAEL | 31/10/2021 | 31/10/2011 | LYOPHILIZED POWDER FOR CONCENTRATED SOLUTION | I.V; ORAL | VANCOMYCIN AS HYDROCHLORIDE 1G/VIAL | VIAL GLASS TYPE II 1 VIAL | HUMAN | כן | בסל עם הגבלה | A07AA09 - Vancomycin 123-64-30298-11 | VANCOMYCIN MYLAN 1 G. | ונקומיצין מיילן 1 גרם | Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci. It is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. _x000D_ Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. _x000D_ Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. _x000D_ Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. _x000D_ For endocarditis due to Streptococcus viridans or Streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside._x000D_ Vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg Enterococcus fecalis). _x000D_ Vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. In early-onset prosthetic valve endocarditis caused by Staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. _x000D_ Bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. _x000D_ Oral Therapy Vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated Pseudomembrannous colitis due to Staphylococcus enterocolitis and Clostridium difficile. _x000D_ Vancomycin hydrochloride is not effective orally when administered for other types of infection. | MYLAN S.A.S., FRANCE | 117 ALLEE DES PARCS, 69800 SAINT PRIEST | GENMEDIX , ISRAEL | 12 BEIT HARISHONIM STREET, EMEK-HEFER INDUSTRIAL PARK, 3877701 ISRAEL | 31/10/2021 | 31/10/2011 | LYOPHILIZED POWDER FOR CONCENTRATED SOLUTION | I.V; ORAL | VANCOMYCIN AS HYDROCHLORIDE 1G/VIAL | VIAL GLASS TYPE II 1 VIAL | HUMAN | כן | בסל עם הגבלה | A07AA09 - Vancomycin 153-17-34018-00 | VANCOAVENIR 500 MG | ונקואבניר 500 מ"ג | Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci._x000D_ It is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. _x000D_ Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. _x000D_ Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. _x000D_ For endocarditis due to Streptococcus viridans or Streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside._x000D_ Vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg Enterococcus fecalis). _x000D_ Vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. In early-onset prosthetic valve endocarditis caused by Staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. _x000D_ Bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. _x000D_ Oral Therapy Vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated Pseudomembrannous colitis due to Staphylococcus enterocolitis and Clostridium difficile. Vancomycin hydrochloride is not effective orally when administered for other types of infection. | LABORATORIO REIG JOFRE S.A., SPAIN | GRAN CAPITAN 10, 08970 SANT JOAN DESPI, BARCELONA, SPAIN | BIOAVENIR LTD, ISRAEL | 1 DAVID HAMELECH ST., HERZELIA PITUACH 4666101, ISRAEL | 30/11/2020 | 30/11/2019 | POWDER FOR SOLUTION FOR INJECTION | I.V | VANCOMYCIN AS HYDROCHLORIDE 500MG/VIAL | VIAL GLASS TYPE II 10 VIAL; VIAL GLASS TYPE II 1 VIAL | HUMAN | כן | בסל עם הגבלה | A07AA09 - Vancomycin 153-18-34020-00 | VANCOAVENIR 1 G | ונקואבניר 1 ג' | Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci._x000D_ It is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. _x000D_ Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. _x000D_ Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. _x000D_ For endocarditis due to Streptococcus viridans or Streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside._x000D_ Vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg Enterococcus fecalis). _x000D_ Vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. In early-onset prosthetic valve endocarditis caused by Staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. _x000D_ Bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. _x000D_ Oral Therapy Vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated Pseudomembrannous colitis due to Staphylococcus enterocolitis and Clostridium difficile. Vancomycin hydrochloride is not effective orally when administered for other types of infection. | LABORATORIO REIG JOFRE S.A., SPAIN | GRAN CAPITAN 10, 08970 SANT JOAN DESPI, BARCELONA, SPAIN | BIOAVENIR LTD, ISRAEL | 1 DAVID HAMELECH ST., HERZELIA PITUACH 4666101, ISRAEL | 30/11/2020 | 30/11/2019 | POWDER FOR SOLUTION FOR INJECTION | I.V | VANCOMYCIN AS HYDROCHLORIDE 1G/VIAL | VIAL GLASS TYPE II 10 VIAL; VIAL GLASS TYPE II 1 VIAL | HUMAN | כן | בסל עם הגבלה | A07AA09 - Vancomycin 156-96-34029-00 | VANCOMYCIN LYOMARK 500 MG | ונקומיצין ליאומרק 500 מ"ג | Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci. _x000D_ It is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs._x000D_ Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. _x000D_ Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - structure infection and bone infections. _x000D_ Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. _x000D_ For endocarditis due to Streptococcus viridans or Streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside. _x000D_ Vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg Enterococcus fecalis). _x000D_ Vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. In early-onset prosthetic valve endocarditis caused by Staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. _x000D_ Bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. _x000D_ Oral Therapy:_x000D_ Vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated Pseudomembrannous colitis due to Staphylococcus enterocolitis and Clostridium difficile. _x000D_ Vancomycin hydrochloride is not effective orally when administered for other types of infection._x000D_ | LYOMARK PHARMA GMBH, GERMANY | KELTENRING 17, 82041 OBERHACHING, GERMANY | DAVID MARGALIT & CO.LTD | POB 16666 , TEL AVIV 61166 | 31/07/2021 | 29/08/2016 | POWDER FOR CONCENTRATED SOLUTION | I.V; ORAL | VANCOMYCIN AS HYDROCHLORIDE 500 MG | VIAL GLASS TYPE I 10 VIALS | HUMAN | כן | בסל עם הגבלה | A07AA09 - Vancomycin 156-97-34033-00 | VANCOMYCIN LYOMARK 1000 MG | ונקומיצין ליאומרק 1000 מ"ג | Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci. _x000D_ It is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs._x000D_ Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. _x000D_ Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - structure infection and bone infections. _x000D_ Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal infections are purulent and localized. _x000D_ For endocarditis due to Streptococcus viridans or Streptococcus bovis vancomycin hydrochloride has been shown to be effective in combination with an aminoglycoside. _x000D_ Vancomycin hydrochloride has been shown to be effective only in combination with an aminoglycoside for endocarditis due to enterococci (eg Enterococcus fecalis). _x000D_ Vancomycin hydrochloride has been shown to be effective for the treatment of diphtheroid endocareditis. In early-onset prosthetic valve endocarditis caused by Staphylococcus epidermidis or diptheroids vancomycin hydrochloride has been administered successfully in combination with either rifampin an aminoglycoside or combined with both drugs. _x000D_ Bacteriologic cultures of specimens should be obtained for isolation and identification of causative organisms and determination of susceptibilities to vancomycin hydrochloride. _x000D_ Oral Therapy:_x000D_ Vancomycin hydrochloride injection may be given orally for the treatment of antibiotic-associated Pseudomembrannous colitis due to Staphylococcus enterocolitis and Clostridium difficile. _x000D_ Vancomycin hydrochloride is not effective orally when administered for other types of infection._x000D_ | LYOMARK PHARMA GMBH, GERMANY | KELTENRING 17, 82041 OBERHACHING, GERMANY | DAVID MARGALIT & CO.LTD | POB 16666 , TEL AVIV 61166 | 31/07/2021 | 29/08/2016 | POWDER FOR CONCENTRATED SOLUTION | I.V; ORAL | VANCOMYCIN AS HYDROCHLORIDE 1000 MG | VIAL GLASS TYPE I 10 VIALS | HUMAN | כן | בסל עם הגבלה | A07AA09 - Vancomycin 149-55-33667-00 | LORMYX 200 MG | לורמיקס 200 מ"ג | • Casual treatment of diseases of grown-ups and youngsters from 12 years up, caused by bacteria in the gastrointestinal tract, sensitive to Rifaximin:_x000D_ • hepatic encephalopathy _x000D_ • traveller’s diarrhea, caused by not-invasive enteropathogeneous bacteria._x000D_ • Non-complicated diverticular diseases._x000D_ _x000D_ | ALFASIGMA S.P.A., ITALY | VIA E. FERMI 1, 65020 - ALANNO (PE), ITALY | MEGAPHARM LTD | POB 519, HOD HASHARON 4510501 | 31/03/2028 | 31/03/2018 | FILM COATED TABLETS | PER OS | RIFAXIMINE 200 MG POLYMORPHIC FORM ALPHA | BLISTER PVC/PE/PVDC/AL 12 TABLETS; BLISTER PVC/PE/PVDC/AL 24 TABLETS; BLISTER PVC/PE/PVDC/AL 36 TABLETS | HUMAN | כן | בסל עם הגבלה | A07AA11 - Rifaximin 155-60-34282-00 | DIFICLIR | דיפיקליר | Indicated in adults for the treatment of Clostridium difficile infections (CDI) also known as C. difficile-associated diarrhoea (CDAD) | ASTELLAS PHARMA EUROPE B.V, THE NETHERLANDS | SYLVIUSWEG 62, 2333 BE LEIDEN, P.O.B 344, 2300 AH LEIDEN, THE NETHERLANDS | ASTELLAS PHARMA INTERNATIONAL B.V., ISRAEL | 21 HA'MELACHA STREET, ROSH HA'AYIN, 4809157, ISRAEL | 28/02/2021 | 08/03/2016 | FILM COATED TABLETS | PER OS | FIDAXOMICIN 200 MG | BLISTER ALUMINIUM 20 TABLETS | HUMAN | כן | בסל עם הגבלה | A07AA12 - Fidaxomicin 120-34-28424-00 | NORIT TABLETS | נוריט טבליות | Adsorption of intestinal gas as an aid in the treatment of diarrhea | NORIT NEDERLAND B.V | NIJVERHEIDSWEG-NORD 3812 PM AMERSFOORT, THE NETHERLANDS | HIRSHBERG BROTHERS & CO. | POB 400 HERZLIYA 46103 | 31/10/2020 | 31/10/2010 | TABLETS | PER OS | CHARCOAL ACTIVATED 125 MG | BOTTLE 50 TABLETS; BOTTLE 180 TABLETS; BOTTLE 1000 TABLETS | HUMAN | בסל תרופות | A07BA01 - Charcoal activated 134-82-21600-07 | CARBOSYLANE | קרבוסילן | Anti-flatulent, for symptomatic treatment of stomach ache resulting from accumulation of gas, relief of sensation of fullness, meteorism, bloating and flatulence. | LABORATOIRES GRIMBERG, FRANCE | 19 RUE POLIVEAU 75005 PARIS, FRANCE | TRIMA TRADING (1961), ISRAEL | POST MAABAROT 4023000, ISRAEL | 30/06/2021 | 30/06/2011 | CAPSULES | PER OS | SIMETHICONE 45 MG ; CHARCOAL ACTIVATED 140 MG | BLISTER PVC/ALUMINIUM 48 CAPSULES | HUMAN | בסל תרופות | A07BA51 - Charcoal activated, combinations 120-36-25951-00 | EUCARBON | אאוקרברן | Mild laxative, anti-flatulant. | F. TRENKA CHEM-PHARM FABRIC, AUSTRIA | PRINZ-EUGEN-STRASSE 70, 1040 VIENNA, AUSTRIA | TRUPHARM MARKETING 1985 LTD. | POB 8105,NATHANYA | 31/10/2020 | 31/10/2010 | TABLETS | PER OS | SENNAE FOLIUM 105 MG ; RHUBARB 25 MG ; SULFUR PURIFIED 50 MG ; MEDICINAL CHARCOAL 180 MG | BLISTER PVC/PVDC/ALUMINIUM 30 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 100 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 10 TABLETS | HUMAN | כן | בסל תרופות | A07BA51 - Charcoal activated, combinations 131-72-30868-00 | KALBETEN FORTE SUSPENSION | קלבטן פורטה תרחיף | Relief of diarrhea, nausea, flatulence, convulsive stomach pains, upset stomach. _x000D_ As a preventative treatment of traveler's diarrhea. | SAM-ON LTD.,ISRAEL | 25 HAAVODA ST., BAT-YAM, 59602 ISRAEL | SAM-ON LTD | 25 HAAVODA ST., BAT-YAM, 59602 ISRAEL | 31/10/2024 | 31/10/2014 | SUSPENSION | PER OS | BISMUTH SUB SALICYLATE 262 MG / 7.5 ML | BOTTLE HDPE 100 ML | HUMAN | בסל תרופות | A07BB - BISMUTH PREPARATIONS; A02BX05 - Bismuth subcitrate 114-90-29652-00 | KALBETEN TABLETS | קלבטן טבליות | Relief of diarrhea, nausea, flatulence, convulsive stomach pains, uspet stomach. _x000D_ As a preventative treatment of traveler's diarrhea._x000D_ | SAM-ON LTD.,ISRAEL | 25 HAAVODA ST., BAT-YAM, 59602 ISRAEL | SAM-ON LTD | 25 HAAVODA ST., BAT-YAM, 59602 ISRAEL | 30/06/2024 | 30/06/2014 | TABLETS | PER OS | BISMUTH SUB SALICYLATE 262 MG | BLISTER PVC/ALUMINIUM 20 TABLETS; BLISTER PVC/ALUMINIUM 30 TABLETS; BLISTER PVC/ALUMINIUM 40 TABLETS; BLISTER PVC/ALUMINIUM 10 TABLETS; BOTTLE HDPE 10 TABLETS | HUMAN | בסל תרופות | A07BB - BISMUTH PREPARATIONS; C05AX02 - Bismuth preparations, combinations 025-10-20676-00 | IMODIUM CAPSULES | אימודיום כמוסות | Control and symptomatic relief of acute diarrhea. | JANSSEN CILAG S.A., FRANCE | DOMAINE DE MAIGREMONT 27100, VAL DE REUIL | J-C HEALTH CARE LTD | KIBBUTZ SHEFAYIM, SHEFAYIM MALL, 6099000 | 31/10/2021 | 31/10/2011 | CAPSULES | PER OS | LOPERAMIDE HYDROCHLORIDE 2 MG | BLISTER PVC/ALUMINIUM 6 CAPSULES; BLISTER PVC/ALUMINIUM 10 CAPSULES | HUMAN | בסל תרופות | A07DA - ANTIPROPULSIVES; A07DA03 - Loperamide 066-22-28060-00 | LOPERID CAPSULES | לופריד כמוסות | Control and symptomatic relief of acute diarrhea. | REKAH PHARMACEUTICAL PROD.LTD | 30,HAMELACHA ST. HOLON 58851 | VITAMED PHARMACEUTICAL INDUSTRIES LTD | 6 HATACHANA ST. ,P.O.BOX 114, BINYAMINA 3055002, ISRAEL | 31/01/2025 | 31/01/2015 | CAPSULES | PER OS | LOPERAMIDE HYDROCHLORIDE 2 MG | BLISTER PVC/PVDC/ALUMINIUM 10 CAPSULES | HUMAN | בסל תרופות | A07DA03 - Loperamide 067-64-28224-00 | STOPIT | סטופיט | Acute diarrhoea. | RAFA LABORATORIES LTD, JERUSALEM | POB 405, JERUSALEM 9100301, ISRAEL | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/04/2020 | 30/04/2010 | CAPSULES | PER OS | LOPERAMIDE HYDROCHLORIDE 2 MG | BLISTER PVC/ALUMINIUM 10 CAPSULES | HUMAN | בסל תרופות | A07DA03 - Loperamide 119-92-29984-00 | REKAMIDE | רקמיד | Control and symptomatic relief of acute diarrhea. | REKAH PHARMACEUTICAL PROD.LTD | 30,HAMELACHA ST. HOLON 58851 | REKAH PHARMACEUTICAL INDUSTRY | 30 HAMELACHA ST.HOLON 58859 | 31/08/2020 | 31/08/2010 | TABLETS | PER OS | LOPERAMIDE HYDROCHLORIDE 2 MG | BLISTER PVC/ALUMINIUM 10 TABLETS | HUMAN | בסל תרופות | A07DA03 - Loperamide 131-10-30956-00 | LORAMIDE | לורמיד | Control and symptomatic relief of acute diarrhea._x000D_ | PERRIGO COMPANY, USA | 515 EASTERN AVE., ALLEGAN, MICHIGAN, USA | PERRIGO ISRAEL AGENCIES LTD, ISRAEL | 1 RAKEFET ST., SHOHAM, ISRAEL | 31/05/2024 | 31/05/2014 | CAPLETS | PER OS | LOPERAMIDE HYDROCHLORIDE 2 MG | BLISTER PVC/PVDC 12 CAPLETS; BLISTER PVC/PVDC 18 CAPLETS; BLISTER PVC/PVDC 24 CAPLETS; BLISTER PVC/PVDC 30 CAPLETS; BLISTER PVC/PVDC 6 CAPLETS | HUMAN | בסל תרופות | A07DA03 - Loperamide 135-81-31537-00 | LOPI-CARE TABLETS | לופי-קאר טבליות | Control and symptomatic relief of acute diarrhea. | REKAH PHARMACEUTICAL PROD.LTD | 30,HAMELACHA ST. HOLON 58851 | REKAH PHARMACEUTICAL INDUSTRY | 30 HAMELACHA ST.HOLON 58859 | 31/08/2020 | 31/08/2010 | TABLETS | PER OS | LOPERAMIDE HYDROCHLORIDE 2 MG | BLISTER PVC/ALUMINIUM 10 TABLETS | HUMAN | A07DA03 - Loperamide 117-27-29896-00 | PROCTOFOAM H.C. | פרוקטופואם H.C | Proctofoam HC is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses of the anal region. | KREMERS URBAN PHARMACEUTICALS INC., USA | 1101, "C" AVENUE WEST, SEYMOUR, IN 47274, USA | MEGAPHARM LTD | POB 519, HOD HASHARON 4510501 | 31/10/2020 | 17/11/2015 | FOAM | RECTAL | HYDROCORTISONE ACETATE 1% ; PRAMOCAINE HYDROCHLORIDE 1% | AEROSOL CAN 10 G | HUMAN | כן | A07EA02 - Hydrocortisone 121-91-30196-00 | CORTIFOAM | קורטיפואם | Anti-inflammatory corticosteroid as adjunctive therapy in the topical treatment of ulcerative proctitis of the rectum. | KREMERS URBAN PHARMACEUTICALS INC., USA | 1101, "C" AVENUE WEST, SEYMOUR, IN 47274, USA | MEGAPHARM LTD | POB 519, HOD HASHARON 4510501 | 28/02/2021 | 28/02/2011 | FOAM | RECTAL | HYDROCORTISONE ACETATE 10%W/W | CONTAINER ALUMINIUM 15 G | HUMAN | כן | בסל תרופות | A07EA02 - Hydrocortisone 124-11-30345-00 | EPIFOAM | אפיפואם | Relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. | KREMERS URBAN PHARMACEUTICALS INC., USA | 1101, "C" AVENUE WEST, SEYMOUR, IN 47274, USA | MEGAPHARM LTD | POB 519, HOD HASHARON 4510501 | 30/11/2026 | 30/11/2016 | FOAM | TOPICAL | PRAMOCAINE HYDROCHLORIDE 0.9363%W/W ; HYDROCORTISONE ACETATE 0.9363%W/W | AEROSOL ALUMINIUM 10 G | HUMAN | כן | A07EA02 - Hydrocortisone 104-52-28653-00 | BUDESON 3 MG CAPSULES | בודסון 3 מ"ג כמוסות | Acute mild to moderate Crohn’s disease with involvement of the ileum (twisted intestine) and/or ascending colon (part of large bowel). _x000D_ Collagenous colitis._x000D_ Autoimmune hepatitis._x000D_ | DR. FALK PHARMA, GERMANY | LEINENWEBERSTR.5, FREIBURG, GERMANY | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 28/02/2022 | 28/02/2012 | CAPSULES | PER OS | BUDESONIDE 3 MG | BLISTER PVC/PVDC/ALUMINIUM 100 CAPSULES | HUMAN | כן | בסל עם הגבלה | A07EA06 - Budesonide 104-52-28653-01 | BUDESON 3 MG CAPSULES | בודסון 3 מ"ג כמוסות | Acute mild to moderate Crohn’s disease with involvement of the ileum (twisted intestine) and/or ascending colon (part of large bowel). _x000D_ Collagenous colitis._x000D_ Autoimmune hepatitis._x000D_ | DR. FALK PHARMA, GERMANY | LEINENWEBERSTR.5, FREIBURG, GERMANY | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 28/02/2022 | 13/12/2018 | CAPSULES | PER OS | BUDESONIDE 3 MG | BLISTER PVC/PVDC/ALUMINIUM 100 CAPSULES | HUMAN | כן | בסל עם הגבלה | A07EA06 - Budesonide 126-43-30527-00 | NASOCORT AQUA 32 MCG/DOSE | נזוקורט אקווה 32 מק"ג/מנה | Seasonal and perennial allergic rhinitis, and vasomotor rhinitis. _x000D_ Preventively against nasal polyps after polypectomy. _x000D_ Symptomatic treatment in nasal polyposis. | ASTRA ZENECA AB., SWEDEN | S-151 85 SODERTALJE, SWEDEN | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 31/08/2022 | 31/08/2012 | NASAL SPRAY | NASAL | BUDESONIDE MICRONIZED 0.64 MG/ML | BOTTLE GLASS 1 x 120 DOSES | HUMAN | כן | לא בסל תרופות | A07EA06 - Budesonide 126-44-30528-00 | NASOCORT AQUA 64 MCG/DOSE | נזוקורט אקווה 64 מק"ג/מנה | Seasonal and perennial allergic rhinitis, and vasomotor rhinitis. _x000D_ Preventively against nasal polyps after polypectomy. _x000D_ Symptomatic treatment in nasal polyposis._x000D_ | ASTRA ZENECA AB., SWEDEN | KVARNBERGAGATAN 12, S - 151 85 SODERTALJE, SWEDEN | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 31/08/2022 | 31/08/2012 | NASAL SPRAY | NASAL | BUDESONIDE MICRONIZED 1.28 MG/ML | BOTTLE GLASS 1 x 120 DOSES | HUMAN | כן | לא בסל תרופות | A07EA06 - Budesonide 155-34-34254-00 | CORTIMENT | קורטימנט | For induction of remission in patients with mild to moderate active ulcerative colitis (UC). | COSMO SPA, ITALY | VIA C, COLOMBO, 1, 20020, LAINATE-MILAN, ITALY | FERRING PHARMACEUTICALS LTD | 8 HASHITA ST, IND. PARK CAESAREA 3088900 | 31/12/2020 | 21/01/2016 | TABLETS PROLONGED RELEASE | PER OS | BUDESONIDE 9 MG | BLISTER PVC/PA/ALUMINIUM 10 TABLETS; BLISTER PVC/PA/ALUMINIUM 20 TABLETS; BLISTER PVC/PA/ALUMINIUM 30 TABLETS; BLISTER PVC/PA/ALUMINIUM 50 TABLETS; BLISTER PVC/PA/ALUMINIUM 60 TABLETS; BLISTER PVC/PA/ALUMINIUM 80 TABLETS | HUMAN | כן | בסל עם הגבלה | A07EA06 - Budesonide 157-65-34837-00 | BUDESON 9 MG GRANULES | בודסון 9 מ"ג גרגירים | Acute mild to moderate Crohn’s disease with involvement of the ileium (twisted intestine) and/or ascending colon (part of large bowel)._x000D_ Collagenous colitis._x000D_ | DR. FALK PHARMA, GERMANY | LEINENWEBERSTR.5, FREIBURG, GERMANY | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/12/2021 | 09/01/2017 | GRANULES GASTRO-RESISTANT | PER OS | BUDESONIDE 9 MG | SACHET PETP/ALU/LDPE 30 SACHETS | HUMAN | כן | בסל עם הגבלה | A07EA06 - Budesonide 157-65-34837-02 | BUDESON 9 MG GRANULES | בודסון 9 מ"ג גרגירים | Acute mild to moderate Crohn’s disease with involvement of the ileium (twisted intestine) and/or ascending colon (part of large bowel)._x000D_ Collagenous colitis._x000D_ | DR. FALK PHARMA, GERMANY | LEINENWEBERSTR.5, FREIBURG, GERMANY | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/12/2021 | 12/02/2017 | GRANULES GASTRO-RESISTANT | PER OS | BUDESONIDE 9 MG | SACHET PETP/ALU/LDPE 30 SACHETS | HUMAN | כן | בסל עם הגבלה | A07EA06 - Budesonide 157-65-34837-03 | BUDESON 9 MG GRANULES | בודסון 9 מ"ג גרגירים | Acute mild to moderate Crohn’s disease with involvement of the ileium (twisted intestine) and/or ascending colon (part of large bowel)._x000D_ Collagenous colitis._x000D_ | DR. FALK PHARMA, GERMANY | LEINENWEBERSTR.5, FREIBURG, GERMANY | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/12/2021 | 09/01/2017 | GRANULES GASTRO-RESISTANT | PER OS | BUDESONIDE 9 MG | SACHET PETP/ALU/LDPE 30 SACHETS | HUMAN | כן | בסל עם הגבלה | A07EA06 - Budesonide 163-16-36104-00 | JORVEZA 1 MG | ג'ורבזה 1 מ"ג | Treatment of eosinophilic esophagitis (EoE) in adults. | DR. FALK PHARMA, GERMANY | LEINENWEBERSTR.5, FREIBURG, GERMANY | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/11/2024 | 30/12/2019 | TABLETS ORODISPERSIBLE | PER OS | BUDESONIDE 1 MG | BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 90 TABLETS | HUMAN | כן | A07EA06 - Budesonide 137-64-23871-00 | PENTASA ENEMA | פנטסה חוקן | Ulcerative colitis - Chron's disease | FERRING GmbH ,GERMANY | WITTLAND 11 d-24109 KIEL, GERMANY | FERRING PHARMACEUTICALS LTD | 8 HASHITA ST, IND. PARK CAESAREA 3088900 | 30/11/2022 | 30/11/2012 | ENEMA | RECTAL | MESALAZINE 1G / 100 ML | BOTTLE LDPE 7 ENEMA | HUMAN | כן | בסל תרופות | A07EC - AMINOSALICYLIC ACID AND SIMILAR AGENTS; A07EC02 - Mesalazine 113-34-20570-00 | SALAZOPYRIN EN | סלאזופירין אי.אנ. | For active rheumatoid arthritis which is not controlled by antiinflammatory drugs._x000D_ Ulcerative colitis, Crohn's disease, Pyoderma gangrenosum. | RECIPHARM UPPSALA AB, SWEDEN | BJORKGATAN 30, SE 75182 UPPSALA, SWEDEN | PFIZER PFE PHARMACEUTICALS ISRAEL LTD | 9 SHENKAR STREET, 46725 HERZLIYA PITUACH, ISRAEL | 31/12/2023 | 31/12/2013 | TABLETS ENTERIC COATED | PER OS | SULFASALAZINE 500 MG | BOTTLE HDPE 100 TABLETS; BOTTLE HDPE 300 TABLETS; BLISTER PVC/ALUMINIUM 30 TABLETS; BLISTER PVC/ALUMINIUM 100 TABLETS | HUMAN | כן | בסל תרופות | A07EC01 - Sulfasalazine 113-35-21579-00 | SALAZOPYRIN | סלאזופירין | Treatment of ulcerative colitis and Crohn's disease. | RECIPHARM UPPSALA AB, SWEDEN | BJORKGATAN 30, SE 75182 UPPSALA, SWEDEN | PFIZER PFE PHARMACEUTICALS ISRAEL LTD | 9 SHENKAR STREET, 46725 HERZLIYA PITUACH, ISRAEL | 31/12/2023 | 31/12/2013 | TABLETS | PER OS | SULFASALAZINE 500 MG | BOTTLE HDPE 100 TABLETS; BOTTLE HDPE 300 TABLETS; BLISTER PVC/ALUMINIUM 30 TABLETS; BLISTER PVC/ALUMINIUM 100 TABLETS | HUMAN | כן | בסל תרופות | A07EC01 - Sulfasalazine 029-58-25321-00 | RAFASSAL 4 GRAM ENEMA | ראפאסאל 4 חוקן גרם | Treatment and prevention of ulcerative colitis and Crohn's disease. | RAFA LABORATORIES LTD, JERUSALEM | POB 405, JERUSALEM 9100301, ISRAEL | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/11/2022 | 30/11/2012 | ENEMA | RECTAL | MESALAZINE 4G / 60 G 5 - Aminosalicylic acid | BOTTLE POLYETHYLENE 7 x 60 G | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine 065-99-25654-00 | ASACOL 400 | אסאקול 400 | Maintenance of remission in ulcerative colitis and for treatment of acute episodes in crohn's disease. | TILLOTTS PHARMA AG, SWITZERLAND | BASLERSTRASSE 15 4310 RHEINFELDEN, SWITZERLAND | TRADIS GAT LTD | 32 HASHACHAM ST., PETAH TIQVA | 30/04/2024 | 30/04/2014 | TABLETS ENTERIC COATED | PER OS | MESALAZINE 400 MG | BLISTER PVC/ALUMINIUM 100 TABLETS | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine 065-99-25654-01 | ASACOL 400 | אסאקול 400 | Maintenance of remission in ulcerative colitis and for treatment of acute episodes in crohn's disease. | TILLOTTS PHARMA AG, SWITZERLAND | BASLERSTRASSE 15 4310 RHEINFELDEN, SWITZERLAND | TRADIS GAT LTD | 32 HASHACHAM ST., PETAH TIQVA | 30/04/2024 | 15/07/2018 | TABLETS ENTERIC COATED | PER OS | MESALAZINE 400 MG | BLISTER PVC/ALUMINIUM 100 TABLETS | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine 120-39-26001-00 | RAFASSAL 1 GRAM ENEMA | רפאסאל 1 גרם חוקן | Treatment and prevention of ulcerative colitis and Crohn's disease. | RAFA LABORATORIES LTD, JERUSALEM | POB 405, JERUSALEM 9100301, ISRAEL | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/06/2024 | 30/06/2014 | ENEMA | RECTAL | MESALAZINE 1 G 5 - Aminosalicylic acid | BOTTLE POLYETHYLENE 7 x 60 G | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine (טלפון נייד הושמט)-00 | RAFASSAL 500 MG SUPPOSITORIES | רפאסאל 500 מ"ג פתילות | Treatment and prevention of ulcerative colitis and Crohn's disease. | RAFA LABORATORIES LTD, JERUSALEM | POB 405, JERUSALEM 9100301, ISRAEL | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/10/2020 | 31/10/2010 | SUPPOSITORIES | RECTAL | MESALAZINE 500 MG 5 - Aminosalicylic acid | STRIPS PVC/PE 30 SUPPOSITORIES | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine (טלפון נייד הושמט)-00 | RAFASSAL 500 MG CAPLETS | רפאסאל 500 מ"ג קפליות | Treatment and prevention of ulcerative colitis and Crohn's disease. | RAFA LABORATORIES LTD, JERUSALEM | POB 405, JERUSALEM 9100301, ISRAEL | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/10/2020 | 31/10/2010 | GASTRO RESISTANT CAPLETS | PER OS | MESALAZINE 500 MG 5 - Aminosalicylic acid | BLISTER PVC/PVDC/ALUMINIUM 60 CAPLETS | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine 062-73-26904-00 | PENTASA SUPPOSITORIES | פנטסה פתילות | Ulcerative proctitis. | FERRING INTERNATIONAL CENTER SA, SWITZERLAND | CHEMIN DE LA VERGOGNAUSAZ 50, 1162 ST-PREX, SWITZERLAND | FERRING PHARMACEUTICALS LTD | 8 HASHITA ST, IND. PARK CAESAREA 3088900 | 31/01/2024 | 31/01/2014 | SUPPOSITORIES | RECTAL | MESALAZINE 1000 MG | BLISTER PACK PVC/ALUMINIUM 28 SUPPOSITORIES | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine 064-73-26905-00 | PENTASA SLOW RELEASE TABLETS 500 MG | פנטסה טבליות בשחרור איטי 500 מ"ג | Ulcerative colitis. _x000D_ Crohn's disease._x000D_ | FERRING INTERNATIONAL CENTER SA, SWITZERLAND | CHEMIN DE LA VERGOGNAUSAZ 50, 1162 ST-PREX, SWITZERLAND | FERRING PHARMACEUTICALS LTD | 8 HASHITA ST, IND. PARK CAESAREA 3088900 | 30/06/2024 | 30/06/2014 | TABLETS SLOW RELEASE | PER OS | MESALAZINE 500 MG | BLISTER PVC/OPA/AL 10 TABLETS; BLISTER PVC/OPA/AL 20 TABLETS; BLISTER PVC/OPA/AL 50 TABLETS; BLISTER PVC/OPA/AL 100 TABLETS | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine 069-50-28345-00 | RAFASSAL 1 GRAM SUPPOSITORIES | רפאסאל 1 גרם פתילות | Treatment and prevention of ulcerative colitis and Crohn's disease. | RAFA LABORATORIES LTD, JERUSALEM | POB 405, JERUSALEM 9100301, ISRAEL | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 30/11/2020 | 30/11/2010 | SUPPOSITORIES | RECTAL | MESALAZINE 1000 MG 5 - Aminosalicylic acid | STRIPS PVC/PE 15 SUPPOSITORIES; STRIPS PVC/PE 30 SUPPOSITORIES | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine 067-80-28346-00 | RAFASSAL 1 GRAM CAPLETS | רפאסאל 1 גרם קפליות | Treatment and prevention of ulcerative colitis and Crohn's disease. | RAFA LABORATORIES LTD, JERUSALEM | POB 405, JERUSALEM 9100301, ISRAEL | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/05/2020 | 31/05/2010 | GASTRO RESISTANT CAPLETS | PER OS | MESALAZINE 1000.0 MG 5 - Aminosalicylic acid | BLISTER PVC/ALUMINIUM 3 x 10 CAPLETS | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine 114-57-29591-00 | PENTASA SLOW RELEASE GRANULES 1 GR. | פנטסה גרנולות בשחרור איטי 1 גרם | Treatment of mild to moderate ulcerative colitis or crohn's disease. | FERRING INTERNATIONAL CENTER SA, SWITZERLAND | CHEMIN DE LA VERGOGNAUSAZ 50, 1162 ST-PREX, SWITZERLAND | FERRING PHARMACEUTICALS LTD | 8 HASHITA ST, IND. PARK CAESAREA 3088900 | 31/05/2024 | 31/05/2014 | GRANULES | PER OS | MESALAZINE 1G | SACHET POLYESTER/ALUMINIUM/LDPE 50 ; SACHET POLYESTER/ALUMINIUM/LDPE 100 ; SACHET POLYESTER/ALUMINIUM/LDPE 120 ; SACHET POLYESTER/ALUMINIUM/LDPE 150 | HUMAN | כן | בסל עם הגבלה | A07EC02 - Mesalazine 133-39-31029-00 | ASACOL 800 | אסאקול 800 | Maintenance of remission in ulcerative colitis and for treatment of acute episodes in crohn's disease. | TILLOTTS PHARMA AG, SWITZERLAND | BASLERSTRASSE 15 4310 RHEINFELDEN, SWITZERLAND | TRADIS GAT LTD | 32 HASHACHAM ST., PETAH TIQVA | 31/10/2020 | 31/10/2010 | TABLETS ENTERIC COATED | PER OS | MESALAZINE 800 MG | BLISTER PVC/ALUMINIUM 60 TABLETS; BLISTER PVC/ALUMINIUM 10 TABLETS | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine 133-39-31029-01 | ASACOL 800 | אסאקול 800 | Maintenance of remission in ulcerative colitis and for treatment of acute episodes in crohn's disease. | TILLOTTS PHARMA AG, SWITZERLAND | BASLERSTRASSE 15 4310 RHEINFELDEN, SWITZERLAND | TRADIS GAT LTD | 32 HASHACHAM ST., PETAH TIQVA | 31/10/2020 | 15/07/2018 | TABLETS ENTERIC COATED | PER OS | MESALAZINE 800 MG | BLISTER PVC/ALUMINIUM 60 TABLETS; BLISTER PVC/ALUMINIUM 10 TABLETS | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine 138-91-31560-00 | PENTASA SLOW RELEASE GRANULES 2 G | פנטסה גרנולות בשיחרור איטי 2 גרם | Mild to moderate ulcerative colitis or Crohn's disease._x000D_ | FERRING INTERNATIONAL CENTER SA, SWITZERLAND | CHEMIN DE LA VERGOGNAUSAZ 50, 1162 ST-PREX, SWITZERLAND | FERRING PHARMACEUTICALS LTD | 8 HASHITA ST, IND. PARK CAESAREA 3088900 | 31/07/2023 | 31/07/2013 | GRANULES | PER OS | MESALAZINE 2 G | SACHET POLYESTER/ALUMINIUM/LDPE 120 ; SACHET POLYESTER/ALUMINIUM/LDPE 60 | HUMAN | כן | בסל עם הגבלה | A07EC02 - Mesalazine 147-06-33401-00 | PENTASA SLOW RELEASE TABLETS 1 GRAM | פנטסה טבליות בשחרור איטי 1 גרם | Mild to moderate ulcerative colitis. _x000D_ Crohn's disease._x000D_ | FERRING INTERNATIONAL CENTER SA, SWITZERLAND | CHEMIN DE LA VERGOGNAUSAZ 50, 1162 ST-PREX, SWITZERLAND | FERRING PHARMACEUTICALS LTD | 8 HASHITA ST, IND. PARK CAESAREA 3088900 | 31/12/2026 | 31/12/2016 | TABLETS SLOW RELEASE | PER OS | MESALAZINE 1 G | BLISTER ALUMINIUM 60 TABLETS | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine 147-06-33401-01 | PENTASA SLOW RELEASE TABLETS 1 GRAM | פנטסה טבליות בשחרור איטי 1 גרם | Mild to moderate ulcerative colitis. _x000D_ Crohn's disease._x000D_ | FERRING INTERNATIONAL CENTER SA, SWITZERLAND | CHEMIN DE LA VERGOGNAUSAZ 50, 1162 ST-PREX, SWITZERLAND | FERRING PHARMACEUTICALS LTD | 8 HASHITA ST, IND. PARK CAESAREA 3088900 | 31/12/2026 | 31/12/2016 | TABLETS SLOW RELEASE | PER OS | MESALAZINE 1 G | BLISTER ALUMINIUM 60 TABLETS | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine 151-72-33698-00 | RAFASSAL 1 GRAM GRANULES | רפאסאל 1 גרם גרגירים | For the treatment of acute episodes and the maintenance of remission of ulcerative colitis. | DR. FALK PHARMA, GERMANY | LEINENWEBERSTR.5, FREIBURG, GERMANY | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/03/2029 | 31/03/2019 | GRANULES PROLONGED RELEASE GASTRO RESISTANT | PER OS | MESALAZINE (5 - AMINOSALICYLIC ACID) 1G | PACKETS PETP/ALU/LDPE 30 SACHETS; PACKETS PETP/ALU/LDPE 50 SACHETS; PACKETS PETP/ALU/LDPE 100 SACHETS | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine 151-72-33698-01 | RAFASSAL 1 GRAM GRANULES | רפאסאל 1 גרם גרגירים | For the treatment of acute episodes and the maintenance of remission of ulcerative colitis. | DR. FALK PHARMA, GERMANY | LEINENWEBERSTR.5, FREIBURG, GERMANY | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/03/2029 | 31/03/2019 | GRANULES PROLONGED RELEASE GASTRO RESISTANT | PER OS | MESALAZINE (5 - AMINOSALICYLIC ACID) 1G | PACKETS PETP/ALU/LDPE 30 SACHETS; PACKETS PETP/ALU/LDPE 50 SACHETS; PACKETS PETP/ALU/LDPE 100 SACHETS | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine 151-72-33698-02 | RAFASSAL 1 GRAM GRANULES | רפאסאל 1 גרם גרגירים | For the treatment of acute episodes and the maintenance of remission of ulcerative colitis. | DR. FALK PHARMA, GERMANY | LEINENWEBERSTR.5, FREIBURG, GERMANY | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/03/2029 | 22/01/2020 | GRANULES PROLONGED RELEASE GASTRO RESISTANT | PER OS | MESALAZINE (5 - AMINOSALICYLIC ACID) 1G | PACKETS PETP/ALU/LDPE 30 SACHETS; PACKETS PETP/ALU/LDPE 50 SACHETS; PACKETS PETP/ALU/LDPE 100 SACHETS | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine 151-73-33700-00 | RAFASSAL 1.5 GRAM GRANULES | רפאסאל 1.5 גרם גרגירים | For the treatment of acute episodes and the maintenance of remission of ulcerative colitis. | DR. FALK PHARMA, GERMANY | LEINENWEBERSTR.5, FREIBURG, GERMANY | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/03/2029 | 31/03/2019 | GRANULES PROLONGED RELEASE GASTRO RESISTANT | PER OS | MESALAZINE (5 - AMINOSALICYLIC ACID) 1.5G | PACKETS PETP/ALU/LDPE 30 SACHETS; PACKETS PETP/ALU/LDPE 50 SACHETS; PACKETS PETP/ALU/LDPE 100 SACHETS | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine 151-73-33700-01 | RAFASSAL 1.5 GRAM GRANULES | רפאסאל 1.5 גרם גרגירים | For the treatment of acute episodes and the maintenance of remission of ulcerative colitis. | DR. FALK PHARMA, GERMANY | LEINENWEBERSTR.5, FREIBURG, GERMANY | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/03/2029 | 31/03/2019 | GRANULES PROLONGED RELEASE GASTRO RESISTANT | PER OS | MESALAZINE (5 - AMINOSALICYLIC ACID) 1.5G | PACKETS PETP/ALU/LDPE 30 SACHETS; PACKETS PETP/ALU/LDPE 50 SACHETS; PACKETS PETP/ALU/LDPE 100 SACHETS | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine 151-73-33700-02 | RAFASSAL 1.5 GRAM GRANULES | רפאסאל 1.5 גרם גרגירים | For the treatment of acute episodes and the maintenance of remission of ulcerative colitis. | DR. FALK PHARMA, GERMANY | LEINENWEBERSTR.5, FREIBURG, GERMANY | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/03/2029 | 22/01/2020 | GRANULES PROLONGED RELEASE GASTRO RESISTANT | PER OS | MESALAZINE (5 - AMINOSALICYLIC ACID) 1.5G | PACKETS PETP/ALU/LDPE 30 SACHETS; PACKETS PETP/ALU/LDPE 50 SACHETS; PACKETS PETP/ALU/LDPE 100 SACHETS | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine 151-74-33701-00 | RAFASSAL 3 GRAM GRANULES | רפאסאל 3 גרם גרגירים | For the treatment of acute episodes and the maintenance of remission of ulcerative colitis. | DR. FALK PHARMA, GERMANY | LEINENWEBERSTR.5, FREIBURG, GERMANY | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/03/2029 | 31/03/2019 | GRANULES PROLONGED RELEASE GASTRO RESISTANT | PER OS | MESALAZINE (5 - AMINOSALICYLIC ACID) 3G | PACKETS PETP/ALU/LDPE 30 SACHETS; PACKETS PETP/ALU/LDPE 50 SACHETS; PACKETS PETP/ALU/LDPE 100 SACHETS | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine 151-74-33701-03 | RAFASSAL 3 GRAM GRANULES | רפאסאל 3 גרם גרגירים | For the treatment of acute episodes and the maintenance of remission of ulcerative colitis. | DR. FALK PHARMA, GERMANY | LEINENWEBERSTR.5, FREIBURG, GERMANY | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/03/2029 | 22/01/2020 | GRANULES PROLONGED RELEASE GASTRO RESISTANT | PER OS | MESALAZINE (5 - AMINOSALICYLIC ACID) 3G | PACKETS PETP/ALU/LDPE 30 SACHETS; PACKETS PETP/ALU/LDPE 50 SACHETS; PACKETS PETP/ALU/LDPE 100 SACHETS | HUMAN | כן | בסל תרופות | A07EC02 - Mesalazine 155-55-34070-00 | MEZAVANT 1200 MG | מזוונט 1200 מ"ג | For the induction of clinical and endoscopic remission in patients with mild to moderate, active ulcerative colitis. _x000D_ For maintenance of remission. | COSMO SPA, ITALY | VIA C, COLOMBO, 1, 20020, LAINATE-MILAN, ITALY | MEDISON PHARMA LTD | 10 HASHILOACH ST.,POB 7090 PETACH TIKVA | 28/02/2021 | 03/03/2016 | TABLETS PROLONGED RELEASE | PER OS | MESALAZINE 1200 MG | BLISTER POLYAMIDE/ALUMINIUM/PVC 60 TABLETS; BLISTER POLYAMIDE/ALUMINIUM/PVC 120 TABLETS | HUMAN | כן | A07EC02 - Mesalazine 157-47-34816-00 | PENTASA SLOW RELEASE GRANULES 4 G. | פנטסה גרנולות בשחרור איטי 4 גרם | Mild to moderate ulcerative colitis or crohn's disease. | FERRING INTERNATIONAL CENTER SA, SWITZERLAND | CHEMIN DE LA VERGOGNAUSAZ 50, 1162 ST-PREX, SWITZERLAND | FERRING PHARMACEUTICALS LTD | 8 HASHITA ST, IND. PARK CAESAREA 3088900 | 30/11/2021 | 06/12/2016 | GRANULES | PER OS | MESALAZINE 4000 MG | SACHET POLYESTER/ALUMINIUM/POLYETHYLENE 30 SACHETS | HUMAN | כן | בסל עם הגבלה | A07EC02 - Mesalazine (טלפון נייד הושמט)-00 | RAZIN | רזין | For the treatment of severe obesity that has not responded to an appropriate diet - a minimal body mass index of 30 kg/m2 is required. | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | CTS CHEMICAL INDUSTRIES LTD, ISRAEL | 3 HAKIDMA ST., KIRYAT MALACHI 83057, ISRAEL | 31/08/2022 | 31/08/2012 | CAPSULES | PER OS | PHENTERMINE AS RESINATE 15 MG | BLISTER PVC/ALUMINIUM 30 CAPSULES | HUMAN | Psychoteraphy | כן | לא בסל תרופות | A08AA01 - Phentermine 157-94-34372-00 | BELVIQ ® 10 MG | בלוויק ® 10 מ"ג | Belviq is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of:_x000D_ • 30 kg/m2 or greater (obese), or _x000D_ • 27 kg/m2 or greater (overweight) in the presence of at least one weight related _x000D_ comorbid condition (e.g., hypertension, dyslipidemia, type 2 diabetes) _x000D_ | EISAI CO. LTD, JAPAN | 4-6-10, KOISHIKAWA, BUKYO-KU, TOKYO, 112-8088, JAPAN | ABIC MARKETING LTD, ISRAEL | INDUSTRIAL ZONE, KIRYAT NORDAU, P.O.B. 8077, NETHANYA, ISRAEL | 28/02/2022 | 15/02/2017 | FILM COATED TABLETS | PER OS | LORCASERIN HYDROCHLORIDE HEMIHYDRATE 10.4 MG | BLISTER PVC/ACLAR/ALUMINIUM 10 TABLETS; BLISTER PVC/ACLAR/ALUMINIUM 14 TABLETS; BLISTER PVC/ACLAR/ALUMINIUM 56 TABLETS; BLISTER PVC/ACLAR/ALUMINIUM 60 TABLETS | HUMAN | כן | A08AA11 - Lorcaserin 114-32-29627-00 | XENICAL | קסניקל | Xenical is indicated in conjunction with a mildly hypocaloric diet for the treatment of obese patients with a body mass index (BMI) greater or equal to 30 kg/m2, or overweight patients (BMI > 28 kg/m2) with associated risk factors. | CHEPLAPHARM ARZNEIMITTEL GMBH, GERMANY | BAHNHOFSTRASSE 1A, 17498 MESEKENHAGEN, GERMANY | TZAMAL BIO-PHARMA LTD | 20 HAMAGSHIMIM ST.,KIRYAT MATALON,PETAH-TIKVA | 31/05/2024 | 31/05/2014 | CAPSULES | PER OS | ORLISTAT 120 MG | BLISTER PVC/PVDC 7 CAPSULES; BLISTER PVC/PVDC 21 CAPSULES; BLISTER PVC/PVDC 42 CAPSULES; BLISTER PVC/PVDC 84 CAPSULES | HUMAN | כן | A08AB01 - Orlistat 103-48-28837-00 | CREON 10.000 | קראון 10.000 | Pancreatic exocrine insufficiency. | ABBOTT LABORATORIES GMBH , GERMANY | FREUNDALLEE 9A, 30173 HANNOVER, GERMANY | ABBOTT MEDICAL LABORATORIES LTD, ISRAEL | KIRIAT ATIDIM, POB 58099, TEL-AVIV 61580, ISRAEL | 31/12/2021 | 31/12/2011 | CAPSULES | PER OS | PANCREATIN 150 MG | BOTTLE HDPE 100 CAPSULES; BOTTLE HDPE 200 CAPSULES | HUMAN | בסל עם הגבלה | A09AA02 - Multienzymes (lipase, protease etc.) 119-75-29972-00 | CREON 25000 | קראון 25000 | For the treatment of pancreatic exocrine insufficiency. | ABBOTT LABORATORIES GMBH , GERMANY | FREUNDALLEE 9A, 30173 HANNOVER, GERMANY | ABBOTT MEDICAL LABORATORIES LTD, ISRAEL | KIRIAT ATIDIM, POB 58099, TEL-AVIV 61580, ISRAEL | 31/08/2020 | 31/08/2010 | CAPSULES | PER OS | PANCREATIN 300 MG | BOTTLE HDPE 100 CAPSULES; BOTTLE HDPE 50 CAPSULES | HUMAN | כן | בסל עם הגבלה | A09AA02 - Multienzymes (lipase, protease etc.) 144-04-32928-00 | PICO - SALAX ORANGE | פיקו - סלקס אורנג' | To clean the bowel Prior to X-ray examination, endoscopy or surgery._x000D_ _x000D_ | FERRING GmbH ,GERMANY | WITTLAND 11 d-24109 KIEL, GERMANY | FERRING PHARMACEUTICALS LTD | 8 HASHITA ST, IND. PARK CAESAREA 3088900 | 31/07/2025 | 31/07/2015 | POWDER FOR SOLUTION | PER OS | SODIUM PICOSULFATE 10 MG ; CITRIC ACID ANHYDROUS 12G ; MAGNESIUM OXIDE 3.5G | SACHET PAPER/POLYETHYLENE /ALUMINIUM 2 x 16.1 G | HUMAN | כן | בסל תרופות | A09AB04 - Citric acid; S01AX10 - Sodium propionate 025-17-21245-00 | BABYZIM DROPS | בייביזים טיפות | Treatment of constipation and flatulence. | SAM-ON LTD.,ISRAEL | 25 HAAVODA ST., BAT-YAM, 59602 ISRAEL | SAM-ON LTD | 25 HAAVODA ST., BAT-YAM, 59602 ISRAEL | 31/10/2021 | 31/10/2011 | DROPS | PER OS | PEPSIN 0.6%W/V ; NICOTINIC ACID 0.2%W/V ; SODIUM GLYCEROPHOSPHATE 0.8%W/V | BOTTLE HDPE 40 ML | HUMAN | A09AC01 - Pepsin and acid preparations (טלפון נייד הושמט)-00 | HUMULIN R | הומולין R | For the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis | ELI LILLY & COMPANY LTD., USA | LILLY TECHNOLOGY CENTER, INDIANOPOLIS, INDIANA 46285, USA | ELI LILLY ISRAEL LTD, ISRAEL | 4 HASHEIZAF ST., POB 4246 RA'ANANA 4366411, ISRAEL | 31/07/2021 | 31/07/2011 | SOLUTION FOR INJECTION | I.V; S.C | INSULIN (HUMAN) 100 IU/ML | CARTRIDGE GLASS TYPE I 5 x 3 ML | HUMAN | כן | בסל תרופות | A10AB01 - Insulin (human) (טלפון נייד הושמט)-22 | HUMULIN R | הומולין R | For the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis | LILLY S.A., SPAIN | AVDA DE LA INDUSTRIA 30 28108, ALCOBENDAS, MADRID, SPAIN | ELI LILLY ISRAEL LTD, ISRAEL | 4 HASHEIZAF ST., POB 4246 RA'ANANA 4366411, ISRAEL | 31/07/2021 | 31/07/2011 | SOLUTION FOR INJECTION | I.V; S.C | INSULIN (HUMAN) 100 IU/ML | VIAL GLASS TYPE I 1 x 10 ML | HUMAN | כן | בסל תרופות | A10AB01 - Insulin (human) 049-86-26015-00 | ACTRAPID VIAL | אקטרפיד ויאל | Therapeutic indications_x000D_ Actrapid is indicated for treatment of diabetes mellitus._x000D_ _x000D_ | NOVO NORDISK A/S, DENMARK | NOVO ALLE DK-2880 BAGSVAERD, DENMARK | NOVO NORDISK LTD, ISRAEL | 20 HATA'AS ST.,INDUSTR. AREA, KFAR SABA 4442520, ISRAEL | 31/07/2020 | 31/07/2010 | SOLUTION FOR INJECTION | I.V; S.C | INSULIN (HUMAN) 100IU/ML | VIAL GLASS TYPE I 1 x 10 ML | HUMAN | כן | בסל תרופות | A10AB01 - Insulin (human) 049-82-26016-00 | ACTRAPID PENFILL | אקטרפיד פנפיל | Therapeutic indications_x000D_ Actrapid is indicated for treatment of diabetes mellitus._x000D_ _x000D_ | NOVO NORDISK A/S, DENMARK | NOVO ALLE DK-2880 BAGSVAERD, DENMARK | NOVO NORDISK LTD, ISRAEL | 20 HATA'AS ST.,INDUSTR. AREA, KFAR SABA 4442520, ISRAEL | 31/07/2020 | 31/07/2010 | SOLUTION FOR INJECTION | I.V; S.C | INSULIN (HUMAN) 100U/ML | CARTRIDGE GLASS TYPE I 5 x 3 ML | HUMAN | כן | בסל תרופות | A10AB01 - Insulin (human) (טלפון נייד הושמט)-00 | HUMULIN 70/30 | הומולין 70/30 | For the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis | ELI LILLY & COMPANY LTD., USA | LILLY TECHNOLOGY CENTER, INDIANOPOLIS, INDIANA 46285, USA | ELI LILLY ISRAEL LTD, ISRAEL | 4 HASHEIZAF ST., POB 4246 RA'ANANA 4366411, ISRAEL | 31/07/2021 | 31/07/2011 | SUSPENSION FOR INJECTION | S.C | INSULIN (HUMAN) 100 IU/ML | CARTRIDGE GLASS TYPE I 5 x 3 ML | HUMAN | כן | בסל תרופות | A10AB01 - Insulin (human) (טלפון נייד הושמט)-11 | HUMULIN 70/30 | הומולין 70/30 | For the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis | LILLY S.A., SPAIN | AVDA DE LA INDUSTRIA 30 28108, ALCOBENDAS, MADRID, SPAIN | ELI LILLY ISRAEL LTD, ISRAEL | 4 HASHEIZAF ST., POB 4246 RA'ANANA 4366411, ISRAEL | 31/07/2021 | 31/07/2011 | SUSPENSION FOR INJECTION | S.C | INSULIN (HUMAN) 100 IU/ML | VIAL GLASS TYPE I 1 x 10 ML | HUMAN | כן | בסל תרופות | A10AB01 - Insulin (human) 102-83-28580-00 | HUMALOG | הומלוג | Humalog is indicated for the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. _x000D_ Humalog is also indicated for the initial stabilization of diabetes mellitus. | LILLY FRANCE S.A.S., FRANCE | RUE DU COLONEL LILY 67640, FEGERSHEIM,FRANCE | ELI LILLY ISRAEL LTD | 11 SHENKAR ST,GAV-YAM 4,HERZLIYA PITUACH | 31/07/2021 | 31/07/2011 | SOLUTION FOR INJECTION | S.C; I.V; I.M | INSULIN LISPRO 100U/ML | CARTRIDGE GLASS TYPE I 5 x 3 ML | HUMAN | כן | בסל עם הגבלה | A10AB04 - Insulin lispro 102-83-28580-22 | HUMALOG | הומלוג | Humalog is indicated for the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. _x000D_ Humalog is also indicated for the initial stabilization of diabetes mellitus. | LILLY S.A., SPAIN | AVDA DE LA INDUSTRIA 30 28108, ALCOBENDAS, MADRID, SPAIN | ELI LILLY ISRAEL LTD | 11 SHENKAR ST,GAV-YAM 4,HERZLIYA PITUACH | 31/07/2021 | 31/07/2011 | SOLUTION FOR INJECTION | S.C; I.V | INSULIN LISPRO 100U/ML | VIAL GLASS TYPE I 1 x 10 ML | HUMAN | כן | בסל עם הגבלה | A10AB04 - Insulin lispro 115-34-29722-00 | HUMALOG MIX 25 | הומלוג מיקס 25 | For the treatment of patients with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. | LILLY FRANCE S.A.S., FRANCE | RUE DU COLONEL LILY 67640, FEGERSHEIM,FRANCE | ELI LILLY ISRAEL LTD | 11 SHENKAR ST,GAV-YAM 4,HERZLIYA PITUACH | 31/07/2024 | 31/07/2014 | SUSPENSION FOR INJECTION | S.C | INSULIN LISPRO 25% ; INSULIN LISPRO PROTAMINE 75% | CARTRIDGE GLASS TYPE I 5 x 3 ML | HUMAN | כן | בסל עם הגבלה | A10AB04 - Insulin lispro 115-35-29723-00 | HUMALOG MIX 50 | הומלוג מיקס 50 | For the treatment of patients with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. | ELI LILLY & COMPANY LTD., USA | LILLY TECHNOLOGY CENTER, INDIANOPOLIS, INDIANA 46285, USA | ELI LILLY ISRAEL LTD | 11 SHENKAR ST,GAV-YAM 4,HERZLIYA PITUACH | 31/07/2024 | 31/07/2014 | SUSPENSION FOR INJECTION | S.C | INSULIN LISPRO 50% ; INSULIN LISPRO PROTAMINE 50% | CARTRIDGE GLASS TYPE I 5 x 3 ML | HUMAN | כן | בסל עם הגבלה | A10AB04 - Insulin lispro 143-44-33216-00 | HUMALOG KWIKPEN 100 U/ML | הומלוג קוויק פן 100 יח'/מ"ל | Humalog KwikPen is indicated for the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. _x000D_ Humalog is also indicated for the initial stabalization of diabetes mellitus. | ELI LILLY & COMPANY LTD., USA | LILLY TECHNOLOGY CENTER, INDIANOPOLIS, INDIANA 46285, USA | ELI LILLY ISRAEL LTD | 11 SHENKAR ST,GAV-YAM 4,HERZLIYA PITUACH | 30/04/2025 | 30/04/2015 | SOLUTION FOR INJECTION | I.V; S.C | INSULIN LISPRO 100U/ML | PEN INJECTOR GLASS TYPE I 5 x 3 ML | HUMAN | כן | בסל עם הגבלה | A10AB04 - Insulin lispro 143-45-33217-00 | HUMALOG MIX 25 KWIKPEN | הומלוג מיקס 25 קוויק פן | Humalog Mix 25 KwikPen is indicated for the treatment of patients with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. | ELI LILLY & COMPANY LTD., USA | LILLY TECHNOLOGY CENTER, INDIANOPOLIS, INDIANA 46285, USA | ELI LILLY ISRAEL LTD | 11 SHENKAR ST,GAV-YAM 4,HERZLIYA PITUACH | 30/04/2025 | 30/04/2015 | SUSPENSION FOR INJECTION | S.C | INSULIN LISPRO 25% ; INSULIN LISPRO AS PROTAMINE 75% | PEN INJECTOR GLASS TYPE I 5 x 3 ML | HUMAN | כן | בסל עם הגבלה | A10AB04 - Insulin lispro 143-46-33218-00 | HUMALOG MIX 50 KWIKPEN | הומלוג מיקס 50 קוויק פן | Humalog Mix 50 KwikPen is indicated for the treatment of patients with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. | ELI LILLY & COMPANY LTD., USA | LILLY TECHNOLOGY CENTER, INDIANOPOLIS, INDIANA 46285, USA | ELI LILLY ISRAEL LTD | 11 SHENKAR ST,GAV-YAM 4,HERZLIYA PITUACH | 30/04/2025 | 30/04/2015 | SUSPENSION FOR INJECTION | S.C | INSULIN LISPRO 50% ; INSULIN LISPRO AS PROTAMINE 50% | PEN INJECTOR GLASS TYPE I 5 x 3 ML | HUMAN | כן | בסל עם הגבלה | A10AB04 - Insulin lispro 155-39-34483-00 | HUMALOG KWIKPEN 200 U/ML | הומלוג קוויק פן 200 יח'/מ"ל | For the treatment of adults with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. _x000D_ Humalog KwikPen 200 units/ml is also indicated for the initial stabilisation of diabetes mellitus. | LILLY FRANCE | 2 RUE DU COLONEL LILLY, 67640 FEGERSHEIM, FRANCE | ELI LILLY ISRAEL LTD | 11 SHENKAR ST,GAV-YAM 4,HERZLIYA PITUACH | 31/01/2021 | 07/02/2016 | SOLUTION FOR INJECTION | S.C | INSULIN LISPRO 200U/ML | PEN INJECTOR GLASS TYPE I 2 x 3 ML; PEN INJECTOR GLASS TYPE I 5 x 3 ML | HUMAN | כן | בסל עם הגבלה | A10AB04 - Insulin lispro 118-94-29983-00 | NOVORAPID | נובורפיד | Treatment of patients with diabetes mellitus in adults, adolescents and children aged 2 years and above. | NOVO NORDISK A/S, DENMARK | NOVO ALLE DK-2880 BAGSVAERD, DENMARK | NOVO NORDISK LTD, ISRAEL | 20 HATA'AS ST.,INDUSTR. AREA, KFAR SABA 4442520, ISRAEL | 30/06/2020 | 30/06/2010 | SOLUTION FOR INJECTION | S.C | INSULIN ASPART 100U/ML | PRE FILLED PEN GLASS TYPE I 5 x 3 ML; PRE FILLED PEN GLASS TYPE I 1 x 3 ML; PRE FILLED PEN GLASS TYPE I 1 x 3 ML; PRE FILLED PEN GLASS TYPE I 5 x 3 ML; PRE FILLED PEN GLASS TYPE I 1 x 3 ML; CARTRIDGE GLASS TYPE I 5 x 3 ML; VIAL GLASS TYPE I 1 x 10 ML | HUMAN | כן | בסל עם הגבלה | A10AB05 - Insulin aspart 122-67-30240-00 | NOVOMIX 30 PENFILL | נובומיקס 30 פנפיל | Treatment of diabetes mellitus. | NOVO NORDISK A/S, DENMARK | NOVO ALLE DK-2880 BAGSVAERD, DENMARK | NOVO NORDISK LTD, ISRAEL | 20 HATA'AS ST.,INDUSTR. AREA, KFAR SABA 4442520, ISRAEL | 30/06/2021 | 30/06/2011 | SUSPENSION FOR INJECTION | S.C | INSULIN ASPART 100IU/ML | CARTRIDGE GLASS TYPE I 5 x 3 ML | HUMAN | כן | בסל עם הגבלה | A10AB05 - Insulin aspart 138-75-31773-00 | NOVOMIX 50 FLEXPEN | נובומיקס 50 פלקספן | NovoMix 50 is indicated for treatment of diabetes mellitus in adults. | NOVO NORDISK A/S, DENMARK | NOVO ALLE DK-2880 BAGSVAERD, DENMARK | NOVO NORDISK LTD, ISRAEL | 20 HATA'AS ST.,INDUSTR. AREA, KFAR SABA 4442520, ISRAEL | 31/05/2023 | 31/05/2013 | SUSPENSION FOR INJECTION | S.C | INSULIN ASPART 100U/ML | PRE FILLED PEN GLASS TYPE I 5 x 3 ML | HUMAN | כן | בסל עם הגבלה | A10AB05 - Insulin aspart 138-76-31774-00 | NOVOMIX 70 FLEXPEN | נובומיקס 70 פלקספן | NovoMix 70 is indicated for treatment of diabetes mellitus in adults. | NOVO NORDISK A/S, DENMARK | NOVO ALLE DK-2880 BAGSVAERD, DENMARK | NOVO NORDISK LTD, ISRAEL | 20 HATA'AS ST.,INDUSTR. AREA, KFAR SABA 4442520, ISRAEL | 31/05/2023 | 31/05/2013 | SUSPENSION FOR INJECTION | S.C | INSULIN ASPART 100U/ML | PRE FILLED PEN GLASS TYPE I 5 x 3 ML | HUMAN | כן | בסל עם הגבלה | A10AB05 - Insulin aspart 162-63-35192-00 | FIASP | פיאספ | Treatment of diabetes mellitus in adults | NOVO NORDISK A/S, DENMARK | NOVO ALLE DK-2880 BAGSVAERD, DENMARK | NOVO NORDISK LTD, ISRAEL | 20 HATA'AS ST.,INDUSTR. AREA, KFAR SABA 4442520, ISRAEL | 31/08/2024 | 02/09/2019 | SOLUTION FOR INJECTION | S.C | INSULIN ASPART 100U/ML | PRE FILLED PEN GLASS TYPE I 1 x 3 ML; PRE FILLED PEN GLASS TYPE I 5 x 3 ML; CARTRIDGE GLASS TYPE I 5 x 3 ML; VIAL GLASS TYPE I 1 x 10 ML | HUMAN | כן | בסל עם הגבלה | A10AB05 - Insulin aspart 132-94-31195-00 | APIDRA | אפידרה | Treatment of adults, adolescents and children, 6 years or older with diabetes mellitus, where treatment with insulin is required. | SANOFI - AVENTIS DEUTSCHLAND GMBH, GERMANY | INDUSTRIEPARK HOCHST, D-65926, FRANKFURT AM MAIN, GERMANY | SANOFI - AVENTIS ISRAEL LTD | 10 BENI GAON, POB 8090, NETANYA 4250499, ISRAEL | 31/05/2020 | 31/05/2010 | SOLUTION FOR INJECTION | S.C | INSULIN GLULISINE 100U/ML | PRE FILLED PEN GLASS TYPE I 5 x 3 ML; CARTRIDGE GLASS TYPE I 5 x 3 ML; VIAL GLASS TYPE I 1 x 10 ML | HUMAN | כן | בסל עם הגבלה | A10AB06 - Insulin glulisine (טלפון נייד הושמט)-00 | HUMULIN N | הומולין N | For the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis | ELI LILLY & COMPANY LTD., USA | LILLY TECHNOLOGY CENTER, INDIANOPOLIS, INDIANA 46285, USA | ELI LILLY ISRAEL LTD, ISRAEL | 4 HASHEIZAF ST., POB 4246 RA'ANANA 4366411, ISRAEL | 31/07/2021 | 31/07/2011 | SUSPENSION FOR INJECTION | S.C | INSULIN (HUMAN) 100 IU/ML | CARTRIDGE GLASS TYPE I 5 x 3 ML | HUMAN | כן | בסל תרופות | A10AC01 - Insulin (human) (טלפון נייד הושמט)-22 | HUMULIN N | הומולין N | For the treatment of patients with diabetes mellitus who require insulin for the maintenance of glucose homeostasis | LILLY S.A., SPAIN | AVDA DE LA INDUSTRIA 30 28108, ALCOBENDAS, MADRID, SPAIN | ELI LILLY ISRAEL LTD, ISRAEL | 4 HASHEIZAF ST., POB 4246 RA'ANANA 4366411, ISRAEL | 31/07/2021 | 31/07/2011 | SUSPENSION FOR INJECTION | S.C | INSULIN (HUMAN) 100 IU/ML | VIAL GLASS TYPE I 1 x 10 ML | HUMAN | כן | בסל תרופות | A10AC01 - Insulin (human) 049-88-26013-00 | INSULATARD VIAL | אינסולטרד ויאל | Treatment of diabetes mellitus. | NOVO NORDISK A/S, DENMARK | NOVO ALLE DK-2880 BAGSVAERD, DENMARK | NOVO NORDISK LTD, ISRAEL | 20 HATA'AS ST.,INDUSTR. AREA, KFAR SABA 4442520, ISRAEL | 31/07/2020 | 31/07/2010 | SUSPENSION FOR INJECTION | S.C | INSULIN (HUMAN) 100IU/ML | VIAL GLASS TYPE I 1 x 10 ML | HUMAN | כן | בסל תרופות | A10AC01 - Insulin (human) 049-83-26014-00 | INSULATARD PENFILL | אינסולטרד פנפיל | _x000D_ Insulatard is indicated for treatment of diabetes mellitus_x000D_ | NOVO NORDISK A/S, DENMARK | NOVO ALLE DK-2880 BAGSVAERD, DENMARK | NOVO NORDISK LTD, ISRAEL | 20 HATA'AS ST.,INDUSTR. AREA, KFAR SABA 4442520, ISRAEL | 31/07/2020 | 31/07/2010 | SUSPENSION FOR INJECTION | S.C | INSULIN (HUMAN) 100IU/ML | CARTRIDGE GLASS TYPE I 5 x 3 ML | HUMAN | כן | בסל תרופות | A10AC01 - Insulin (human) 049-85-26012-00 | MIXTARD 30 VIAL | מיקסטרד 30 ויאל | Treatment of diabetes mellitus. | NOVO NORDISK A/S, DENMARK | NOVO ALLE DK-2880 BAGSVAERD, DENMARK | NOVO NORDISK LTD, ISRAEL | 20 HATA'AS ST.,INDUSTR. AREA, KFAR SABA 4442520, ISRAEL | 31/07/2020 | 31/07/2010 | SUSPENSION FOR INJECTION | S.C | INSULIN (HUMAN) 100IU/ML | VIAL GLASS TYPE I 1 x 10 ML | HUMAN | כן | בסל תרופות | A10AD01 - Insulin (human) 049-84-26018-00 | MIXTARD 30 PENFILL | מיקסטרד 30 פנפיל | Therapeutic indications_x000D_ Mixtard is indicated for treatment of diabetes mellitus._x000D_ _x000D_ | NOVO NORDISK A/S, DENMARK | NOVO ALLE DK-2880 BAGSVAERD, DENMARK | NOVO NORDISK LTD, ISRAEL | 20 HATA'AS ST.,INDUSTR. AREA, KFAR SABA 4442520, ISRAEL | 31/07/2020 | 31/07/2010 | SUSPENSION FOR INJECTION | S.C | INSULIN (HUMAN) 100IU/ML | CARTRIDGE GLASS TYPE I 5 x 3 ML | HUMAN | כן | בסל תרופות | A10AD01 - Insulin (human) 127-24-30599-00 | NOVOMIX 30 FLEXPEN | נובומיקס 30 פלקספן | NovoMix® 30 is indicated for treatment of diabetes mellitus in adults, adolescents and children aged 10 years and above. | NOVO NORDISK A/S, DENMARK | NOVO ALLE DK-2880 BAGSVAERD, DENMARK | NOVO NORDISK LTD, ISRAEL | 20 HATA'AS ST.,INDUSTR. AREA, KFAR SABA 4442520, ISRAEL | 30/11/2022 | 30/11/2012 | SUSPENSION FOR INJECTION | S.C | INSULIN ASPART 100U/ML | PRE FILLED PEN 5 x 3 ML; PRE FILLED PEN 1 x 3 ML | HUMAN | כן | בסל עם הגבלה | A10AD05 - Insulin aspart 152-10-33910-00 | RYZODEG | רייזודג | Treatment of diabetes mellitus in adults, adolescents and children from the age of 12 years. | NOVO NORDISK A/S, DENMARK | NOVO ALLE DK-2880 BAGSVAERD, DENMARK | NOVO NORDISK LTD, ISRAEL | 20 HATA'AS ST.,INDUSTR. AREA, KFAR SABA 4442520, ISRAEL | 31/05/2029 | 31/05/2019 | SOLUTION FOR INJECTION | S.C | INSULIN DEGLUDEC 70U/ML ; INSULIN ASPART 30U/ML | PRE FILLED PEN GLASS TYPE I 1 x 3 ML; PRE FILLED PEN GLASS TYPE I 5 x 3 ML; PRE FILLED PEN GLASS TYPE I 1 x 3 ML; CARTRIDGE GLASS TYPE I 5 x 3 ML | HUMAN | כן | בסל עם הגבלה | A10AD05 - Insulin aspart 124-36-30365-00 | LANTUS 100 UNITS/ML | לנטוס 100 יחידות/מ"ל | Treatment of adult and pediatric patients, 6 years and over, with type 1 diabetes mellitus or adults patients with type 2 diabetes mellitus who require basal (long acting) insulin for the control of hyperglycemia. | SANOFI - AVENTIS DEUTSCHLAND GMBH, GERMANY | INDUSTRIEPARK HOCHST, D-65926, FRANKFURT AM MAIN, GERMANY | SANOFI - AVENTIS ISRAEL LTD | 10 BENI GAON, POB 8090, NETANYA 4250499, ISRAEL | 31/12/2021 | 31/12/2011 | SOLUTION FOR INJECTION | S.C | INSULIN GLARGINE 100U/ML | VIAL GLASS TYPE I 1 x 10 ML; VIAL GLASS TYPE I 2 x 10 ML; VIAL GLASS TYPE I 5 x 10 ML; VIAL GLASS TYPE I 10 x 10 ML; CARTRIDGE GLASS TYPE I 4 x 3 ML; CARTRIDGE GLASS TYPE I 10 x 3 ML; PRE FILLED PEN GLASS TYPE I 5 x 3 ML; CARTRIDGE GLASS TYPE I 5 x 3 ML | HUMAN | כן | בסל עם הגבלה | A10AE - INSULINS AND ANALOGUES, LONG ACTING; A10AE04 - Insulin glargine 155-01-34409-00 | BASAGLAR | בסגלר | Treatment of adult patients 18 years and over with type 1 or type 2 diabetes mellitus who require basal (long acting) insulin for the control of hyperglycaemia. | LILLY FRANCE | 2 RUE DU COLONEL LILLY, 67640 FEGERSHEIM, FRANCE | ELI LILLY ISRAEL LTD, ISRAEL | 4 HASHEIZAF ST., POB 4246 RA'ANANA 4366411, ISRAEL | 30/11/2020 | 09/12/2015 | SOLUTION FOR INJECTION | S.C | INSULIN GLARGINE 100U/ML | PREFILLED PEN 1 x 3 ML; CARTRIDGE GLASS TYPE I 1 x 3 ML; CARTRIDGE GLASS TYPE I 2 x 3 ML; CARTRIDGE GLASS TYPE I 5 x 3 ML; CARTRIDGE GLASS TYPE I 10 x 3 ML; PREFILLED PEN 10 x 3 ML; PREFILLED PEN 5 x 3 ML; PREFILLED PEN 2 x 3 ML; PREFILLED PEN 10 x 3 ML; PREFILLED PEN 5 x 3 ML; PREFILLED PEN 2 x 3 ML; PREFILLED PEN 1 x 3 ML | HUMAN | כן | בסל עם הגבלה | A10AE04 - Insulin glargine 155-31-34440-00 | TOUJEO | טוג'או | Treatment of diabetes mellitus in adults._x000D_ _x000D_ | SANOFI - AVENTIS DEUTSCHLAND GMBH, GERMANY | INDUSTRIEPARK HOCHST, D-65926, FRANKFURT AM MAIN, GERMANY | SANOFI - AVENTIS ISRAEL LTD | 10 BENI GAON, POB 8090, NETANYA 4250499, ISRAEL | 31/12/2020 | 20/01/2016 | SOLUTION FOR INJECTION | S.C | INSULIN GLARGINE 300U/ML | PRE FILLED PEN GLASS TYPE I 1 x 1.5 ML; PRE FILLED PEN GLASS TYPE I 3 x 1.5 ML; PRE FILLED PEN GLASS TYPE I 5 x 1.5 ML | HUMAN | כן | בסל עם הגבלה | A10AE04 - Insulin glargine 132-40-31119-00 | LEVEMIR | לבמיר | Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above. | NOVO NORDISK A/S, DENMARK | NOVO ALLE DK-2880 BAGSVAERD, DENMARK | NOVO NORDISK LTD, ISRAEL | 20 HATA'AS ST.,INDUSTR. AREA, KFAR SABA 4442520, ISRAEL | 31/01/2025 | 31/01/2015 | SOLUTION FOR INJECTION | S.C | INSULIN DETEMIR 100U/ML | PRE FILLED PEN GLASS TYPE I 5 x 3 ML; CARTRIDGE GLASS TYPE I 5 x 3 ML; PRE FILLED PEN GLASS TYPE I 1 x 3 ML | HUMAN | כן | בסל עם הגבלה | A10AE05 - Insulin detemir 151-66-33908-00 | TREGLUDEC 100U/ML | טרגלודק 100 יחידות/מיליליטר | Treatment of diabetes mellitus in adults, adolescents and children from the age of 1 year. | NOVO NORDISK A/S, DENMARK | NOVO ALLE DK-2880 BAGSVAERD, DENMARK | NOVO NORDISK LTD, ISRAEL | 20 HATA'AS ST.,INDUSTR. AREA, KFAR SABA 4442520, ISRAEL | 31/03/2029 | 31/03/2019 | SOLUTION FOR INJECTION | S.C | INSULIN DEGLUDEC 100U/ML | CARTRIDGE GLASS TYPE I 5 x 3 ML; PRE FILLED PEN GLASS TYPE I 1 x 3 ML; PRE FILLED PEN GLASS TYPE I 5 x 3 ML; PRE FILLED PEN GLASS TYPE I 1 x 3 ML | HUMAN | כן | בסל עם הגבלה | A10AE06 - Insulin degludec 151-65-33911-00 | TREGLUDEC 200 U/ML | טרגלודק 200 יחידות/מיליליטר | Treatment of diabetes mellitus in adults, adolescents and children from the age of 1 year. | NOVO NORDISK A/S, DENMARK | NOVO ALLE DK-2880 BAGSVAERD, DENMARK | NOVO NORDISK LTD, ISRAEL | 20 HATA'AS ST.,INDUSTR. AREA, KFAR SABA 4442520, ISRAEL | 31/03/2029 | 31/03/2019 | SOLUTION FOR INJECTION | S.C | INSULIN DEGLUDEC 200U/ML | PRE FILLED PEN GLASS TYPE I 1 x 3 ML; PRE FILLED PEN GLASS TYPE I 3 x 3 ML; PRE FILLED PEN GLASS TYPE I 1 x 3 ML | HUMAN | כן | בסל עם הגבלה | A10AE06 - Insulin degludec 155-72-34607-00 | XULTOPHY | זולטופיי | Xultophy is indicated for the treatment of adults with type 2 diabetes mellitus to improve glycaemic control in combination with oral glucose-lowering medicinal products when these alone or combined with a GLP-1 receptor agonist or basal insulin do not provide adequate glycaemic control. | NOVO NORDISK A/S, DENMARK | NOVO ALLE DK-2880 BAGSVAERD, DENMARK | NOVO NORDISK LTD, ISRAEL | 20 HATA'AS ST.,INDUSTR. AREA, KFAR SABA 4442520, ISRAEL | 28/02/2021 | 17/03/2016 | SOLUTION FOR INJECTION | S.C | INSULIN DEGLUDEC 100U/ML ; LIRAGLUTIDE 3.6MG/ML | PRE FILLED PEN GLASS TYPE I 1 x 3 ML; PRE FILLED PEN GLASS TYPE I 3 x 3 ML; PRE FILLED PEN GLASS TYPE I 5 x 3 ML | HUMAN | כן | בסל עם הגבלה | A10AE56 - insulin degludec and liraglutide 014-95-24736-11 | GLUCOPHAGE | גלוקופג' | Glucophage is indicated in diet-failed, non-insulin dependent diabetic patients, especially if overweight, either alone as initial therapy or in combination with a sulfonylyrea. _x000D_ Occasionally, as adjuvant therapy in insulin-dependent diabetic patients particularly who are usually obese and not well controlled with insulin. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | ABIC LTD. | IND. ZONE, KIRYAT NORDAU,POB 8077,NATHANYA | 31/10/2020 | 31/12/2010 | CAPLETS | PER OS | METFORMIN HYDROCHLORIDE 850 MG | BLISTER PVC/ALUMINIUM 500 CAPLETS; BLISTER PVC/ALUMINIUM 24 CAPLETS; BLISTER PVC/ALUMINIUM 30 CAPLETS; BLISTER PVC/ALUMINIUM 48 CAPLETS; BLISTER PVC/ALUMINIUM 360 CAPLETS; BLISTER PVC/ALUMINIUM 420 CAPLETS; BLISTER PVC/ALUMINIUM 480 CAPLETS | HUMAN | כן | בסל תרופות | A10BA02 - Metformin 014-95-24736-12 | GLUCOPHAGE | גלוקופג' | _x000D_ _x000D_ Treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control._x000D_ • In adults, Glucophage may be used as monotherapy or in combination with other oral anti-diabetic agents or with insulin._x000D_ • In children from 10 years of age and adolescents, Glucophage may be used as monotherapy or in combination with insulin._x000D_ A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure_x000D_ | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | ABIC LTD. | IND. ZONE, KIRYAT NORDAU,POB 8077,NATHANYA | 31/10/2020 | 12/05/2014 | CAPLETS | PER OS | METFORMIN HYDROCHLORIDE 850 MG | BLISTER PVC/ALUMINIUM 500 CAPLETS; BLISTER PVC/ALUMINIUM 24 CAPLETS; BLISTER PVC/ALUMINIUM 30 CAPLETS; BLISTER PVC/ALUMINIUM 48 CAPLETS; BLISTER PVC/ALUMINIUM 360 CAPLETS; BLISTER PVC/ALUMINIUM 420 CAPLETS; BLISTER PVC/ALUMINIUM 480 CAPLETS | HUMAN | כן | בסל תרופות | A10BA02 - Metformin 112-20-29498-00 | GLUCOMIN | גלוקומין | Glucomin is indicated in diet-failed, non-insulin dependent diabetic patients, especially if overweight, either alone as initial therapy or in combination with a sulfonylurea. _x000D_ Occasionally, as adjuvant therapy in insulin-dependent diabetic patients particularly who are usually obese and not well controlled with insulin._x000D_ | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | 30/09/2023 | 30/09/2013 | CAPLETS | PER OS | METFORMIN HYDROCHLORIDE 850 MG | BLISTER PVC 10 CAPLETS; BLISTER PVC 28 CAPLETS; BLISTER PVC 30 CAPLETS; BLISTER PVC 100 CAPLETS | HUMAN | כן | בסל תרופות | A10BA02 - Metformin 112-20-29498-01 | GLUCOMIN | גלוקומין | Glucomin is indicated in diet-failed, non-insulin dependent diabetic patients, especially if overweight, either alone as initial therapy or in combination with a sulfonylurea. _x000D_ Occasionally, as adjuvant therapy in insulin-dependent diabetic patients particularly who are usually obese and not well controlled with insulin._x000D_ | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | 30/09/2023 | 26/01/2015 | CAPLETS | PER OS | METFORMIN HYDROCHLORIDE 850 MG | BLISTER PVC 10 CAPLETS; BLISTER PVC 28 CAPLETS; BLISTER PVC 30 CAPLETS; BLISTER PVC 100 CAPLETS | HUMAN | כן | בסל תרופות | A10BA02 - Metformin 130-25-30822-18 | METFORMIN TEVA ® | מטפורמין טבע ® | Metformin Teva is indicated in diet - failed non - insulin dependent diabetic patients especially if overweight either alone as initial therapy or in combination with a sulfonylurea. _x000D_ Occasionally as adjuvant therapy in insulin - dependent diabetic patients particularly who are usually obese and not well controlled with insulin. | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH TIQVA 49131, ISRAEL | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL | POB 3190, PETAH-TIQVA 49131, ISRAEL | 31/01/2024 | 20/06/2016 | TABLETS | PER OS | METFORMIN HYDROCHLORIDE 850 MG | BLISTER PVDC/ALUMINIUM 30 TABLETS | HUMAN | כן | בסל תרופות | A10BA02 - Metformin 139-88-31705-14 | JANUET 50 MG/1000 MG | ג'נואט 50 מ"ג / 1000 מ"ג | Januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. _x000D_ Important limitations of use:_x000D_ Januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings._x000D_ Januet has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januet._x000D_ | MERCK SHARP & DOHME CORP., USA | ONE MERCK DRIVE, POB 100, WHITEHOUSE STATION, NJ 08889-0100, USA | MERCK SHARP & DOHME ISRAEL LTD | POB 7121,PETAH-TIQVA 49170 | 30/11/2023 | 23/08/2016 | TABLETS | PER OS | SITAGLIPTIN AS MONOHYDRATE PHOSPHATE 50 MG ; METFORMIN HYDROCHLORIDE 1000 MG | BLISTER PVC/PE/PVDC/AL 7 TABLETS; BLISTER PVC/PE/PVDC/AL 10 TABLETS; BLISTER PVC/PE/PVDC/AL 14 TABLETS; BLISTER PVC/PE/PVDC/AL 28 TABLETS; BLISTER PVC/PE/PVDC/AL 30 TABLETS; BLISTER PVC/PE/PVDC/AL 56 TABLETS | HUMAN | כן | לא בסל תרופות | A10BA02 - Metformin 139-89-31706-12 | JANUET 50 MG/500 MG | ג'נואט 50 מ"ג/500 מ"ג | Januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. _x000D_ Important limitations of use:_x000D_ Januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings._x000D_ Januet has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januet._x000D_ | MERCK SHARP & DOHME CORP., USA | ONE MERCK DRIVE, POB 100, WHITEHOUSE STATION, NJ 08889-0100, USA | MERCK SHARP & DOHME ISRAEL LTD | POB 7121,PETAH-TIQVA 49170 | 30/11/2023 | 30/11/2013 | TABLETS | PER OS | SITAGLIPTIN AS MONOHYDRATE PHOSPHATE 50 MG ; METFORMIN HYDROCHLORIDE 500 MG | BLISTER PVC/PE/PVDC/AL 10 TABLETS; BLISTER PVC/PE/PVDC/AL 14 TABLETS; BLISTER PVC/PE/PVDC/AL 28 TABLETS; BLISTER PVC/PE/PVDC/AL 30 TABLETS; BLISTER PVC/PE/PVDC/AL 56 TABLETS; BLISTER PVC/PE/PVDC/AL 7 TABLETS | HUMAN | כן | לא בסל תרופות | A10BA02 - Metformin 139-89-31706-15 | JANUET 50 MG/500 MG | ג'נואט 50 מ"ג/500 מ"ג | Januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. _x000D_ Important limitations of use:_x000D_ Januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings._x000D_ Januet has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januet._x000D_ | MERCK SHARP & DOHME CORP., USA | ONE MERCK DRIVE, POB 100, WHITEHOUSE STATION, NJ 08889-0100, USA | MERCK SHARP & DOHME ISRAEL LTD | POB 7121,PETAH-TIQVA 49170 | 30/11/2023 | 23/08/2016 | TABLETS | PER OS | SITAGLIPTIN AS MONOHYDRATE PHOSPHATE 50 MG ; METFORMIN HYDROCHLORIDE 500 MG | BLISTER PVC/PE/PVDC/AL 7 TABLETS; BLISTER PVC/PE/PVDC/AL 10 TABLETS; BLISTER PVC/PE/PVDC/AL 14 TABLETS; BLISTER PVC/PE/PVDC/AL 28 TABLETS; BLISTER PVC/PE/PVDC/AL 30 TABLETS; BLISTER PVC/PE/PVDC/AL 56 TABLETS | HUMAN | כן | לא בסל תרופות | A10BA02 - Metformin 139-90-31902-12 | JANUET 50 MG/850 MG | ג'נואט 50 מ"ג/850 מ"ג | Januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. _x000D_ Important limitations of use:_x000D_ Januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings._x000D_ Januet has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januet._x000D_ | MERCK SHARP & DOHME CORP., USA | ONE MERCK DRIVE, POB 100, WHITEHOUSE STATION, NJ 08889-0100, USA | MERCK SHARP & DOHME ISRAEL LTD | POB 7121,PETAH-TIQVA 49170 | 30/11/2023 | 30/11/2013 | TABLETS | PER OS | SITAGLIPTIN AS MONOHYDRATE PHOSPHATE 50 MG ; METFORMIN HYDROCHLORIDE 850 MG | BLISTER PVC/PE/PVDC/AL 7 TABLETS; BLISTER PVC/PE/PVDC/AL 10 TABLETS; BLISTER PVC/PE/PVDC/AL 14 TABLETS; BLISTER PVC/PE/PVDC/AL 28 TABLETS; BLISTER PVC/PE/PVDC/AL 30 TABLETS; BLISTER PVC/PE/PVDC/AL 56 TABLETS | HUMAN | כן | לא בסל תרופות | A10BA02 - Metformin 139-90-31902-14 | JANUET 50 MG/850 MG | ג'נואט 50 מ"ג/850 מ"ג | Januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. _x000D_ Important limitations of use:_x000D_ Januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings._x000D_ Januet has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januet._x000D_ _x000D_ | MERCK SHARP & DOHME CORP., USA | ONE MERCK DRIVE, POB 100, WHITEHOUSE STATION, NJ 08889-0100, USA | MERCK SHARP & DOHME ISRAEL LTD | POB 7121,PETAH-TIQVA 49170 | 30/11/2023 | 23/08/2016 | TABLETS | PER OS | SITAGLIPTIN AS MONOHYDRATE PHOSPHATE 50 MG ; METFORMIN HYDROCHLORIDE 850 MG | BLISTER PVC/PE/PVDC/AL 7 TABLETS; BLISTER PVC/PE/PVDC/AL 10 TABLETS; BLISTER PVC/PE/PVDC/AL 14 TABLETS; BLISTER PVC/PE/PVDC/AL 28 TABLETS; BLISTER PVC/PE/PVDC/AL 30 TABLETS; BLISTER PVC/PE/PVDC/AL 56 TABLETS | HUMAN | כן | לא בסל תרופות | A10BA02 - Metformin 150-19-33741-00 | TRAJENTA DUO 2.5 MG/ 1000 MG | טרג'נטה דואו 2.5 מ"ג/1000 מ"ג | As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate. _x000D_ TRAJENTA-DUO should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings. _x000D_ TRAJENTA-DUO has not been studied in patients with a history of pancreatitis. _x000D_ It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using TRAJENTA-DUO. | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG, GERMANY | BINGER STRASSE 173, D-55216, INGELHEIM AM RHEIN, GERMANY | BOEHRINGER INGELHEIM ISRAEL LTD. | MEDINAT HA-YEHUDIM ST. 89,B.O.X 4124, 4676672 HERZLIA PITUACH | 30/06/2028 | 30/06/2018 | FILM COATED TABLETS | PER OS | LINAGLIPTIN 2.5 MG ; METFORMIN HYDROCHLORIDE 1000 MG | BLISTER PVC/ALUMINIUM 60 TABLETS; BLISTER PVC/ALUMINIUM 14 TABLETS | HUMAN | כן | A10BA02 - Metformin 150-19-33741-01 | TRAJENTA DUO 2.5 MG/ 1000 MG | טרג'נטה דואו 2.5 מ"ג/1000 מ"ג | As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate. _x000D_ TRAJENTA-DUO should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings. _x000D_ TRAJENTA-DUO has not been studied in patients with a history of pancreatitis. _x000D_ It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using TRAJENTA-DUO. | BOEHRINGER INGELHEIM ELLAS A.E., GREECE | 5TH KM PAIANIA-MARKOPOULO KOROPI ATTIKI 19400, GREECE | BOEHRINGER INGELHEIM ISRAEL LTD. | MEDINAT HA-YEHUDIM ST. 89,B.O.X 4124, 4676672 HERZLIA PITUACH | 30/06/2028 | 30/06/2018 | FILM COATED TABLETS | PER OS | LINAGLIPTIN 2.5 MG ; METFORMIN HYDROCHLORIDE 1000 MG | BLISTER PVC/ALUMINIUM 60 TABLETS; BLISTER PVC/ALUMINIUM 14 TABLETS | HUMAN | כן | A10BA02 - Metformin 151-31-33932-00 | JANUET XR 50/500 MG TABLETS | ג'נואט 50/500 מ"ג XR טבליות | Januet XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate _x000D_ | MERCK SHARP & DOHME CORP., USA | ONE MERCK DRIVE, POB 100, WHITEHOUSE STATION, NJ 08889-0100, USA | MERCK SHARP & DOHME ISRAEL LTD | POB 7121,PETAH-TIQVA 49170 | 31/01/2029 | 31/01/2019 | TABLETS EXTENDED RELEASE | PER OS | SITAGLIPTIN AS PHOSPHATE SALT 50 MG ; METFORMIN HYDROCHLORIDE 500 MG | BOTTLE HDPE 14 TABLETS; BOTTLE HDPE 60 TABLETS | HUMAN | כן | A10BA02 - Metformin 151-31-33932-02 | JANUET XR 50/500 MG TABLETS | ג'נואט 50/500 מ"ג XR טבליות | Januet XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate _x000D_ | MERCK SHARP & DOHME CORP., USA | ONE MERCK DRIVE, POB 100, WHITEHOUSE STATION, NJ 08889-0100, USA | MERCK SHARP & DOHME ISRAEL LTD | POB 7121,PETAH-TIQVA 49170 | 31/01/2029 | 31/01/2019 | TABLETS EXTENDED RELEASE | PER OS | SITAGLIPTIN AS PHOSPHATE SALT 50 MG ; METFORMIN HYDROCHLORIDE 500 MG | BOTTLE HDPE 14 TABLETS; BOTTLE HDPE 60 TABLETS | HUMAN | כן | A10BA02 - Metformin 151-32-33933-00 | JANUET XR 50/1000 MG TABLETS | ג'נואט 50/1000 מ"ג XR טבליות | Januet XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate _x000D_ | MERCK SHARP & DOHME CORP., USA | ONE MERCK DRIVE, POB 100, WHITEHOUSE STATION, NJ 08889-0100, USA | MERCK SHARP & DOHME ISRAEL LTD | POB 7121,PETAH-TIQVA 49170 | 31/01/2029 | 31/01/2019 | TABLETS EXTENDED RELEASE | PER OS | SITAGLIPTIN AS PHOSPHATE SALT 50 MG ; METFORMIN HYDROCHLORIDE 1000 MG | BOTTLE HDPE 14 TABLETS; BOTTLE HDPE 60 TABLETS | HUMAN | כן | A10BA02 - Metformin 151-32-33933-02 | JANUET XR 50/1000 MG TABLETS | ג'נואט 50/1000 מ"ג XR טבליות | Januet XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate _x000D_ | MERCK SHARP & DOHME CORP., USA | ONE MERCK DRIVE, POB 100, WHITEHOUSE STATION, NJ 08889-0100, USA | MERCK SHARP & DOHME ISRAEL LTD | POB 7121,PETAH-TIQVA 49170 | 31/01/2029 | 31/01/2019 | TABLETS EXTENDED RELEASE | PER OS | SITAGLIPTIN AS PHOSPHATE SALT 50 MG ; METFORMIN HYDROCHLORIDE 1000 MG | BOTTLE HDPE 14 TABLETS; BOTTLE HDPE 60 TABLETS | HUMAN | כן | A10BA02 - Metformin 151-33-33934-00 | JANUET XR 100/1000 MG TABLETS | ג'נואט 100/1000 מ"ג XR טבליות | Januet XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate _x000D_ | MERCK SHARP & DOHME CORP., USA | ONE MERCK DRIVE, POB 100, WHITEHOUSE STATION, NJ 08889-0100, USA | MERCK SHARP & DOHME ISRAEL LTD | POB 7121,PETAH-TIQVA 49170 | 31/01/2029 | 31/01/2019 | TABLETS EXTENDED RELEASE | PER OS | SITAGLIPTIN AS PHOSPHATE SALT 100 MG ; METFORMIN HYDROCHLORIDE 1000 MG | BOTTLE HDPE 7 TABLETS; BOTTLE HDPE 30 TABLETS | HUMAN | כן | A10BA02 - Metformin 151-33-33934-02 | JANUET XR 100/1000 MG TABLETS | ג'נואט 100/1000 מ"ג XR טבליות | Januet XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin extended-release is appropriate _x000D_ | MERCK SHARP & DOHME CORP., USA | ONE MERCK DRIVE, POB 100, WHITEHOUSE STATION, NJ 08889-0100, USA | MERCK SHARP & DOHME ISRAEL LTD | POB 7121,PETAH-TIQVA 49170 | 31/01/2029 | 31/01/2019 | TABLETS EXTENDED RELEASE | PER OS | SITAGLIPTIN AS PHOSPHATE SALT 100 MG ; METFORMIN HYDROCHLORIDE 1000 MG | BOTTLE HDPE 7 TABLETS; BOTTLE HDPE 30 TABLETS | HUMAN | כן | A10BA02 - Metformin 162-59-35148-00 | METFORMIN INOVAMED | מטפורמין אינובמד | Treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control._x000D_ • In adults, Metformin may be used as monotherapy or in combination with other oral anti-diabetic agents or with insulin._x000D_ • In children from 10 years of age and adolescents, Metformin may be used as monotherapy or in combination with insulin._x000D_ A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure_x000D_ | AUROBINDO PHARMA LTD., INDIA | PLOT # 2, MAITRIVIHAR, AMEERPET, HYDERABAD, TELANGANA 500 038, INDIA | INOVAMED LTD | 55 BEER GANIM STREET, P.O.B 62, EVEN YEHUDA 40500, ISRAEL | 31/07/2024 | 08/08/2019 | FILM COATED TABLETS | PER OS | METFORMIN HYDROCHLORIDE 850 MG | BLISTER PVC/ALUMINIUM 30 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 30 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BA02 - Metformin 162-59-35148-01 | METFORMIN INOVAMED | מטפורמין אינובמד | Treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control._x000D_ • In adults, Metformin may be used as monotherapy or in combination with other oral anti-diabetic agents or with insulin._x000D_ • In children from 10 years of age and adolescents, Metformin may be used as monotherapy or in combination with insulin._x000D_ A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure | AUROBINDO PHARMA LTD., INDIA | PLOT # 2, MAITRIVIHAR, AMEERPET, HYDERABAD, TELANGANA 500 038, INDIA | INOVAMED LTD | 55 BEER GANIM STREET, P.O.B 62, EVEN YEHUDA 40500, ISRAEL | 31/07/2024 | 08/08/2019 | FILM COATED TABLETS | PER OS | METFORMIN HYDROCHLORIDE 850 MG | BLISTER PVC/ALUMINIUM 30 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 30 TABLETS | HUMAN | כן | A10BA02 - Metformin 162-59-35148-02 | METFORMIN INOVAMED | מטפורמין אינובמד | Treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control._x000D_ • In adults, Metformin may be used as monotherapy or in combination with other oral anti-diabetic agents or with insulin._x000D_ • In children from 10 years of age and adolescents, Metformin may be used as monotherapy or in combination with insulin._x000D_ A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure | AUROBINDO PHARMA LTD., INDIA | PLOT # 2, MAITRIVIHAR, AMEERPET, HYDERABAD, TELANGANA 500 038, INDIA | INOVAMED LTD | 55 BEER GANIM STREET, P.O.B 62, EVEN YEHUDA 40500, ISRAEL | 31/07/2024 | 08/08/2019 | FILM COATED TABLETS | PER OS | METFORMIN HYDROCHLORIDE 850 MG | BLISTER PVC/ALUMINIUM 30 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 30 TABLETS | HUMAN | כן | A10BA02 - Metformin 162-59-35148-03 | METFORMIN INOVAMED | מטפורמין אינובמד | Treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control._x000D_ • In adults, Metformin may be used as monotherapy or in combination with other oral anti-diabetic agents or with insulin._x000D_ • In children from 10 years of age and adolescents, Metformin may be used as monotherapy or in combination with insulin._x000D_ A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure | AUROBINDO PHARMA LTD., INDIA | PLOT # 2, MAITRIVIHAR, AMEERPET, HYDERABAD, TELANGANA 500 038, INDIA | INOVAMED LTD | 55 BEER GANIM STREET, P.O.B 62, EVEN YEHUDA 40500, ISRAEL | 31/07/2024 | 08/08/2019 | FILM COATED TABLETS | PER OS | METFORMIN HYDROCHLORIDE 850 MG | BLISTER PVC/ALUMINIUM 30 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 30 TABLETS | HUMAN | כן | A10BA02 - Metformin 150-65-33826-00 | COMPETACT 15 MG / 850 MG | קומפטקט 15 מ"ג / 850 מ"ג | Competact is indicated as second line treatment of type 2 diabetes mellitus adult patients,particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone._x000D_ After initiation of therapy with pioglitazone, patients should be reviewed after 3 to 6 months to assess adequacy of response to treatment (e.g. reduction in HbA1c). In patients who fail to show an adequate response, pioglitazone should be discontinued. In light of potential risks with prolonged therapy, prescribers should confirm at subsequent routine reviews that the benefit of pioglitazone is maintained. _x000D_ | TAKEDA PHARMA A/S, DENMARK | DYBENDAL ALLE 10, DK-2630 TAASTRUP, DENMARK | ABIC MARKETING LTD, ISRAEL | INDUSTRIAL ZONE, KIRYAT NORDAU, P.O.B. 8077, NETHANYA, ISRAEL | 31/07/2028 | 31/07/2018 | FILM COATED TABLETS | PER OS | METFORMIN HYDROCHLORIDE 850 MG ; PIOGLITAZONE AS HYDROCHLORIDE 15 MG | BLISTER ALUMINIUM /ALUMINIUM 14 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 28 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 50 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 56 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 60 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 90 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 98 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 112 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 180 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 196 TABLETS | HUMAN | כן | A10BA02 - Metformin; A10BG03 - Pioglitazone 150-65-33826-01 | COMPETACT 15 MG / 850 MG | קומפטקט 15 מ"ג / 850 מ"ג | Competact is indicated as second line treatment of type 2 diabetes mellitus adult patients,particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone._x000D_ After initiation of therapy with pioglitazone, patients should be reviewed after 3 to 6 months to assess adequacy of response to treatment (e.g. reduction in HbA1c). In patients who fail to show an adequate response, pioglitazone should be discontinued. In light of potential risks with prolonged therapy, prescribers should confirm at subsequent routine reviews that the benefit of pioglitazone is maintained. _x000D_ | TAKEDA PHARMA A/S, DENMARK | DYBENDAL ALLE 10, DK-2630 TAASTRUP, DENMARK | ABIC MARKETING LTD, ISRAEL | INDUSTRIAL ZONE, KIRYAT NORDAU, P.O.B. 8077, NETHANYA, ISRAEL | 31/07/2028 | 12/11/2019 | FILM COATED TABLETS | PER OS | METFORMIN HYDROCHLORIDE 850 MG ; PIOGLITAZONE AS HYDROCHLORIDE 15 MG | BLISTER ALUMINIUM /ALUMINIUM 14 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 28 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 50 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 56 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 60 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 90 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 98 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 112 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 180 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 196 TABLETS | HUMAN | כן | A10BA02 - Metformin; A10BG03 - Pioglitazone 143-88-32042-01 | EUCREAS 50/850 MG | יוקריאס 50/850 מ"ג | Eucreas is indicated in the treatment of type 2 diabetes mellitus:_x000D_ - Eucreas is indicated in the treatment of adult patients who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets._x000D_ - Eucreas is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled with metformin and a sulphonylurea._x000D_ - Eucreas is indicated in triple combination therapy with insulin as an adjunct to diet and exercise to improve glycaemic control in adult patients when insulin at a stable dose and metformin alone do not provide adequate glycaemic control._x000D_ _x000D_ | NOVARTIS PHARMA PRODUKTIONS GMBH | OFLINGERSTRASSE 44, D-79664 WEHR, GERMANY | NOVARTIS ISRAEL LTD | P.O.B 7126, TEL AVIV, ISRAEL | 31/03/2027 | 31/03/2017 | FILM COATED TABLETS | PER OS | VILDAGLIPTIN 50 MG ; METFORMIN HYDROCHLORIDE 850 MG | BLISTER PA/ALUMINIUM/PVC 60 TABLETS | HUMAN | כן | לא בסל תרופות | A10BA02 - Metformin; A10BH02 - Vildagliptin 150-18-33740-00 | TRAJENTA DUO 2.5 MG / 850 MG | טרג'נטה דואו 2.5 מ"ג/850 מ"ג | As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate. _x000D_ TRAJENTA-DUO should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings. _x000D_ TRAJENTA-DUO has not been studied in patients with a history of pancreatitis. _x000D_ It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using TRAJENTA-DUO. | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG, GERMANY | BINGER STRASSE 173, D-55216, INGELHEIM AM RHEIN, GERMANY | BOEHRINGER INGELHEIM ISRAEL LTD. | MEDINAT HA-YEHUDIM ST. 89,B.O.X 4124, 4676672 HERZLIA PITUACH | 30/06/2028 | 30/06/2018 | FILM COATED TABLETS | PER OS | METFORMIN HYDROCHLORIDE 850 MG ; LINAGLIPTIN 2.5 MG | BLISTER PVC/ALUMINIUM 14 TABLETS; BLISTER PVC/ALUMINIUM 60 TABLETS | HUMAN | כן | A10BA02 - Metformin; A10BH05 - Linagliptin 150-18-33740-01 | TRAJENTA DUO 2.5 MG / 850 MG | טרג'נטה דואו 2.5 מ"ג/850 מ"ג | As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate. _x000D_ TRAJENTA-DUO should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings. _x000D_ TRAJENTA-DUO has not been studied in patients with a history of pancreatitis. _x000D_ It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using TRAJENTA-DUO. | BOEHRINGER INGELHEIM ELLAS A.E., GREECE | 5TH KM PAIANIA-MARKOPOULO KOROPI ATTIKI 19400, GREECE | BOEHRINGER INGELHEIM ISRAEL LTD. | MEDINAT HA-YEHUDIM ST. 89,B.O.X 4124, 4676672 HERZLIA PITUACH | 30/06/2028 | 30/06/2018 | FILM COATED TABLETS | PER OS | METFORMIN HYDROCHLORIDE 850 MG ; LINAGLIPTIN 2.5 MG | BLISTER PVC/ALUMINIUM 14 TABLETS; BLISTER PVC/ALUMINIUM 60 TABLETS | HUMAN | כן | A10BA02 - Metformin; A10BH05 - Linagliptin 040-08-20814-00 | GLUBEN | גלובן | Control of hyperglycemia in stable, mild, nonketosis prone Glibenclamide responsive type II diabetes mellitus, which cannot be controlled by proper dietary management or when insulin therapy is inappropriate. | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | DEXCEL LTD, ISRAEL | 1 DEXCEL STREET, OR AKIVA 3060000, ISRAEL | 31/03/2024 | 31/03/2014 | TABLETS | PER OS | GLIBENCLAMIDE 5 MG | BLISTER PVC 28 TABLETS; BLISTER PVC 30 TABLETS; BLISTER PVC 50 TABLETS; BLISTER PVC 100 TABLETS; BLISTER PVC 1000 TABLETS; BLISTER PVC 10 TABLETS | HUMAN | כן | בסל תרופות | A10BB01 - Glibenclamide 132-27-27134-00 | GLUCO-RITE | גלוקו-רייט | Is indicated as an adjunct to diet for the control of hyperglycemia and its associated symptomatology in patients with diabetes mellitus type II | PERRIGO ISRAEL PHARMACEUTICALS LTD | P.O.B 16, YERUHAM | PERRIGO ISRAEL PHARMACEUTICALS LTD | POB 16, YERUHAM | 31/01/2025 | 31/01/2015 | TABLETS | PER OS | GLIPIZIDE 5 MG | BLISTER PVC/PVDC 30 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BB07 - Glipizide 118-83-29932-00 | AMARYL 2 MG | אמריל 2 מ"ג | Non-insulin-dependent diabetes melitus ( adult-onset diabetes, type II diabetes), when diet, regular physical exercise, and weight reduction alone cannot maintain therapeutically suitable blood glucose levels. | SANOFI S.P.A., ITALY | STRADA STATALE 17 KM 22, I-67019 SCOPPITO (L'AQUILA), ITALY | SANOFI - AVENTIS ISRAEL LTD | 10 BENI GAON, POB 8090, NETANYA 4250499, ISRAEL | 31/05/2020 | 31/05/2010 | TABLETS | PER OS | GLIMEPIRIDE 2 MG | BLISTER PVC/ALUMINIUM 30 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BB12 - Glimepiride 118-84-29933-00 | AMARYL 3 MG | אמריל 3 מ"ג | Non-insulin-dependent diabetes melitus ( adult-onset diabetes, type II diabetes), when diet, regular physical exercise, and weight reduction alone cannot maintain therapeutically suitable blood glucose levels. | SANOFI S.P.A., ITALY | STRADA STATALE 17 KM 22, I-67019 SCOPPITO (L'AQUILA), ITALY | SANOFI - AVENTIS ISRAEL LTD | 10 BENI GAON, POB 8090, NETANYA 4250499, ISRAEL | 31/05/2020 | 31/05/2010 | TABLETS | PER OS | GLIMEPIRIDE 3 MG | BLISTER PVC/ALUMINIUM 30 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BB12 - Glimepiride 118-82-29934-00 | AMARYL 1 MG | אמריל 1 מ"ג | Non-insulin-dependent diabetes melitus ( adult-onset diabetes, type II diabetes), when diet, regular physical exercise, and weight reduction alone cannot maintain therapeutically suitable blood glucose levels. | SANOFI S.P.A., ITALY | STRADA STATALE 17 KM 22, I-67019 SCOPPITO (L'AQUILA), ITALY | SANOFI - AVENTIS ISRAEL LTD | 10 BENI GAON, POB 8090, NETANYA 4250499, ISRAEL | 31/05/2020 | 31/05/2010 | TABLETS | PER OS | GLIMEPIRIDE 1 MG | BLISTER PVC/ALUMINIUM 30 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BB12 - Glimepiride 141-68-31917-00 | AMARYL 4 MG | אמריל 4 מ"ג | Non-insulin-dependent diabetes melitus ( adult-onset diabetes, type II diabetes), when diet, regular physical exercise, and weight reduction alone cannot maintain therapeutically suitable blood glucose levels. | SANOFI S.P.A., ITALY | STRADA STATALE 17 KM 22, I-67019 SCOPPITO (L'AQUILA), ITALY | SANOFI - AVENTIS ISRAEL LTD | 10 BENI GAON, POB 8090, NETANYA 4250499, ISRAEL | 30/09/2024 | 30/09/2014 | TABLETS | PER OS | GLIMEPIRIDE 4 MG | BLISTER PVC/ALUMINIUM 30 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BB12 - Glimepiride 151-15-33843-00 | GLIMEPIRIDE TEVA ® 1 MG | גלימפירייד טבע ® 1 מ"ג | Non-insulin-dependent diabetes mellitus (adult-onset diabetes, type II diabetes), when diet, regular physical exercise, and weight reduction alone cannot maintain therapeutically suitable blood glucose levels. | TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY | PALLAGI UT 13, DEBRECEN, HUNGARY 4042 | ABIC MARKETING LTD, ISRAEL | INDUSTRIAL ZONE, KIRYAT NORDAU, P.O.B. 8077, NETHANYA, ISRAEL | 30/11/2028 | 30/11/2018 | TABLETS | PER OS | GLIMEPIRIDE 1 MG | BLISTER PVC/PVDC/ALUMINIUM 30 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BB12 - Glimepiride 151-16-33859-00 | GLIMEPIRIDE TEVA ® 2 MG | גלימפירייד טבע ® 2 מ"ג | Non-insulin-dependent diabetes mellitus (adult-onset diabetes, type II diabetes), when diet, regular physical exercise, and weight reduction alone cannot maintain therapeutically suitable blood glucose levels. | TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY | PALLAGI UT 13, DEBRECEN, HUNGARY 4042 | ABIC MARKETING LTD, ISRAEL | INDUSTRIAL ZONE, KIRYAT NORDAU, P.O.B. 8077, NETHANYA, ISRAEL | 30/11/2028 | 30/11/2018 | TABLETS | PER OS | GLIMEPIRIDE 2 MG | BLISTER PVC/PVDC/ALUMINIUM 30 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BB12 - Glimepiride 151-17-33870-00 | GLIMEPIRIDE TEVA ® 3 MG | גלימפירייד טבע ® 3 מ"ג | Non-insulin-dependent diabetes mellitus (adult-onset diabetes, type II diabetes), when diet, regular physical exercise, and weight reduction alone cannot maintain therapeutically suitable blood glucose levels. | TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY | PALLAGI UT 13, DEBRECEN, HUNGARY 4042 | ABIC MARKETING LTD, ISRAEL | INDUSTRIAL ZONE, KIRYAT NORDAU, P.O.B. 8077, NETHANYA, ISRAEL | 30/11/2028 | 30/11/2018 | TABLETS | PER OS | GLIMEPIRIDE 3 MG | BLISTER PVC/PVDC/ALUMINIUM 30 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BB12 - Glimepiride 151-18-33871-00 | GLIMEPIRIDE TEVA ® 4 MG | גלימפירייד טבע ® 4 מ"ג | Non-insulin-dependent diabetes mellitus (adult-onset diabetes, type II diabetes), when diet, regular physical exercise, and weight reduction alone cannot maintain therapeutically suitable blood glucose levels. | TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY | PALLAGI UT 13, DEBRECEN, HUNGARY 4042 | ABIC MARKETING LTD, ISRAEL | INDUSTRIAL ZONE, KIRYAT NORDAU, P.O.B. 8077, NETHANYA, ISRAEL | 30/11/2028 | 30/11/2018 | TABLETS | PER OS | GLIMEPIRIDE 4 MG | BLISTER PVC/PVDC/ALUMINIUM 30 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BB12 - Glimepiride 155-66-34419-01 | XIGDUO XR 5 MG/500 MG | קסיגדו 5 מ"ג/ 500 מ"ג XR | XIGDUO XR (dapagliflozin and metformin HCl extended-release) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate. | BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY, PUERTO RICO | STATE ROAD # 3, KM 77.5, HUMACAO, PUERTO RICO 00791 | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 28/02/2021 | 16/03/2016 | TABLETS EXTENDED RELEASE | PER OS | METFORMIN HYDROCHLORIDE 502.61 MG with 0.5% magnesium stearete; DAPAGLIFLOZIN PROPANEDIOL 6.150 MG | BLISTER ALUMINIUM /ALUMINIUM 7 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 14 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 28 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 56 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD15 - Metformin and Dapagliflozin 155-66-34419-02 | XIGDUO XR 5 MG/500 MG | קסיגדו 5 מ"ג/ 500 מ"ג XR | XIGDUO XR (dapagliflozin and metformin HCl extended-release) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate. | BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY, PUERTO RICO | STATE ROAD # 3, KM 77.5, HUMACAO, PUERTO RICO 00791 | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 28/02/2021 | 09/11/2017 | TABLETS EXTENDED RELEASE | PER OS | METFORMIN HYDROCHLORIDE 502.61 MG with 0.5% magnesium stearete; DAPAGLIFLOZIN PROPANEDIOL 6.150 MG | BLISTER ALUMINIUM /ALUMINIUM 7 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 14 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 28 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 56 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD15 - Metformin and Dapagliflozin 155-67-34424-01 | XIGDUO XR 5 MG/1000 MG | קסיגדו 5 מ"ג/ 1000 מ"ג XR | XIGDUO XR (dapagliflozin and metformin HCl extended-release) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate. | BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY, PUERTO RICO | STATE ROAD # 3, KM 77.5, HUMACAO, PUERTO RICO 00791 | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 28/02/2021 | 16/03/2016 | TABLETS EXTENDED RELEASE | PER OS | METFORMIN HYDROCHLORIDE 1005.04 MG with 0.5% magnesium stearete; DAPAGLIFLOZIN PROPANEDIOL 6.150 MG | BLISTER ALUMINIUM /ALUMINIUM 56 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 14 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 28 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 7 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD15 - Metformin and Dapagliflozin 155-67-34424-02 | XIGDUO XR 5 MG/1000 MG | קסיגדו 5 מ"ג/ 1000 מ"ג XR | XIGDUO XR (dapagliflozin and metformin HCl extended-release) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate. | BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY, PUERTO RICO | STATE ROAD # 3, KM 77.5, HUMACAO, PUERTO RICO 00791 | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 28/02/2021 | 09/11/2017 | TABLETS EXTENDED RELEASE | PER OS | METFORMIN HYDROCHLORIDE 1005.04 MG with 0.5% magnesium stearete; DAPAGLIFLOZIN PROPANEDIOL 6.150 MG | BLISTER ALUMINIUM /ALUMINIUM 56 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 14 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 28 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 7 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD15 - Metformin and Dapagliflozin 155-68-34425-01 | XIGDUO XR 10 MG/500 MG | קסיגדו 10 מ"ג/ 500 מ"ג XR | XIGDUO XR (dapagliflozin and metformin HCl extended-release) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate. | BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY, PUERTO RICO | STATE ROAD # 3, KM 77.5, HUMACAO, PUERTO RICO 00791 | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 28/02/2021 | 16/03/2016 | TABLETS EXTENDED RELEASE | PER OS | METFORMIN HYDROCHLORIDE 502.61 MG with 0.5% magnesium stearete; DAPAGLIFLOZIN PROPANEDIOL 12.30 MG | BLISTER ALUMINIUM /ALUMINIUM 7 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 14 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 28 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 56 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD15 - Metformin and Dapagliflozin 155-68-34425-02 | XIGDUO XR 10 MG/500 MG | קסיגדו 10 מ"ג/ 500 מ"ג XR | XIGDUO XR (dapagliflozin and metformin HCl extended-release) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate. | BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY, PUERTO RICO | STATE ROAD # 3, KM 77.5, HUMACAO, PUERTO RICO 00791 | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 28/02/2021 | 09/11/2017 | TABLETS EXTENDED RELEASE | PER OS | METFORMIN HYDROCHLORIDE 502.61 MG with 0.5% magnesium stearete; DAPAGLIFLOZIN PROPANEDIOL 12.30 MG | BLISTER ALUMINIUM /ALUMINIUM 7 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 14 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 28 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 56 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD15 - Metformin and Dapagliflozin 155-69-34428-01 | XIGDUO XR 10 MG/1000 MG | קסיגדו 10 מ"ג/ 1000 מ"ג XR | XIGDUO XR (dapagliflozin and metformin HCl extended-release) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate. | BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY, PUERTO RICO | STATE ROAD # 3, KM 77.5, HUMACAO, PUERTO RICO 00791 | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 28/02/2021 | 16/03/2016 | TABLETS EXTENDED RELEASE | PER OS | METFORMIN HYDROCHLORIDE 1005.04 MG with 0.5% magnesium stearete; DAPAGLIFLOZIN PROPANEDIOL 12.30 MG | BLISTER ALUMINIUM /ALUMINIUM 7 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 14 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 28 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 56 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD15 - Metformin and Dapagliflozin 155-69-34428-02 | XIGDUO XR 10 MG/1000 MG | קסיגדו 10 מ"ג/ 1000 מ"ג XR | XIGDUO XR (dapagliflozin and metformin HCl extended-release) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate. | BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY, PUERTO RICO | STATE ROAD # 3, KM 77.5, HUMACAO, PUERTO RICO 00791 | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 28/02/2021 | 09/11/2017 | TABLETS EXTENDED RELEASE | PER OS | METFORMIN HYDROCHLORIDE 1005.04 MG with 0.5% magnesium stearete; DAPAGLIFLOZIN PROPANEDIOL 12.30 MG | BLISTER ALUMINIUM /ALUMINIUM 7 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 14 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 28 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 56 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD15 - Metformin and Dapagliflozin 154-22-34202-00 | JARDIANCE 10 MG | ג'ארדיאנס 10 מ"ג | Jardiance is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus._x000D_ To reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease._x000D_ _x000D_ Limitation of Use_x000D_ Jardiance is not recommended for patients with type 1 diabetes or for the treatment of diabetic ketoacidosis._x000D_ _x000D_ _x000D_ | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG, GERMANY | BINGER STRASSE 173, D-55216, INGELHEIM AM RHEIN, GERMANY | BOEHRINGER INGELHEIM ISRAEL LTD. | MEDINAT HA-YEHUDIM ST. 89,B.O.X 4124, 4676672 HERZLIA PITUACH | 31/07/2020 | 10/08/2015 | FILM COATED TABLETS | PER OS | EMPAGLIFLOZIN 10 MG | BLISTER PVC/ALUMINIUM 7 TABLETS; BLISTER PVC/ALUMINIUM 30 TABLETS; BLISTER PVC/ALUMINIUM 60 TABLETS; BLISTER PVC/ALUMINIUM 90 TABLETS | HUMAN | בסל עם הגבלה | A10BD19 - Linagliptin and Empagliflozin 154-23-34203-00 | JARDIANCE 25 MG | ג'ארדיאנס 25 מ"ג | Jardiance is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus._x000D_ To reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease._x000D_ _x000D_ Limitation of Use_x000D_ Jardiance is not recommended for patients with type 1 diabetes or for the treatment of diabetic ketoacidosis._x000D_ | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG, GERMANY | BINGER STRASSE 173, D-55216, INGELHEIM AM RHEIN, GERMANY | BOEHRINGER INGELHEIM ISRAEL LTD. | MEDINAT HA-YEHUDIM ST. 89,B.O.X 4124, 4676672 HERZLIA PITUACH | 31/07/2020 | 10/08/2015 | FILM COATED TABLETS | PER OS | EMPAGLIFLOZIN 25 MG | BLISTER PVC/ALUMINIUM 7 TABLETS; BLISTER PVC/ALUMINIUM 30 TABLETS; BLISTER PVC/ALUMINIUM 60 TABLETS; BLISTER PVC/ALUMINIUM 90 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD19 - Linagliptin and Empagliflozin 155-75-34509-00 | GLYXAMBI 25 MG/5 MG | גליקסמבי 25 מ"ג /5 מ"ג | GLYXAMBI tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and linagliptin is appropriate. _x000D_ Limitations of Use_x000D_ GLYXAMBI is not recommended for patients with type 1 diabetes or for the treatment of diabetic ketoacidosis._x000D_ GLYXAMBI has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using GLYXAMBI._x000D_ | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG, GERMANY | BINGER STRASSE 173, D-55216, INGELHEIM AM RHEIN, GERMANY | BOEHRINGER INGELHEIM ISRAEL LTD. | MEDINAT HA-YEHUDIM ST. 89,B.O.X 4124, 4676672 HERZLIA PITUACH | 28/02/2021 | 21/03/2016 | FILM COATED TABLETS | PER OS | LINAGLIPTIN 5 MG ; EMPAGLIFLOZIN 25 MG | BLISTER PVC/PVDC/ALUMINIUM 7 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 30 TABLETS | HUMAN | כן | A10BD19 - Linagliptin and Empagliflozin 155-76-34531-00 | GLYXAMBI 10 MG/5 MG | גליקסמבי 10 מ"ג /5 מ"ג | GLYXAMBI tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and linagliptin is appropriate. _x000D_ Limitations of Use_x000D_ GLYXAMBI is not recommended for patients with type 1 diabetes or for the treatment of diabetic ketoacidosis._x000D_ GLYXAMBI has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using GLYXAMBI._x000D_ | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG, GERMANY | BINGER STRASSE 173, D-55216, INGELHEIM AM RHEIN, GERMANY | BOEHRINGER INGELHEIM ISRAEL LTD. | MEDINAT HA-YEHUDIM ST. 89,B.O.X 4124, 4676672 HERZLIA PITUACH | 28/02/2021 | 21/03/2016 | FILM COATED TABLETS | PER OS | LINAGLIPTIN 5 MG ; EMPAGLIFLOZIN 10 MG | BLISTER PVC/PVDC/ALUMINIUM 7 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 30 TABLETS | HUMAN | כן | A10BD19 - Linagliptin and Empagliflozin 155-26-34512-00 | JARDIANCE DUO 5 MG/850 MG | ג'ארדיאנס דואו 5 מ"ג / 850 מ"ג | Jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control_x000D_ • in patients inadequately controlled on their maximally tolerated dose of metformin alone._x000D_ • in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin._x000D_ • in patients already being treated with the combination of empagliflozin and metformin as separate tablets._x000D_ | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG, GERMANY | BINGER STRASSE 173, D-55216, INGELHEIM AM RHEIN, GERMANY | BOEHRINGER INGELHEIM ISRAEL LTD. | MEDINAT HA-YEHUDIM ST. 89,B.O.X 4124, 4676672 HERZLIA PITUACH | 31/12/2020 | 11/01/2016 | FILM COATED TABLETS | PER OS | EMPAGLIFLOZIN 5 MG ; METFORMIN HYDROCHLORIDE 850 MG | BLISTER PVC/PVDC/ALUMINIUM 14 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 60 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 180 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD20 - Metformin and Empagliflozin 155-26-34512-01 | JARDIANCE DUO 5 MG/850 MG | ג'ארדיאנס דואו 5 מ"ג / 850 מ"ג | Jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control_x000D_ • in patients inadequately controlled on their maximally tolerated dose of metformin alone._x000D_ • in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin._x000D_ • in patients already being treated with the combination of empagliflozin and metformin as separate tablets._x000D_ | BOEHRINGER INGELHEIM ELLAS A.E., GREECE | 5TH KM PAIANIA-MARKOPOULO KOROPI ATTIKI 19400, GREECE | BOEHRINGER INGELHEIM ISRAEL LTD. | MEDINAT HA-YEHUDIM ST. 89,B.O.X 4124, 4676672 HERZLIA PITUACH | 31/12/2020 | 07/11/2017 | FILM COATED TABLETS | PER OS | EMPAGLIFLOZIN 5 MG ; METFORMIN HYDROCHLORIDE 850 MG | BLISTER PVC/PVDC/ALUMINIUM 14 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 60 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 180 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD20 - Metformin and Empagliflozin 155-27-34532-00 | JARDIANCE DUO 12.5 MG/1000 MG | ג'ארדיאנס דואו 12.5 מ"ג /1000מ"ג | Jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control_x000D_ • in patients inadequately controlled on their maximally tolerated dose of metformin alone._x000D_ • in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin._x000D_ • in patients already being treated with the combination of empagliflozin and metformin as separate tablets._x000D_ | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG, GERMANY | BINGER STRASSE 173, D-55216, INGELHEIM AM RHEIN, GERMANY | BOEHRINGER INGELHEIM ISRAEL LTD. | MEDINAT HA-YEHUDIM ST. 89,B.O.X 4124, 4676672 HERZLIA PITUACH | 31/12/2020 | 11/01/2016 | FILM COATED TABLETS | PER OS | EMPAGLIFLOZIN 12.5 MG ; METFORMIN HYDROCHLORIDE 1000 MG | BLISTER PVC/PVDC/ALUMINIUM 14 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 60 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 180 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD20 - Metformin and Empagliflozin 155-27-34532-01 | JARDIANCE DUO 12.5 MG/1000 MG | ג'ארדיאנס דואו 12.5 מ"ג /1000מ"ג | Jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control_x000D_ • in patients inadequately controlled on their maximally tolerated dose of metformin alone._x000D_ • in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin._x000D_ • in patients already being treated with the combination of empagliflozin and metformin as separate tablets._x000D_ | BOEHRINGER INGELHEIM ELLAS A.E., GREECE | 5TH KM PAIANIA-MARKOPOULO KOROPI ATTIKI 19400, GREECE | BOEHRINGER INGELHEIM ISRAEL LTD. | MEDINAT HA-YEHUDIM ST. 89,B.O.X 4124, 4676672 HERZLIA PITUACH | 31/12/2020 | 07/11/2017 | FILM COATED TABLETS | PER OS | EMPAGLIFLOZIN 12.5 MG ; METFORMIN HYDROCHLORIDE 1000 MG | BLISTER PVC/PVDC/ALUMINIUM 14 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 60 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 180 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD20 - Metformin and Empagliflozin 155-28-34533-00 | JARDIANCE DUO 5 MG/1000 MG | ג'ארדיאנס דואו 5 מ"ג / 1000 מ"ג | Jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control_x000D_ • in patients inadequately controlled on their maximally tolerated dose of metformin alone._x000D_ • in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin._x000D_ • in patients already being treated with the combination of empagliflozin and metformin as separate tablets._x000D_ | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG, GERMANY | BINGER STRASSE 173, D-55216, INGELHEIM AM RHEIN, GERMANY | BOEHRINGER INGELHEIM ISRAEL LTD. | MEDINAT HA-YEHUDIM ST. 89,B.O.X 4124, 4676672 HERZLIA PITUACH | 31/12/2020 | 11/01/2016 | FILM COATED TABLETS | PER OS | EMPAGLIFLOZIN 5 MG ; METFORMIN HYDROCHLORIDE 1000 MG | BLISTER PVC/PVDC/ALUMINIUM 14 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 60 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 180 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD20 - Metformin and Empagliflozin 155-28-34533-01 | JARDIANCE DUO 5 MG/1000 MG | ג'ארדיאנס דואו 5 מ"ג / 1000 מ"ג | Jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control_x000D_ • in patients inadequately controlled on their maximally tolerated dose of metformin alone._x000D_ • in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin._x000D_ • in patients already being treated with the combination of empagliflozin and metformin as separate tablets._x000D_ | BOEHRINGER INGELHEIM ELLAS A.E., GREECE | 5TH KM PAIANIA-MARKOPOULO KOROPI ATTIKI 19400, GREECE | BOEHRINGER INGELHEIM ISRAEL LTD. | MEDINAT HA-YEHUDIM ST. 89,B.O.X 4124, 4676672 HERZLIA PITUACH | 31/12/2020 | 07/11/2017 | FILM COATED TABLETS | PER OS | EMPAGLIFLOZIN 5 MG ; METFORMIN HYDROCHLORIDE 1000 MG | BLISTER PVC/PVDC/ALUMINIUM 14 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 60 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 180 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD20 - Metformin and Empagliflozin 155-29-34534-00 | JARDIANCE DUO 12.5 MG/850 MG | ג'ארדיאנס דואו 12.5 מ"ג / 850 מ"ג | Jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control_x000D_ • in patients inadequately controlled on their maximally tolerated dose of metformin alone._x000D_ • in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin._x000D_ • in patients already being treated with the combination of empagliflozin and metformin as separate tablets._x000D_ | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG, GERMANY | BINGER STRASSE 173, D-55216, INGELHEIM AM RHEIN, GERMANY | BOEHRINGER INGELHEIM ISRAEL LTD. | MEDINAT HA-YEHUDIM ST. 89,B.O.X 4124, 4676672 HERZLIA PITUACH | 31/12/2020 | 11/01/2016 | FILM COATED TABLETS | PER OS | EMPAGLIFLOZIN 12.5 MG ; METFORMIN HYDROCHLORIDE 850 MG | BLISTER PVC/PVDC/ALUMINIUM 14 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 60 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 180 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD20 - Metformin and Empagliflozin 155-29-34534-01 | JARDIANCE DUO 12.5 MG/850 MG | ג'ארדיאנס דואו 12.5 מ"ג / 850 מ"ג | Jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control_x000D_ • in patients inadequately controlled on their maximally tolerated dose of metformin alone._x000D_ • in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin._x000D_ • in patients already being treated with the combination of empagliflozin and metformin as separate tablets._x000D_ | BOEHRINGER INGELHEIM ELLAS A.E., GREECE | 5TH KM PAIANIA-MARKOPOULO KOROPI ATTIKI 19400, GREECE | BOEHRINGER INGELHEIM ISRAEL LTD. | MEDINAT HA-YEHUDIM ST. 89,B.O.X 4124, 4676672 HERZLIA PITUACH | 31/12/2020 | 07/11/2017 | FILM COATED TABLETS | PER OS | EMPAGLIFLOZIN 12.5 MG ; METFORMIN HYDROCHLORIDE 850 MG | BLISTER PVC/PVDC/ALUMINIUM 14 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 60 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 180 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD20 - Metformin and Empagliflozin 159-25-34922-00 | JARDIANCE DUO 5 MG/500 MG | ג'ארדיאנס דואו 5 מ"ג / 500 מ"ג | Jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control_x000D_ • in patients inadequately controlled on their maximally tolerated dose of metformin alone._x000D_ • in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin._x000D_ • in patients already being treated with the combination of empagliflozin and metformin as separate tablets._x000D_ | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG | BINGER STRASSE 173,55216, INGELHEIM AM RHEIN, GERMANY | BOEHRINGER INGELHEIM ISRAEL LTD. | MEDINAT HA-YEHUDIM ST. 89,B.O.X 4124, 4676672 HERZLIA PITUACH | 31/08/2022 | 27/09/2017 | FILM COATED TABLETS | PER OS | EMPAGLIFLOZIN 5 MG ; METFORMIN HYDROCHLORIDE 500 MG | BLISTER PVC/PVDC/ALUMINIUM 14 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 60 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 180 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD20 - Metformin and Empagliflozin 159-25-34922-01 | JARDIANCE DUO 5 MG/500 MG | ג'ארדיאנס דואו 5 מ"ג / 500 מ"ג | Jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control_x000D_ • in patients inadequately controlled on their maximally tolerated dose of metformin alone._x000D_ • in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin._x000D_ • in patients already being treated with the combination of empagliflozin and metformin as separate tablets._x000D_ | BOEHRINGER INGELHEIM ELLAS A.E., GREECE | 5TH KM PAIANIA-MARKOPOULO KOROPI ATTIKI 19400, GREECE | BOEHRINGER INGELHEIM ISRAEL LTD. | MEDINAT HA-YEHUDIM ST. 89,B.O.X 4124, 4676672 HERZLIA PITUACH | 31/08/2022 | 05/11/2018 | FILM COATED TABLETS | PER OS | EMPAGLIFLOZIN 5 MG ; METFORMIN HYDROCHLORIDE 500 MG | BLISTER PVC/PVDC/ALUMINIUM 14 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 60 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 180 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD20 - Metformin and Empagliflozin 159-26-34923-00 | JARDIANCE DUO 12.5 MG/500 MG | ג'ארדיאנס דואו 12.5 מ"ג / 500 מ"ג | Jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control_x000D_ • in patients inadequately controlled on their maximally tolerated dose of metformin alone._x000D_ • in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin._x000D_ • in patients already being treated with the combination of empagliflozin and metformin as separate tablets._x000D_ | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG | BINGER STRASSE 173,55216, INGELHEIM AM RHEIN, GERMANY | BOEHRINGER INGELHEIM ISRAEL LTD. | MEDINAT HA-YEHUDIM ST. 89,B.O.X 4124, 4676672 HERZLIA PITUACH | 31/08/2022 | 27/09/2017 | FILM COATED TABLETS | PER OS | EMPAGLIFLOZIN 12.5 MG ; METFORMIN HYDROCHLORIDE 500 MG | BLISTER PVC/PVDC/ALUMINIUM 14 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 60 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 180 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD20 - Metformin and Empagliflozin 159-26-34923-01 | JARDIANCE DUO 12.5 MG/500 MG | ג'ארדיאנס דואו 12.5 מ"ג / 500 מ"ג | Jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control_x000D_ • in patients inadequately controlled on their maximally tolerated dose of metformin alone._x000D_ • in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin._x000D_ • in patients already being treated with the combination of empagliflozin and metformin as separate tablets._x000D_ | BOEHRINGER INGELHEIM ELLAS A.E., GREECE | 5TH KM PAIANIA-MARKOPOULO KOROPI ATTIKI 19400, GREECE | BOEHRINGER INGELHEIM ISRAEL LTD. | MEDINAT HA-YEHUDIM ST. 89,B.O.X 4124, 4676672 HERZLIA PITUACH | 31/08/2022 | 03/03/2019 | FILM COATED TABLETS | PER OS | EMPAGLIFLOZIN 12.5 MG ; METFORMIN HYDROCHLORIDE 500 MG | BLISTER PVC/PVDC/ALUMINIUM 14 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 60 TABLETS; BLISTER PVC/PVDC/ALUMINIUM 180 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD20 - Metformin and Empagliflozin 162-14-35331-00 | QTERN | קיוטרן | Qtern, fixed dose combination of saxagliptin and dapagliflozin, is indicated in adults aged 18 years and older with type 2 diabetes mellitus:_x000D_ - to improve glycaemic control when metformin and/or sulphonylurea (SU) and one of the monocomponents of Qtern do not provide adequate glycaemic control,_x000D_ - when already being treated with the free combination of dapagliflozin and saxagliptin._x000D_ | ASTRA ZENECA PHARMACEUTICALS LP, USA | 4601 HIGHWAY 62 EAST, MOUNT VERNON, INDIANA 47620, USA | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 31/03/2024 | 29/04/2019 | FILM COATED TABLETS | PER OS | DAPAGLIFLOZIN AS PROPANEDIOL 10 MG ; SAXAGLIPTIN AS HYDROCHLORIDE MONOHYDRATE 5 MG | BLISTER PA/ALUMINIUM/PVC 14 TABLETS; BLISTER PA/ALUMINIUM/PVC 28 TABLETS; BLISTER PA/ALUMINIUM/PVC 30 TABLETS; BLISTER PA/ALUMINIUM/PVC 98 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD21 - Saxagliptin and Dapagliflozin 162-14-35331-01 | QTERN | קיוטרן | Qtern, fixed dose combination of saxagliptin and dapagliflozin, is indicated in adults aged 18 years and older with type 2 diabetes mellitus:_x000D_ - to improve glycaemic control when metformin and/or sulphonylurea (SU) and one of the monocomponents of Qtern do not provide adequate glycaemic control,_x000D_ - when already being treated with the free combination of dapagliflozin and saxagliptin._x000D_ | ASTRA ZENECA PHARMACEUTICALS LP, USA | 4601 HIGHWAY 62 EAST, MOUNT VERNON, INDIANA 47620, USA | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 31/03/2024 | 29/04/2019 | FILM COATED TABLETS | PER OS | DAPAGLIFLOZIN AS PROPANEDIOL 10 MG ; SAXAGLIPTIN AS HYDROCHLORIDE MONOHYDRATE 5 MG | BLISTER PA/ALUMINIUM/PVC 14 TABLETS; BLISTER PA/ALUMINIUM/PVC 28 TABLETS; BLISTER PA/ALUMINIUM/PVC 30 TABLETS; BLISTER PA/ALUMINIUM/PVC 98 TABLETS | HUMAN | כן | A10BD21 - Saxagliptin and Dapagliflozin 162-14-35331-02 | QTERN | קיוטרן | Qtern, fixed dose combination of saxagliptin and dapagliflozin, is indicated in adults aged 18 years and older with type 2 diabetes mellitus:_x000D_ - to improve glycaemic control when metformin and/or sulphonylurea (SU) and one of the monocomponents of Qtern do not provide adequate glycaemic control,_x000D_ - when already being treated with the free combination of dapagliflozin and saxagliptin._x000D_ | ASTRA ZENECA PHARMACEUTICALS LP, USA | 4601 HIGHWAY 62 EAST, MOUNT VERNON, INDIANA 47620, USA | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 31/03/2024 | 29/04/2019 | FILM COATED TABLETS | PER OS | DAPAGLIFLOZIN AS PROPANEDIOL 10 MG ; SAXAGLIPTIN AS HYDROCHLORIDE MONOHYDRATE 5 MG | BLISTER PA/ALUMINIUM/PVC 14 TABLETS; BLISTER PA/ALUMINIUM/PVC 28 TABLETS; BLISTER PA/ALUMINIUM/PVC 30 TABLETS; BLISTER PA/ALUMINIUM/PVC 98 TABLETS | HUMAN | כן | A10BD21 - Saxagliptin and Dapagliflozin 162-14-35331-03 | QTERN | קיוטרן | Qtern, fixed dose combination of saxagliptin and dapagliflozin, is indicated in adults aged 18 years and older with type 2 diabetes mellitus:_x000D_ - to improve glycaemic control when metformin and/or sulphonylurea (SU) and one of the monocomponents of Qtern do not provide adequate glycaemic control,_x000D_ - when already being treated with the free combination of dapagliflozin and saxagliptin._x000D_ | ASTRA ZENECA PHARMACEUTICALS LP, USA | 4601 HIGHWAY 62 EAST, MOUNT VERNON, INDIANA 47620, USA | ASTRA ZENECA (ISRAEL) LTD | 6 HACHARASH ST., BUILDING E, P.O.B. 14, PARK MIGDALEI HOD HASHARON, HOD HASHARON 4524075, ISRAEL | 31/03/2024 | 29/04/2019 | FILM COATED TABLETS | PER OS | DAPAGLIFLOZIN AS PROPANEDIOL 10 MG ; SAXAGLIPTIN AS HYDROCHLORIDE MONOHYDRATE 5 MG | BLISTER PA/ALUMINIUM/PVC 14 TABLETS; BLISTER PA/ALUMINIUM/PVC 28 TABLETS; BLISTER PA/ALUMINIUM/PVC 30 TABLETS; BLISTER PA/ALUMINIUM/PVC 98 TABLETS | HUMAN | כן | A10BD21 - Saxagliptin and Dapagliflozin 161-70-35634-00 | SEGLUROMET 2.5/1000 MG | סגלורומט 2.5/1000 מ"ג | Segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:_x000D_ • in patients not adequately controlled on their maximally tolerated dose of metformin alone_x000D_ • in patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetes _x000D_ • in patients already being treated with the combination of ertugliflozin and metformin as separate tablets. _x000D_ | MERCK SHARP & DOHME CORP., USA | ONE MERCK DRIVE, POB 100, WHITEHOUSE STATION, NJ 08889-0100, USA | MERCK SHARP & DOHME ISRAEL LTD | POB 7121,PETAH-TIQVA 49170 | 31/12/2023 | 28/01/2019 | FILM COATED TABLETS | PER OS | METFORMIN HYDROCHLORIDE 1000 MG ; ERTUGLIFLOZIN (L-PGA) 2.5 MG | BLISTER ALU/PVC/PA/ALU 14 TABLETS; BLISTER ALU/PVC/PA/ALU 28 TABLETS; BLISTER ALU/PVC/PA/ALU 56 TABLETS; BLISTER ALU/PVC/PA/ALU 60 TABLETS; BLISTER ALU/PVC/PA/ALU 168 TABLETS; BLISTER ALU/PVC/PA/ALU 180 TABLETS; BLISTER ALU/PVC/PA/ALU 196 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD23 - metformin and ertugliflozin 161-71-35635-00 | SEGLUROMET 7.5/1000 MG | סגלורומט 7.5/1000 מ"ג | Segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:_x000D_ • in patients not adequately controlled on their maximally tolerated dose of metformin alone_x000D_ • in patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetes _x000D_ • in patients already being treated with the combination of ertugliflozin and metformin as separate tablets. _x000D_ | MERCK SHARP & DOHME CORP., USA | ONE MERCK DRIVE, POB 100, WHITEHOUSE STATION, NJ 08889-0100, USA | MERCK SHARP & DOHME ISRAEL LTD | POB 7121,PETAH-TIQVA 49170 | 31/12/2023 | 28/01/2019 | FILM COATED TABLETS | PER OS | METFORMIN 1000 MG ; ERTUGLIFLOZIN (L-PGA) 7.5 MG | BLISTER ALU/PVC/PA/ALU 14 TABLETS; BLISTER ALU/PVC/PA/ALU 28 TABLETS; BLISTER ALU/PVC/PA/ALU 56 TABLETS; BLISTER ALU/PVC/PA/ALU 60 TABLETS; BLISTER ALU/PVC/PA/ALU 168 TABLETS; BLISTER ALU/PVC/PA/ALU 180 TABLETS; BLISTER ALU/PVC/PA/ALU 196 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BD23 - metformin and ertugliflozin 142-78-31978-00 | ACROSE 50 | אקרוז 50 | Treatment of non-insulin dependent diabetes mellitus (NIDDM) in patients inadequately controlled on diet alone, or on diet and oral hypoglycaemic agents. | BLUEPHARMA INDUSTRIA FARMACEUT.S.A., PORTUGAL | SAO MARTINO DO BISPO,3045-16 COIMBRA,PORTUGAL | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/01/2025 | 31/01/2015 | TABLETS | PER OS | ACARBOSE 50 MG | BLISTER PVC/PE/PVDC/AL 30 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BF01 - Acarbose 142-79-31979-00 | ACROSE 100 | אקרוז 100 | Treatment of non-insulin dependent diabetes mellitus (NIDDM) in patients inadequately controlled on diet alone, or on diet and oral hypoglycaemic agents. | BLUEPHARMA INDUSTRIA FARMACEUT.S.A., PORTUGAL | SAO MARTINO DO BISPO,3045-16 COIMBRA,PORTUGAL | RAFA LABORATORIES LTD | POB 405,JERUSALEM 9100301,ISRAEL | 31/01/2025 | 31/01/2015 | TABLETS | PER OS | ACARBOSE 100 MG | BLISTER PVC/PE/PVDC/AL 30 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BF01 - Acarbose 149-69-33828-00 | ACTOS 15 MG | אקטוס 15 מ"ג | Pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below:_x000D_ as monotherapy _x000D_ - in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance_x000D_ as dual oral therapy in combination with_x000D_ - metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin_x000D_ - a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea._x000D_ as triple oral therapy in combination with _x000D_ - metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy._x000D_ - Pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance ._x000D_ After initiation of therapy with pioglitazone, patients should be reviewed after 3 to 6 months to assess adequacy of response to treatment (e.g. reduction in HbA1c)._x000D_ In patients who fail to show an adequate response, pioglitazone should be discontinued. In light of potential risks with prolonged therapy, prescribers should confirm at subsequent routine reviews that the benefit of pioglitazone is maintained ._x000D_ | TAKEDA PHARMA A/S, DENMARK | DYBENDAL ALLE 10, DK-2630 TAASTRUP, DENMARK | ABIC MARKETING LTD, ISRAEL | INDUSTRIAL ZONE, KIRYAT NORDAU, P.O.B. 8077, NETHANYA, ISRAEL | 31/03/2028 | 31/03/2018 | TABLETS | PER OS | PIOGLITAZONE AS HYDROCHLORIDE 15 MG | BLISTER ALUMINIUM /ALUMINIUM 14 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 28 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 50 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 56 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 84 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 90 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 98 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 112 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 196 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BG03 - Pioglitazone 149-70-33829-00 | ACTOS 30 MG | אקטוס 30 מ"ג | Pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below:_x000D_ as monotherapy _x000D_ - in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance_x000D_ as dual oral therapy in combination with_x000D_ - metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin_x000D_ - a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea._x000D_ as triple oral therapy in combination with _x000D_ - metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy._x000D_ - Pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance ._x000D_ After initiation of therapy with pioglitazone, patients should be reviewed after 3 to 6 months to assess adequacy of response to treatment (e.g. reduction in HbA1c)._x000D_ In patients who fail to show an adequate response, pioglitazone should be discontinued. In light of potential risks with prolonged therapy, prescribers should confirm at subsequent routine reviews that the benefit of pioglitazone is maintained ._x000D_ | TAKEDA PHARMA A/S, DENMARK | DYBENDAL ALLE 10, DK-2630 TAASTRUP, DENMARK | ABIC MARKETING LTD, ISRAEL | INDUSTRIAL ZONE, KIRYAT NORDAU, P.O.B. 8077, NETHANYA, ISRAEL | 31/03/2028 | 31/03/2018 | TABLETS | PER OS | PIOGLITAZONE AS HYDROCHLORIDE 30 MG | BLISTER ALUMINIUM /ALUMINIUM 14 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 28 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 50 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 56 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 84 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 90 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 98 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 112 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 196 TABLETS | HUMAN | כן | בסל עם הגבלה | A10BG03 - Pioglitazone 149-71-33830-00 | ACTOS 45 MG | אקטוס 45 מ"ג | Pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below:_x000D_ as monotherapy _x000D_ - in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance_x000D_ as dual oral therapy in combination with_x000D_ - metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin_x000D_ - a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea._x000D_ as triple oral therapy in combination with _x000D_ - metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy._x000D_ - Pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance ._x000D_ After initiation of therapy with pioglitazone, patients should be reviewed after 3 to 6 months to assess adequacy of response to treatment (e.g. reduction in HbA1c)._x000D_ In patients who fail to show an adequate response, pioglitazone should be discontinued. In light of potential risks with prolonged therapy, prescribers should confirm at subsequent routine reviews that the benefit of pioglitazone is maintained ._x000D_ | TAKEDA PHARMA A/S, DENMARK | DYBENDAL ALLE 10, DK-2630 TAASTRUP, DENMARK | ABIC MARKETING LTD, ISRAEL | INDUSTRIAL ZONE, KIRYAT NORDAU, P.O.B. 8077, NETHANYA, ISRAEL | 31/03/2028 | 31/03/2018 | TABLETS | PER OS | PIOGLITAZONE AS HYDROCHLORIDE 45 MG | BLISTER ALUMINIUM /ALUMINIUM 14 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 28 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 30 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 50 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 56 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 84 TABLETS; BLISTER ALUMINIUM /ALUMINIUM 90 TABLETS; BLISTER